fibrinogen has been researched along with Cardiovascular Stroke in 870 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 388 (44.60) | 18.7374 |
1990's | 204 (23.45) | 18.2507 |
2000's | 193 (22.18) | 29.6817 |
2010's | 73 (8.39) | 24.3611 |
2020's | 12 (1.38) | 2.80 |
Authors | Studies |
---|---|
Duan, Z; Fu, B; Han, D; Luo, C | 1 |
Božič Mijovski, M; Jug, B; Košuta, D; Novaković, M | 1 |
Ji, W; Li, Z; Sun, H; Teng, T; Yang, Q; Yu, Y; Zeng, S; Zhang, C; Zhou, X | 1 |
Brunskill, SJ; Champaneria, R; Dorée, C; Estcourt, LJ; Geneen, LJ; Gibbs, VN; Novak, A; Palmer, AJ; Raval, P | 1 |
Hou, XG; Ma, YT; Wu, TT; Xie, X; Yang, HT; Yang, Y; Zheng, YY | 1 |
Calderón, JM; Carratalá, A; Pozo, A; Rodríguez, E; Sanchis, J | 1 |
Bao, J; Gao, Z; Hu, Y; Liu, W; Wang, L; Ye, L | 1 |
Punjabi, PP | 1 |
Chen, YY; Dong, Y; Duan, L; He, XH; Liu, YM; Ma, RF; Wang, J; Wu, GJ; Yang, XC; Zhang, Y | 1 |
He, D; Li, Z; Song, J; Sun, Z; Yu, T | 1 |
Choe, CU; Jensen, M; Müller, C; Schwedhelm, E; Zeller, T | 1 |
Burns, JC; El-Said, H; Friedman, K; Gordon, JB; Newburger, JW; Tremoulet, AH | 1 |
Altschul, D; Benton, J; Boehme, AK; Cheng, NT; Dardick, J; Esenwa, C; Fernandez-Torres, J; Flomenbaum, D; Frontera, J; Goldman, I; Holland, R; Ishida, K; Kirchoff-Torres, K; Labovitz, D; Lendaris, A; Liberman, AL; Lord, A; Lu, J; Luna, J; Mabie, P; Malaviya, A; Moncrieffe, K; Patel, N; Seiden, J; Snyder, T; Soetanto, A; Toma, A; Torres, J; Willey, J; Yaghi, S | 1 |
Cui, CJ; Dong, Q; Du, Y; Gao, Y; Guo, YL; Li, JJ; Li, S; Li, XL; Qing, P; Sun, J; Wu, NQ; Xu, RX; Yang, SH; Zhang, Y; Zhu, CG | 1 |
Burke, DL; Jackson, D; Kirkham, J; Price, M; Riley, RD; Salanti, G; White, IR | 1 |
Ahluwalia, J; Das, R; Dogra, RK; Jamwal, M; Rohit, MK; Sharma, P; Vishwajeet, V | 1 |
Battah, A; El-Fattah, AAA; Nabil, M; Sadik, NAH; Sedrak, H | 1 |
Aguilar, E; Altes, P; Álvarez, LR; Esteban, C; García-Díaz, AM; Jiménez, PE; Monreal, M; Perez, P; Sahuquillo, JC; Sánchez Muñoz-Torrero, JF | 1 |
Kvaløy, JT; Midttun, Ø; Mjelva, ØR; Nilsen, DWT; Nordrehaug, JE; Nygård, O; Pedersen, EKR; Seifert, R; Svingen, GFT; Ueland, PM | 1 |
Jung, JM; Kim, SU; Kwon, DY; Park, JW; Park, MH | 1 |
Bugert, P; González Maldonado, S; Grafetstätter, M; Groß, ML; Hüsing, A; Johnson, T; Kaaks, R; Kloss, M; Kühn, T; Pletsch-Borba, L; Sookthai, D | 1 |
Bundred, PE; Kasielska-Trojan, A; Manning, JT; Mason, L; Smith-Straney, T | 1 |
Becker, DM; Becker, LC; Bielak, LF; Bielinski, SJ; Boerwinkle, E; Bowden, J; Brody, JA; Chasman, DI; Chen, YI; Davey Smith, G; de Maat, MPM; de Vries, PS; Dehghan, A; Delgado, G; Dörr, M; Franco, OH; Fu, YP; Giulianini, F; Groß, S; Guo, X; Hartwig, FP; Hemani, G; Huffman, JE; Johnson, AD; Jukema, JW; Kacprowski, T; Kardia, SLR; Kleber, ME; Koenig, W; März, W; Mathias, RA; McKnight, B; Meitinger, T; Morrison, AC; Müller-Nuraysid, M; O'Donnell, CJ; Pankratz, N; Peters, A; Petersman, A; Peyser, PA; Psaty, BM; Ridker, PM; Rotter, JI; Sattar, N; Smith, JA; Smith, NL; Song, C; Strauch, K; Tang, W; Taylor, KD; Tracy, R; Trompet, S; Uitterlinden, AG; Waldenberger, M; Ward-Caviness, CK; Wiggins, KL; Yanek, LR; Yao, J | 1 |
Braekkan, SK; Evensen, LH; Gabrielsen, ME; Hansen, JB; Hveem, K; Mathiesen, EB; Morelli, VM; Njølstad, I; Rinde, LB; Rosendaal, FR; Småbrekke, B | 1 |
Bacci, S; De Cosmo, S; Pacilli, A; Trischitta, V | 1 |
Fukui, T; Sasaki, K; Tabata, M; Takanashi, S | 1 |
Ajello, L; Assennato, P; Caruso, M; Castellano, F; Iacona, R; La Franca, E; Mancuso, D; Novo, S; Sansone, A | 1 |
Abdel Gader, AG; Al Aseri, Z; Habib, SS; Kurdi, MI; Suriya, MO | 1 |
Kofidis, T; Nithya, V; Plotkin, M; Rufaihah, AJ; Seliktar, D; Shen, J; Vaibavi, SR; Wang, J | 1 |
Gorczyca-Michta, I; Górska, R; Wożakowska-Kapłon, B; Włosowicz, M | 1 |
Bandinelli, S; Basu, S; Baumert, J; Becker, DM; Becker, LC; Bevan, S; Bis, JC; Boerwinkle, E; Boomsma, DI; Buckley, BM; Campbell, H; Chambers, JC; Chasman, D; Chen, MH; Clarke, R; Cucca, F; Curb, JD; Danesh, J; Davies, G; de Geus, EJ; Deary, IJ; Dehghan, A; Dichgans, M; Eaton, CB; Erdmann, J; Eriksson, JG; Eriksson, P; Ferrucci, L; Folkersen, L; Folsom, AR; Fornage, M; Franco, OH; Franco-Cereceda, A; Franzosi, MG; Gieger, C; Goel, A; Grant, PJ; Green, D; Gross, M; Grotevendt, A; Guo, X; Hamsten, A; Haritunians, T; Harris, SE; Hayward, C; Hofman, A; Homuth, G; Hopewell, JC; Hottenga, JJ; Huang, J; Huffman, JE; Ikram, MA; Illig, T; Jacobs, D; Johnson, AD; Jukema, JW; Kathiresan, S; Kocher, T; Koenig, W; Kolcic, I; Kooner, JS; Lahti, J; Liewald, DC; Liu, S; Lopez, LM; Lowe, GD; Lumley, T; Mälarstig, A; Markus, HS; McArdle, WL; McKnight, B; Mehra, R; Morange, PE; Mosley, TH; Naitza, S; Navarro, P; Nelson, CP; O'Donnell, CJ; Oudot-Mellakh, T; Palotie, A; Peters, A; Polasek, O; Psaty, BM; Pulanic, D; Räikkönen, K; Redline, S; Reilly, MP; Reiner, AP; Ridker, PM; Rivadeneira, F; Rose, LM; Rothwell, PM; Rotter, JI; Rudan, I; Rudnicka, AR; Rumley, A; Sabater-Lleal, M; Saleheen, D; Samani, NJ; Sanna, S; Sattar, N; Schlessinger, D; Schunkert, H; Seedorf, U; Sennblad, B; Seshadri, S; Shin, SY; Silveira, A; Smith, NL; Song, J; Soranzo, N; Spector, TD; Starr, JM; Steri, M; Stott, DJ; Strachan, DP; Strawbridge, RJ; Sudlow, CL; Swords Jenny, N; Tanaka, T; Tang, W; Tarasov, KV; Taylor, KD; Teichert, M; Teumer, A; Tofler, GH; Tracy, RP; Tregouet, D; Trompet, S; Uitterlinden, AG; van Dongen, J; Völzke, H; Wallace, R; Wallaschofski, H; Watkins, H; Widen, E; Wild, SH; Willemsen, G; Williams, FM; Wilson, JF; Witteman, JC; Wright, AF; Yanek, LR; Yao, J; Zemunik, T | 1 |
Badimon, L; Cubedo, J; Martin-Yuste, V; Padró, T; Ramaiola, I; Sabate-Tenas, M | 1 |
Gu, L; Huang, G; Liang, B; Liu, W; Su, L; Tan, J; Wu, G; Yan, Y | 1 |
Brunetti, ND; Correale, M; Cuculo, A; De Gennaro, L; Di Biase, M; Pellegrino, PL | 1 |
Baci, D; Bearzi, C; Condorelli, G; Fortunato, O; Gargioli, C; Kossover, O; Latronico, MV; Rizzi, R; Seliktar, D; Shapira-Schweitzer, K | 1 |
Dai, W; Li, Y; Lv, YN; Wei, CD; Zheng, HY | 1 |
Kim, EK; Kim, NY; Kwak, YL; Shim, JK; Song, JW | 1 |
Alwi, I; Atmakusumah, D; Aziz, A; Inggriani, S; Irawan, C; Kosasih, A; Lison, L; Reksodiputro, AH; Santoso, T; Saputra, A; Sudoyo, AW; Wintery, M | 1 |
Abbate, R; Bani, D; Becatti, M; Bruschi, G; Fiorillo, C; Gensini, GF; Giusti, B; Gori, AM; Marcucci, R; Taddei, N | 1 |
Chasman, DI; Elias, JA; Loscalzo, J; Ridker, PM; Rose, L | 1 |
Alonso-Orgaz, S; Barderas, MG; de la Cuesta, F; García, Á; González-Juanatey, JR; Grigorian-Shamagian, L; Guitián, E; Moreu, J; Ocaranza-Sánchez, R; Parguiña, AF; Rosa, I; Vélez, P | 1 |
Badimon, L; Cubedo, J; Juan-Babot, O; Martin-Yuste, V; Padró, T; Peña, E; Ramaiola, I; Sabate, M | 1 |
Bojiang, L; Li, J; Tong, L; Wenjin, P; Xiaomin, H; Xin, L; Yingwu, L; Yu, W; Yunyun, W | 1 |
Ádány, R; Balogh, E; Balogh, L; Bereczky, Z; Czuriga, I; Édes, I; Fiatal, S; Gindele, R; Katona, É; Mezei, ZA; Muszbek, L | 1 |
Averett, RD; Fan, NK; Keegan, PM; Platt, MO | 1 |
Assennato, P; Bellia, C; Bonomo, V; Ciaccio, M; Dieli, F; Fiore, M; Giovino, M; Meraviglia, S; Novo, G; Novo, S; Pugliesi, M; Sasso, BL | 1 |
Allouche, N; Derbali, F; Ellefi, H; Gammoudi, A; Gharsallah, N; Hajji, R; Kadri, A; Khabbabi, G; Mnafgui, K | 1 |
Barsova, RM; Favorov, AV; Favorova, OO; Karamova, IM; Kukava, NG; Kulakova, OG; Lvovs, D; Matveeva, NA; Mustafina, OE; Nasibullin, TR; Osmak, GJ; Ruda, MY; Shakhnovich, RM; Sukhinina, TS; Titov, BV; Tsareva, EY | 1 |
Forssell, H; Freitag, M; Halling, A; Lindblad, U; Odeberg, H; Odeberg, J; Persson, ML; Råstam, L; Vaara, I | 1 |
Ang, L; Behnamfar, O; Enright, K; Huynh, A; Kaushal, K; Li, S; Lin, F; Mahmud, E; Palakodeti, S; Patel, M; Ramsis, M; Reeves, R; Teh, P | 1 |
Cheng, WC; Cheow, ES; de Kleijn, D; Lee, CN; Sorokin, V; Sze, SK | 1 |
Bilecen, S; Brandon Bravo Bruinsma, GJ; de Groot, JA; Kalkman, CJ; Moons, KG; Nierich, AP; Spanjersberg, AJ | 1 |
Amouyel, P; Arveiler, D; Bingham, A; Canoui-Poitrine, F; Ducimetiere, P; Empana, JP; Evans, A; Ferrieres, J; Haas, B; Juhan-Vague, I; Luc, G; Montaye, M; Morange, P; Ruidavets, JB | 1 |
Applegate, RJ; Ketch, TR; Kutcher, MA; Lingle, KC; Sacrinty, MT; Sane, DC; Turner, SJ | 1 |
Fefer, P; Hod, H; Matetzky, S; Savion, N; Shenkman, B; Varon, D | 1 |
Antoniades, C; Bellander, T; Chalamandaris, AG; Greven, S; Jacquemin, B; Koenig, W; Müller, M; Nyberg, F; Peters, A; Pistelli, R; Plana, E; Salomaa, V; Sunyer, J | 1 |
Ahmad-Nejad, P; Borggrefe, M; Elmas, E; Neumaier, M; Weiss, C | 1 |
Landoni, G | 1 |
Criado Jimenez, A; Moreno Gomez Limon, I; Palomero Rodríguez, MA; Suarez Gonzalo, L; Varela Crespo, C; Villar Alvarez, F | 1 |
Gu, DF; Huang, JF; Lu, XF; Wang, LY; Yu, HJ; Zhou, XY | 1 |
Assad, JA; Buja, LM; Coulter, S; Fernandes, MR; Perin, EC; Silva, GV; Sousa, AL; Vela, DC; Willerson, JT | 1 |
Baum, SR; Baum, VA; Nikitin, YP; Polonskaya, YV; Ragino, YI; Sadovski, EV | 1 |
Baldari, F; Bellander, T; Breitner, S; Chrysohoou, C; Greven, S; Heid, IM; Illig, T; Jacquemin, B; Koenig, W; Lanki, T; Nyberg, F; Pekkanen, J; Peters, A; Pistelli, R; Rückerl, R; Schneider, A; Stefanadis, C; Sunyer, J; Wichmann, HE | 1 |
Algra, A; Rosendaal, FR; Siegerink, B | 1 |
Amoroso, GR; Assennato, P; Balistreri, CR; Caruso, C; Caruso, M; Coppola, G; Fazio, G; Hoffmann, E; Novo, G; Novo, S; Rotolo, A; Turturici, C | 1 |
Baccarelli, A | 1 |
Fountoulaki, K; Gialeraki, A; Kremastinos, DT; Lekakis, I; Politou, M; Rallidis, LS; Sourides, V; Travlou, A | 1 |
Agewall, S; Henareh, L; Jogestrand, T | 1 |
Blauw, GJ; Buckley, BM; Cobbe, S; de Craen, AJ; Ford, I; Jukema, JW; Lowe, GD; Macfarlane, PW; Murphy, MB; Murray, HM; Packard, CJ; Sattar, N; Shepherd, J; Stott, DJ; Welsh, P; Westendorp, RG | 1 |
Aktoz, M; Ozcelik, F; Tatli, E | 1 |
Abd el-Kader, SS; Abu el-Makrem, MA; Ghazaly, T; Mahmoud, YZ; Matta, R; Nassef, NM; Sayed, D; Zakhary, M | 1 |
Bellander, T; de Faire, U; Leander, K; Ljungman, P; Nyberg, F; Panasevich, S; Pershagen, G; Rosenlund, M | 1 |
Eshraghian, A; Izadi, HR; Naghshvar, F; Pourahmad, M; Shojaie, M | 1 |
Jax, TW; Peters, AJ; Plehn, G; Schoebel, FC | 1 |
Bellander, T; Breitner, S; Forastiere, F; Hampel, R; Illig, T; Jacquemin, B; Katsouyanni, K; Koenig, W; Lanki, T; Ljungman, P; Nyberg, F; Pekkanen, J; Peters, A; Pistelli, R; Pitsavos, C; Rosenqvist, M; Schneider, A; Sunyer, J; von Klot, S | 1 |
Baum, SR; Baum, VA; Nikitin, IuP; Polonskaia, IaV; Ragino, IuI | 1 |
Chakravarti, A; Couper, DJ; Folsom, AR; Kucharska-Newton, AM; Pankow, JS; Prineas, RJ; Rea, TD; Rosamond, WD; Siscovick, DS; Sotoodehnia, N | 1 |
Mocatta, TJ; Paton, LN; Richards, AM; Winterbourn, CC | 1 |
Grønbaek, M; Nordestgaard, BG; Tolstrup, JS | 1 |
Carru, C; Deiana, L; Franconi, F; Maoddi, I; Mureddu, G; Musino, L; Partenza, A; Pilo, P; Rossi, R; Spazzafumo, L; Zinellu, A | 1 |
Carty, CL; Cushman, M; Heagerty, P; Heckbert, SR; Jarvik, GP; Lange, LA; Reiner, AP; Tracy, RP | 1 |
Deev, AD; Metel'skaia, VA; Perova, NV; Ratnikova, LA; Shal'nova, SA; Shkol'nikov, VM; Shkol'nikova, MA | 1 |
Barbieri, M; Boccardi, V; Esposito, A; Marfella, R; Paolisso, G; Papa, M; Portoghese, M; Rizzo, MR | 1 |
Abbas, CC; Begré, S; Haeberli, A; Saner, H; Schmid, JP; Stutz, M; von Känel, R | 1 |
Sinkovic, A | 1 |
Ahn, Y; Cho, JS; Hong, YJ; Jeong, MH; Kim, W | 1 |
Arbel, Y; Banai, S; Berliner, S; Chundadze, T; Finkelstein, A; Halkin, A; Keren, G; Leshem-Rubinow, E; Rogowski, O; Steinvil, A | 1 |
Beer, JH | 1 |
Dennis, M; Jackson, C; Lewis, S; Lowe, G; Rumley, A; Sandercock, P; Sudlow, C; Wardlaw, J; Whiteley, W | 1 |
Avellone, G; Campisi, D; Di Garbo, V; Guarnotta, V; Parrinello, G; Purpura, L; Scaglione, R; Torres, D | 1 |
Bălşeanu, AT; Dănoiu, S; Iancu, I; Mitran, SI; Moţa, M; Pisoschi, C; Riza, A; Sfredel, V | 1 |
Androulakis, E; Antoniades, C; Briasoulis, A; Papageorgiou, N; Stefanadis, C; Tousoulis, D | 1 |
Arbel, G; Aronson, D; Caspi, O; Gepstein, A; Gepstein, L; Habib, M; Seliktar, D; Shapira-Schweitzer, K | 1 |
Frikke-Schmidt, R; Grande, P; Haase, CL; Hornstrup, LS; Nordestgaard, BG; Sillesen, H; Tybjærg-Hansen, A | 1 |
Caulfield, MJ; Kiechl, S; Morris, GE; Motterle, A; Pender, SL; Willeit, J; Xiao, Q; Ye, S | 1 |
Chen, Y; Jin, Z; Li, H; Lv, S; Song, X; Xu, F; Yuan, F; Zhou, Y | 1 |
Baumert, J; Greven, S; Karakas, M; Koenig, W; Peters, A; Rückerl, R | 1 |
Figueras, J; Garcia-Dorado, D; Lidón, RM; Monasterio, J; Sambola, A | 1 |
Bongo, AS; Colli, E; Ferraro, S; Galvani, M; Maffé, S; Marano, G; Panteghini, M; Rossi, L; Santagostino, M; Vendramin, C | 1 |
Doğan, A; Erdogan, D; Icli, A; Varol, E | 1 |
Kacprzak, M; Kidawa, M; Zielińska, M | 1 |
Bakhshaliev, AB; Gadzhiev, RF; Gamidova, ÉS; Kerimova, KN | 1 |
Gong, YJ; Huo, Y; Li, JP; Liu, ZP; Momin, M; Wang, CY; Wang, XG; Zhang, Y; Zheng, B | 1 |
Chu, JY; Huang, XQ; Li, JM; Lin, KQ; Qi, L; Sun, H; Yang, ZQ | 1 |
Dahl, M; Lange, P; Nordestgaard, BG; Thomsen, M; Vestbo, J | 1 |
Dincić, D; Gligić, B; Jovelić, A; Obradović, S; Ratković, N; Vukotić, S | 1 |
Filipiak, KJ; Kołtowski, L; Opolski, G; Rdzanek, A; Stępień, V; Tarchalska-Kryńska, B | 1 |
Bova, M; Caruso, C; Caruso, M; Forte, GI; Lio, D; Massenti, MF; Novo, S; Palmeri, M; Scola, L; Vaccarino, L; Vitale, F; Vitale, S | 1 |
Ang, L; Ilapakurti, M; Lee, MS; Mahmud, E; Palakodeti, V; Thani, KB | 1 |
Chavance, M; Marti, H | 1 |
Almenar Bonet, L; Arnau Vives, MA; Martínez Dolz, LV; Morillas Blasco, P; Osa Sáez, A; Osca Asensi, J; Palencia Pérez, MA; Quesada Carmona, A; Rueda Soriano, J; Sanjuán Máñez, R | 1 |
Aggarwal, A; Gennari, FJ; Kabbani, SS; Rimmer, JM; Schneider, DJ; Sobel, BE; Taatjes, DJ | 1 |
Borrás Pallé, S; Campos Ferrer, C; Gómez Martínez, E; Molina, E; Romero Rodrigo, A; Valentín Segura, V | 1 |
Angelino, P; Aruta, E; Bigi, R; Figura, N; Gai, V; Gandolfo, N; Parravicini, PP; Pellicano, R; Ponzetto, A; Rizzetto, M | 1 |
Blasco, ML; Bodí, V; Chorro, FJ; Facila, L; Gómez-Aldaraví, R; Insa, L; Llácer, A; Mainar, L; Monmeneu, JV; Núñez, J; Sanchis, J; Sanjuan, R | 1 |
Dimcevski, G; Helleberg, I; Holm, J; Kristensen, L; Montvilas, P; Mouritsen, E; Suciu, G; von Eyben, FE; von Eyben, R | 1 |
De Faire, U; Falk, G; Hallqvist, J; Leander, K; Wiman, B | 1 |
Büttcher, E; Ehlers, R; Eltzschig, HK; Helber, U; Hoffmeister, HM; Kazmaier, S; Szabo, S | 1 |
Franz, IW; Hopfenmüller, W; Müller, JF; Röcker, L; Tönnesmann, U; Van Der Meyden, J | 1 |
Cui, X; Dang, Q; Huang, F; Ji, M; Jiang, Y; Li, J; Liu, R; Mu, H; Wang, Y | 1 |
Amouyel, P; Arveiler, D; Dos Santos, C; Evans, A; Ferrières, J; Juhan-Vague, I; Luc, G; Scarabin, PY | 1 |
Antonova, OA; Dudnik, OA; Khaspekova, SG; Mazurov, AV; Pevzner, DV; Ruda, MIa; Samko, AN; Semenov, AV; Staroverov, II; Vlasik, TN | 1 |
Browett, PJ; Cooke, G; French, JK; Gao, W; Goldschmidt-Clermont, P; Liu-Stratton, Y; Lund, M; McDowell, J; Pohorence, J; Sutton, TM; Szymanski, D; Van de Water, NS; White, HD | 1 |
Bell, WR | 1 |
Aliev, OI; Maslov, MJ; Plotnikov, MB; Tjukavkina, NA; Vasiliev, AS | 1 |
Grip, L; Linder, R; Nørgaard, BL; Oldgren, J; Siegbahn, A; Wallentin, L | 1 |
Bartosik-Baschton, A; Baschton, M; Spyra, J; Szczesny, S; Szyguła, J; Słowińska, L; Turczyński, B; Wodniecki, J | 1 |
Amouyel, P; Arveiler, D; Bard, JM; Ducimetiere, P; Evans, A; Ferrieres, J; Fruchart, JC; Juhan-Vague, I; Luc, G | 1 |
Grant, PJ | 1 |
Jaeger, BR | 1 |
Liu, Q; Ma, X; Wang, Y; Yuan, Z; Zhu, J | 1 |
Bennermo, M; Ericsson, CG; Hamsten, A; Hansson, LO; Held, C; Strandberg, LE; Tornvall, P | 1 |
GILCHRIST, E; TULLOCH, JA | 1 |
LOSNER, S; VOLK, BW; WILENSKY, ND | 1 |
LINKO, E; WARIS, E | 1 |
CRASTNOPOL, P; LOSNER, S; VOLK, BW | 2 |
FRADKINA, VE | 1 |
HOLGER-MADSEN, T | 1 |
PHEAR, D; STIRLAND, R | 1 |
RECHENBERGER, J | 1 |
LASCH, F; THEINL, K | 1 |
GILLUM, GN; GORENSTEIN, I; GRAHAM, WK; HAMILTON, A; STEINBERG, MS | 1 |
KOZLOVA, VN; SANDLER, RI | 1 |
DJORDJEVIC, BS; STRASER, T | 1 |
RAEVSKAIA, GA | 1 |
KOZHEVNIKOVA, TL | 1 |
IRANI, MA | 1 |
BRITOV, AN | 1 |
BAYLES, TB; FINKELSTEIN, AE; LEVINE, HD; SMITH, JC; WOERNER, TE | 1 |
HELLE, I | 1 |
EASTHAM, RD; MORGAN, EH | 1 |
JAROSCHEWSKI, AJ; SHAWORONKOWA, EK | 1 |
FREMONT, RE | 1 |
DOBROVOLSKAIA, TI | 1 |
IAROSHEVSKII, AIa; ZHAVORONKOVA, EK | 1 |
VONKAULLA, E; VONKAULLA, KN | 1 |
COTTON, RC; WADE, EG | 1 |
KISELEVA, EN; PETROVA, TR | 1 |
HUME, R | 1 |
FULLERTON, HW; OGSTON, D | 1 |
Cesar, LA; Lemos, PA; Mansur, AP; Maranhão, RC; Ramires, JA; Sposito, AC | 1 |
Jaeger, BR; Labarrere, CA | 1 |
Elikowski, W; Kwaśnikowski, P; Lewandowski, K; Zawilska, K | 1 |
Lowe, GD; Morrison, CE; Nieuwenhuizen, W; Rumley, A; Woodward, M | 1 |
Brennan, SO; George, PM; Maghzal, GJ | 1 |
Engström, G; Hedblad, B; Janzon, L; Lind, P; Lindgärde, F; Stavenow, L; Tydén, P | 1 |
Engström, G; Hedblad, B; Janzon, L; Lind, P; Lindgärde, F; Stavenow, L | 2 |
Bal dit Sollier, C; Choussat, R; Collet, JP; Dalby, M; Drobinski, G; Drouet, L; Gallois, V; Montalescot, G; Soulat, T; Thomas, D; Vicaut, E | 1 |
Aznar, J; Contreras, MT; Corella, D; Falcó, C; Martínez-Sales, V; Réganon, E; Vayá, A; Vila, V | 1 |
Abrams, CS; Cines, DB | 1 |
Martin, F; Martin-Luengo, C; Morinigo, JL; Pabon, P; Palacios, IF; Piedra, I; Sanchez, PL | 1 |
Amighi, J; Exner, M; Minar, E; Mlekusch, W; Sabeti, S; Schillinger, M; Schlager, O; Wagner, O | 1 |
Connor, JM; Cooke, A; Fowkes, FG; Lee, AJ; Lowe, GD; Rumley, A; Smith, FB | 1 |
Amighi, J; Exner, M; Minar, E; Mlekusch, W; Muellner, M; Rumpold, H; Sabeti, S; Schillinger, M; Wagner, O | 1 |
Basili, S; Bertazzoni, G; Di Francoi, M; Diurni, V; Ferroni, P; Rosa, A; Scarpellini, MG | 1 |
Benes, M; Hermens, WT; Richter, R; Speijer, H | 1 |
Byrne, CE; Cannon, CP; Fitzgerald, A; Fitzgerald, DJ; Shields, DC | 1 |
Engström, G; Hedblad, B; Janzon, L; Jonsson, S; Lind, P; Lindgärde, F; Stavenow, L | 1 |
Fujii, A; Funabiki, M; Morikawa, Y; Nishida, Y; Nishizaki, K; Seki, T | 1 |
Ford, I; Lowe, GD; McMahon, AD; O'Reilly, DS; Packard, CJ; Rumley, A | 1 |
Bergovec, M; Mirat, J; Raguz, M; Raos, V; Romić, Z; Sikić-Vagić, J | 1 |
Aznar, J; Breña, S; Contreras, MT; Corella, D; Martinez-Sales, V; Réganon, E; Vayá, A; Vila, V; Zorio, E | 1 |
Dedobbeleer, C; Melot, C; Renard, M | 1 |
Longstaff, C; Whitton, CM | 1 |
Alte, D; Felix, SB; John, U; Robinson, DM; Schwahn, C; Völzke, H | 1 |
Algra, A; Clark, TG; Gutnikov, SA; Howard, SC; Murphy, MF; Power, DA; Rothwell, PM; van Gijn, J; Warlow, CP | 1 |
Bartnik, M; Efendic, S; Hamsten, A; Malmberg, K; Norhammar, A; Ohrvik, J; Rydén, L; Silveira, A; Tenerz, A | 1 |
Ghosh, K; Khare, A; Kulkarni, B; Mohanty, D; Shetty, S | 1 |
Mazurov, AV; Voskoboĭ, IV | 1 |
Alonso-Orgaz, S; Burgos, ME; Carrasco, C; de Andrés, R; Farré, J; García-Méndez, A; Gómez, J; Granizo, JJ; López Farré, A; Macaya, C; Mateos-Cáceres, PJ; Núñez, A; Rico, LA | 1 |
Agache, I; Bobescu, E; Rădoi, M | 1 |
Chudakova, DA; Minushkina, LO; Nosik, VV; Zateĭshchikov, DA | 1 |
Aillaud, MF; di Minno, G; Eriksson, P; Hamsten, A; Hawe, E; Humphries, S; Juhan-Vague, I; Mannila, MN; Margaglione, M; Mussoni, L; Silveira, A; Tremoli, E; Yudkin, J | 1 |
Cavallini, C; Doggen, CJ; Mannucci, PM; Martini, CH; Rosendaal, FR | 1 |
Bertomeu, V; Bodí, V; Chorro, FJ; Fácila, L; Llàcer, A; Núñez, J; Pellicer, M; Sanchis, J | 1 |
Dimcevski, G; Holm, J; Kristensen, LL; Montvilas, P; Mouritsen, EA; Rasmussen, IH; Suciu, G; Von Eyben, FE; Von Eyben, R | 1 |
Kirbis, J; Milutinović, A; Poglajen, G | 1 |
Ahn, YK; Cho, JG; Hong, SN; Hong, YJ; Hur, SH; Hyun, DW; Jeong, MH; Kang, DG; Kang, JC; Kim, JH; Kim, KB; Kim, KH; Kim, W; Lee, SH; Lee, YS; Lim, SY; Park, HW; Park, JC; Yun, KH | 1 |
Boquist, S; Ericsson, CG; Eriksson, P; Hamsten, A; Lundman, P; Mannila, MN; Samnegård, A; Silveira, A; Tornvall, P | 1 |
Duarte, Eda R; Pellanda, LC; Portal, VL | 1 |
Battler, A; Ben-Dor, I; Haim, M; Harell, D; Hasdai, D; Iakobishvili, Z; Murininkas, D; Nahon, M; Porter, A; Rechavia, E; Scapa, E | 1 |
Bertomeu, V; Bodí, V; Chorro, FJ; Fácila, L; Llàcer, A; Núñez, J; Pellicer, M; Ruiz, V; Sanchis, J | 1 |
Demircan, S; Durna, K; Sahin, M; Yazici, M | 1 |
Abrignani, MG; Braschi, A; Braschi, G; Coppola, G; Corrado, E; Di Girolamo, A; Novo, S; Rizzo, M | 1 |
Dinesen, B; Eliasson, M; Lundblad, D; Rautio, A; Røder, ME | 1 |
Evers, S; Hennersdorf, M; Jax, T; Schwalen, A; Steiner, S; Strauer, BE | 1 |
Bibis, GP; Cokkinos, DV; Foussas, SG; Glyptis, MP; Kardoulas, AD; Lyras, AG; Makrygiannis, SS; Patsourakos, NG; Prekates, AA; Zairis, MN | 1 |
Grønbaek, M; Jensen, MK; Manson, JE; Mukamal, KJ; Pischon, T; Rimm, EB; Stampfer, MJ | 1 |
Gardemann, A; Haberbosch, W | 1 |
Albertini, F; Archetti, S; Assanelli, D; Galeazzi, G; Grassi, M; Mozzini, C; Negrini, R; Pezzini, A; Salvadori, G | 1 |
Amouyel, P; Arocha-Piñango, CL; Arveiler, D; Assmann, G; Bauer, KA; Ben-Shlomo, Y; Benderly, M; Bingham, A; Brunner, E; Campos, G; Cantin, B; Collins, R; Cooper, JA; Cremer, P; Curb, JD; Cushman, M; D'Agostino, R; Dagenais, GR; Danesh, J; Davey Smith, G; de Maat, MP; De Stavola, B; Després, JP; Dickinson, A; Diez-Ewald, MP; Ducimetiere, P; Elwood, PC; Eriksson, H; Espinosa, R; Evans, AE; Fernandez, V; Ferrieres, J; Feskens, EJ; Folsom, AR; Ford, I; Fowkes, FG; Goldbourt, U; Harald, K; Haverkate, F; Hedblad, B; Ireland, B; Jousilahti, P; Juhan-Vague, I; Juzwishin, K; Kannel, WB; Kaptoge, S; Kiechl, S; Kitamura, A; Knottenbelt, C; Koenig, W; Kostis, JB; Kromhout, D; Lamarche, B; Lappas, G; Lee, AJ; Lewington, S; Lind, P; Loewel, H; Lowe, GD; Marchioli, R; Meade, TW; Memon, A; Mijares, M; Miller, GJ; Nagel, D; Nagy, E; Naito, Y; Nyyssönen, K; Palmieri, V; Palosuo, T; Pekkanen, J; Psaty, BM; Rasi, R; Ridker, P; Robertson, M; Rodeghiero, F; Rodriguez, B; Rodriguez-Larralde, A; Rodriquez-Roa, E; Rosenberg, RD; Rosengren, A; Rudnicka, A; Ryder, E; Salomaa, V; Salonen, JT; Sarwar, N; Sato, S; Schulte, H; Shepherd, J; Shipley, M; Smith, FB; Sweetnam, PM; Thompson, SG; Tofler, G; Torres, E; Tosetto, A; Tracy, RP; Tunstall-Pedoe, H; Tuomainen, TP; Tybjaerg-Hansen, A; Vahtera, E; Valagussa, F; Walker, M; Wheeler, J; White, I; Wilhelmsen, L; Willeit, J; Wilson, AC; Wilson, PW; Wood, A; Woodward, M; Wu, K; Yano, K; Yarnell, JW; Yeh, JL | 1 |
Aloui, H; Annabi, N; Ben Khalfallah, A; Naffeti, S; Ousji, M; Sanaa, I | 1 |
Ginsburg, D | 1 |
Brovkin, AN; Chudakova, DA; Dankovtseva, EN; Gaĭdukova, NV; Koroleva, OS; Nosikov, VV; Sidorenko, BA; Tishchenko, VA; Zateĭshchikov, DA | 1 |
Bertina, RM; DE Visser, MC; Doggen, CJ; Rosendaal, FR; Uitte DE Willige, S | 1 |
Bella, JN; Best, LG; Devereux, RB; Kizer, JR; Lee, ET; Liu, JE; Palmieri, V; Roman, MJ | 1 |
Pavlova, TV | 1 |
Suggs, L; Wang, X; Wang, Z; Zhang, G; Zhang, J | 1 |
Ericsson, CG; Eriksson, P; Hamsten, A; Mannila, MN; Silveira, A | 1 |
Stepien, E; Szczeklik, A; Tracz, W; Undas, A | 1 |
Petzelbauer, P; Reingruber, S; Zacharowski, K; Zacharowski, P | 1 |
Adler, Y; Behar, S; Benderly, M; Fisman, EZ; Goldbourt, U; Haim, M; Matas, Z; Tanne, D; Tenenbaum, A; Zimmlichman, R | 1 |
Adler, Y; Behar, S; Benderly, M; Boyko, V; Esper, RJ; Fisman, EZ; Matas, Z; Tanne, D; Tenenbaum, A | 1 |
Balion, C; Bickel, C; Blankenberg, S; Cambien, F; Gerstein, H; Lonn, E; McQueen, MJ; Münzel, T; Pogue, J; Rupprecht, HJ; Smieja, M; Tiret, L; Yusuf, S | 1 |
Allali, Y; Ankri, A; Blanchet, B; Collet, JP; Dumaine, R; Gianetti, J; Lesty, C; Montalescot, G; Payot, L; Silvain, J; Tanguy, ML; Weisel, JW | 1 |
Osadnik, T; Poloński, L; Wasilewski, J | 1 |
Bodanese, LC; Carrion, LJ; Guaragna, JC; Jaeger, CP; Kalil, RA; Petracco, JB | 1 |
Armaganijan, D; Batlouni, M; de Quateli Doi, S; Hirata, MH; Hirata, RD; Luchessi, AD; Picciotti, R; Sampaio, MF; Santos, FC | 1 |
Bickel, C; Blankenberg, S; Espinola-Klein, C; Lackner, KJ; Lubos, E; Messow, CM; Münzel, T; Rupprecht, HJ; Schnabel, R; Sinning, JM; Tiret, L | 1 |
de Faire, U; Eriksson, P; Hamsten, A; Leander, K; Mannila, MN; Silveira, A; Wiman, B | 1 |
Adány, R; Balogh, E; Bereczky, Z; Czuriga, I; Edes, I; Kárpáti, L; Katona, E; Muszbek, L; Pocsai, Z; Széles, G | 1 |
Eriksson, P; Farrell, DH; Hamsten, A; Kazmierczak, SC; Lovely, RS; Mannila, MN; Samnegård, A; Silveira, A | 1 |
Horstkotte, D; Jaster, M; Knie, W; Pauschinger, M; Rauch, U; Schultheiss, HP; Spencker, S; Stellbaum, C; Willich, T | 1 |
Cruz-Flores, S | 1 |
Boehm, O; Emeis, JJ; Friedl, P; Henning, R; Koch, A; Mastan, P; Petzelbauer, P; Reingruber, S; Rother, RP; Zacharowski, K; Zacharowski, PA | 1 |
Hu, Q; Nakamura, Y; Suggs, LJ; Wang, X; Zhang, G; Zhang, J | 1 |
Bennermo, M; Ekström, M; Eriksson, P; Silveira, A; Tornvall, P | 1 |
Ehlert, U; Emini, L; Groessbauer, S; Rüdisüli, K; von Känel, R; Wirtz, PH | 1 |
Balogh, E; Bereczky, Z; Czuriga, I; Edes, I; Kárpáti, L; Katona, E; Muszbek, L; Shemirani, AH | 1 |
Aalto, P; Antoniades, C; Bellander, T; Berglind, N; Chrysohoou, C; Forastiere, F; Greven, S; Jacquemin, B; Koenig, W; Küchenhoff, H; Lanki, T; Ljungman, P; Pekkanen, J; Perucci, CA; Peters, A; Rückerl, R; Schneider, A; Sunyer, J; von Klot, S | 1 |
Baskot, B; Djenić, N; Gligić, B; Miailović, Z; Obradović, S; Orozović, V; Rafajlovski, S; Ratković, N | 1 |
Boothroyd, D; Fortmann, SP; Go, AS; Hlatky, MA; Iribarren, C; Itakura, H; Leung, LL; Quertermous, T; Sobel, BE | 1 |
Algra, A; Howard, SC; Rothwell, PM | 1 |
MEYERS, L | 1 |
Crawley, JT; Lane, DA; Lowe, GD; Rumley, A; Woodward, M | 1 |
Biele, J; Hoppmann, P; Kastrati, A; Koch, W; Mueller, JC; Schömig, A | 1 |
Archetti, S; Assanelli, D; Grassi, M; Kisialiou, A; Mozzini, C; Pezzini, A | 1 |
Coma-Canella, I; Martínez de Sizarrondo, S; Orbe, J; Páramo, JA; Rodríguez, JA; Serrano, R; Zudaire, M | 1 |
Carlson, CS; Carty, CL; Cushman, M; Durda, JP; Hindorff, LA; Jenny, NS; Jones, D; Lange, LA; Nickerson, D; Reiner, AP; Rice, K; Tracy, RP; Walston, J | 1 |
Doggen, CJ; Rosendaal, FR; van der Bom, JG; van der Krabben, MD | 1 |
Billing, E; Held, C; Karlsson, MR; Plüss, CE; Wallen, N | 1 |
Bellander, T; Jacquemin, B; Katsouyanni, K; Koenig, W; Lanki, T; Löwel, H; Panagiotakos, D; Peters, A; Picciotto, S; Schneider, A; Stafoggia, M | 1 |
Arizo, D; Corella, D; Murado, J; Rueda, J; Simó, M; Vayá, A; Zorio, E | 1 |
Bang, HO; Ditzel, J; Thorsen, N | 2 |
Cepelák, V; Cepeláková, H; Dvorák, J | 1 |
Bell, WR; Reiner, AP | 1 |
Harenberg, J; Weber, E; Zimmermann, R | 1 |
Blömer, H; Keisel, I; Theiss, W; Volger, E; Wirtzfeld, A | 1 |
Burridge, DJ; Maskill, MR; O'Connor, JF; O'Malley, BP; Simmonds, JP | 1 |
Ikkala, E; Rasi, V; Torstila, I | 1 |
Brunetti, A; Cafiero, F; de Zio, A; Girolami, A; Gribaldo, A; Patrassi, GM | 1 |
Cannon, PJ; Kaplan, KL; Nichols, AB; Nossel, HL; Owen, J; Sciacca, RR | 1 |
Dormandy, J; Ernst, E; Flute, PT; Matrai, A | 1 |
Douglas, JT; Forbes, CD; Lowe, GD; Prentice, CR | 1 |
Bertina, R; Briët, E; Kolff, J; van der Laarse, A; van Hulsteijn, H | 1 |
Goldenberg, E; Haines, AP; Howarth, D; Meade, TW; Millar Craig, MW; North, WR; Raftery, EB; Stirling, Y | 1 |
Movshovich, BL | 1 |
Goodnough, LT; Ratnoff, OD; Saito, H | 1 |
Dormandy, JA | 3 |
Hladovec, J; Prerovský, I | 1 |
Cristea, A; Cucuianu, MP; Missits, I; Pechet, L; Roman, S; Rus, H | 1 |
Drexler, M; Erbel, R; Kasper, W; Meinertz, T; Meyer, J; Pop, T; Prellwitz, W; Rückel, A | 1 |
Godal, HC; Holm, B | 2 |
Biland, L; Christe, M; Delley, A; Duckert, F; Marbet, GA | 1 |
Buchbinder, N; Charuzi, Y; Fishbein, MC; Ganz, W; Kass, R; Maddahi, J; Marcus, H; Miyamoto, A; Mondkar, A; O'Connor, L; Shell, W; Swan, HJ | 1 |
Barbakar', NG; Mazaev, AV; Suvorova, LA | 1 |
Brayden, GP; Ferguson, DW; Kelly, KJ; Kioschos, JM; Marcus, ML; Schwartz, JL; White, CW | 1 |
Beiküfner, P; Panzram, G; Schmechel, H | 1 |
Deriagina, GP | 1 |
Bergmann, SR; Collen, D; de Geest, H; Fox, KA; Ludbrook, PA; Sobel, BE; Tiefenbrunn, AJ; Van de Werf, F; Verstraete, M | 1 |
Fallon, JT; Gold, HK; Grossbard, E; Guerrero, JL; Hoyng, CF; Khaw, BA; Leinbach, RC; Newell, JB; Vislosky, FM; Yasuda, T | 1 |
Neidhardt, B; Schricker, KT; Weniger, J | 1 |
Godal, HC; Holm, B; Kierulf, P | 1 |
Babu, NS; Dixon, J; Frederiksen, R; Kaiser, AB; Kaplan, P; Page, HL; Roach, A; Tacogue, L; Tennant, SN; Venable, TC | 1 |
Krosch, H; Schäbitz, J | 2 |
Bar-Ilan, I; Cristal, N; Hart, A; Slonim, A | 1 |
Gopal, R; Gupta, B; Prasad, DN; Saxena, KK; Srivastava, RK; Srivastava, SS | 1 |
Acciavatti, A; Del Bigo, C; Di Perri, T; Forconi, S; Galigani, C; Guerrini, M; Pieragalli, D | 1 |
Arrigo, F; Barbera, CM; Consolo, F; Giannetto, M | 1 |
Assennato, P; Caimi, G; Raineri, A; Sarno, A | 1 |
Haeberli, A; Im Hof, V; Mombelli, G; Straub, PW | 1 |
Ganz, W; Geft, IL; Lew, AS; Neer, T; Rodriguez, L; Shah, PK | 1 |
Korsan-Bengtsen, K; Larsson, B; Svärdsudd, K; Tibblin, G; Welin, L; Wilhelmsen, L | 1 |
Amtorp, O; Gormsen, J; Knudsen, JB; Skagen, K | 1 |
Abbate, R; Favilla, S; Gensini, GF; Neri Serneri, GG | 1 |
Cucuianu, MP; Missits, I; Olinic, N; Roman, S | 1 |
Cowley, MJ; Fisher, LM; Garrett, R; Hastillo, A; Hess, ML; Vetrovec, GW | 1 |
Barker, AF | 1 |
Caprissi, LF; Castellanos, H; de Caprissi, ES; Ruggiero, HA; Ruggiero, LH | 1 |
Haas, R; Harenberg, J; Zimmermann, R | 2 |
Davies, MJ; Woolf, N | 1 |
Gofferje, H; Horbach, L; Ollenschläger, G; Prestele, H; Schultis, K | 1 |
Caimi, G; Raineri, A; Sarno, A | 1 |
Cristal, N; Hagay, Z; Hart, A; Ronen, M; Silverman, C; Slonim, A | 1 |
Baughman, DJ; Kostis, JB; Kuo, PT | 1 |
Caprissi, ES; Caprissi, LF; Castellanos, H; Ruggiero, HA | 1 |
Descovich, GC; Gaddi, A; Lenzi, S | 1 |
Carvalho, A; Gold, HK; Haber, E; Khaw, BA; Locke, E; Strauss, HW | 1 |
Gopal, R; Gupta, B; Prasad, DN; Saxena, KK; Singh, RC; Srivastava, RK; Srivastava, SS | 1 |
de Boer, AC; den Ottolander, GJ; Jonker, JJ; Peters, SH | 1 |
Löfmark, R | 1 |
Alkjaersig, N; Fletcher, AP | 1 |
Assennato, P; Caimi, G; Catania, A; Raineri, A; Sarno, A | 1 |
Bolińska, H; Judkiewicz, L; Khawam, E; Niewiarowska, J; Wasiak-Radzikowska, M | 1 |
Geissler, D; Hörtnagl, H; Kunz, F; Zwierzina, WD | 1 |
Allen, J; Bennett, ED; Boyd, MJ; Dodds, AJ; Dormandy, JA; Flute, PT | 1 |
Caimi, G; Catania, A; Francavilla, G; La Bruzzo, S; Romano, A; Sarno, A | 2 |
Ames, PR; Brancaccio, V; Iannaccone, L; Pyke, S | 1 |
Torbet, J | 1 |
Agnelli, G; Callegari, P; Hauert, J; Iorio, A; Parise, P | 1 |
Beier, H; Cohen, AF; Günzler, WA; Hopkins, GR; Koster, RW; van der Wouw, PA | 1 |
Barrios, L; Benit, E; Collen, D; De Man, F; Hermans, L; Kerdsinchai, P; Muyldermans, L; Van den Heuvel, P; Vanderschueren, S; Vrolix, M | 1 |
Bozzoli, C; D'Atena, T; Legnani, C; Massarelli, G; Mazzuca, A; Miniero, R; Muscari, A; Palareti, G; Puddu, GM; Toscano, V | 1 |
Lichtlen, PR; Wolf, R | 1 |
Deutsch, M; Fischer, M; Halbmayer, WM; Haushofer, A; Radek, J; Schön, R | 1 |
Crook, M; Haq, M; Haq, S; Tutt, P | 1 |
Baller, D; Gleichmann, U; Mannebach, H; Miche, E; Prohaska, W; Schmidt, H | 1 |
Chew, CY; Choo, M; Koh, SC; Ratnam, SS; Viegas, OA | 1 |
Koenig, W | 1 |
Baller, D; Gleichmann, U; Mannebach, H; Miche, E; Seggewiss, H | 1 |
Barasch, E; Behar, S; Benderly, M; Caspi, A; Goldbourt, U; Graff, E; Pelled, B; Reicher-Reiss, H; Reisin, L; Roguin, N | 1 |
Martin, M | 1 |
de Groote, P; Decoulx, E; Ducloux, G; Leroy, O; Millaire, A | 1 |
Meade, TW | 1 |
Fowkes, FG | 1 |
Haverkate, F; Kienast, J; Pyke, SD; Thompson, SG; van de Loo, JC | 1 |
Bennett, GM; Meade, TW; Ross-Murphy, SB; Scrutton, MC; Stirling, Y | 1 |
Arveiler, D; Bara, L; Cambien, F; Cambou, JP; Evans, AE; Luc, G; Nicaud, V; Scarabin, PY | 1 |
Stringer, KA | 1 |
Agraou, B; Asseman, P; Bauters, C; Cosson, A; Devos, P; Jude, B; Lepelley, P; McFadden, EP; Susen, S; Vanhaesbroucke, C | 1 |
Clark, P; Cockburn, F; Cowan, RA; Czapla, K; Dunnigan, MG; Farish, E; Hughes, E | 1 |
Cremer, P; Elster, H; Labrot, B; Mann, H; Muche, R; Nagel, D; Seidel, D | 1 |
Brügemann, J; de Graeff, PA; Hillege, HL; Lie, KI; van Boven, AJ; van der Meer, J; van Doormaal, JJ | 1 |
Chandler, WL; Stratton, JR | 1 |
Bara, L; Cambien, F; Nicaud, V; Samama, MM; Tiret, L | 1 |
Agostoni, P; Grazi, S; Guazzi, MD; Marenzi, GC; Salvioni, A | 1 |
Angós, JA; Cornudella, R; Gálvez, MM; Gutiérrez, M; Moreno, JA; Romero, MS | 1 |
Kessler, P; Kubícková, M | 1 |
Cimminiello, C | 1 |
Cesnik, H; Lechner, H; Lechner, P; Walzl, B; Walzl, M | 1 |
Harris, S; Hill, RD; Kleiman, NS; Puleo, P; Roberts, R; Schaaff, LJ; Tracy, RP | 1 |
Abe, S; Goto, S; Handa, S; Hori, S; Ikeda, Y; Kawai, Y; Ogawa, S; Takahashi, E; Watanabe, K | 1 |
Blombäck, M; Green, F; Hamsten, A; Humphries, S | 1 |
Aznar, J; Lacueva, V; Martinez, V; Reganon, E; Ruano, M; Vila, V | 1 |
Bode, C; Freitag, M; Kreuzer, J; Pestel, E; von Hodenberg, E | 1 |
Angós, JA; Cornudella, R; Gálvez, M; Gutiérrez, M; Moreno, JA; Romero, S | 1 |
Creamer, JE; Durrington, PN; Hunt, L; Mackness, MI; MBewu, AD; Turkie, WH | 1 |
Campbell, S; Gunn, J; Rowlands, L; Trudgill, NJ; Tsikaderis, D; Violaris, AG | 1 |
Bergström, K; Chen, J; Hagerman, I; Karlberg, KE; Saldeen, T; Sylvén, C; Wallin, R | 1 |
Jespersen, J; Juhan-Vague, I; Thompson, SG | 1 |
Anderson, JL; Karagounis, LA; Moreno, FL; Sorensen, SG | 1 |
Hummel, L | 1 |
Douglas, JT; Dunn, FG; Gemmill, JD; Hillis, WS; Hogg, KJ; Lowe, GD; Rae, AP | 1 |
Beamer, N; Coull, BM; de Garmo, P; Knox, R; Seaman, G; Sexton, G | 1 |
Allen, A; Anderson, JL; Gomez, MA; Karagounis, LA | 1 |
Kinane, DF; Kweider, M; Lowe, GD; McGowan, DA; Murray, GD | 1 |
Bartholomeus, I; Bonnier, JJ; Hoffmann, JJ; Melman, PG | 1 |
Friesewinkel, O; Marbet, GA; Ritz, R | 1 |
Eriksen, UH; Ingerslev, J; Nielsen, TT | 1 |
Lee, AJ; Lowe, GD; Tunstall-Pedoe, H; Woodward, M | 1 |
Dimitri, G; Graziani, MS; Menegatti, G; Modena, N; Nicoli, M; Righetti, G; Vassanelli, C; Zanolla, L | 1 |
Hoegee-de Nobel, E; Nieuwenhuizen, W; Oethinger, M; Seifried, E; Tanswell, P | 1 |
Arveiler, D; Bara, L; Cambien, F; Cambou, JP; Evans, AE; Luc, G; Poirier, O; Ricard, S; Samama, MM; Scarabin, PY | 1 |
Lowe, GD | 1 |
Ho, CH; Jap, TS; Wang, SP | 1 |
Jounela, A; Peuhkurinen, K; Risteli, J; Risteli, L | 1 |
Arveiler, D; Bara, L; Behague, I; Cambien, F; Cambou, JP; Evans, A; Green, F; Luc, G; Nicaud, V; Poirier, O; Scarabin, PY | 1 |
de Faire, U; Ericsson, CG; Grip, L; Hamsten, A; Nilsson, J; Svane, B | 1 |
Becker, DJ; Ellis, D; Kuller, LH; Lloyd, CE; Orchard, TJ; Wing, RR | 1 |
Amudha, B; Maheswari, RU; Muthu, R; Padma, P; Sathyaraj, D; Shanmugasundaram, KR; Sharada, V; Srinivas, K; Sundaram, P; Veeraraghavan, V | 1 |
Bobins, M; Bukowska, H; Chełstowski, K; Jastrzebska, M; Klinke, M; Naruszewicz, M | 1 |
Bergström, K; Chen, J; Eneroth, P; Hagerman, I; Karlberg, KE; Saldeen, T; Sylvén, C; Wallin, R | 1 |
Assmann, G; Cullen, P; Heinrich, J; Schulte, H | 1 |
Marian, AJ; Roberts, R; Safavi, F; Yu, Q | 1 |
Becker, RC; Bovill, EG; Braunwald, B; Cannon, CP; Knatterud, GL; Randall, A; Thompson, B; Tracy, RP | 1 |
Davies, MJ | 1 |
Giraldi, F; Grazi, S; Guazzi, MD; Lauri, G; Marenzi, G; Perego, GB; Salvioni, A | 1 |
Arima, T; Harubyu, N; Miyahara, K; Miyauchi, T; Nagata, H; Sanada, J; Sonoda, M; Uenomachi, H | 1 |
Blümchen, G; Brestrich, M; Claus, J | 1 |
Iida, M; Iso, H; Kitamura, A; Kiyama, M; Kobayashi, T; Komachi, Y; Naito, Y; Sato, S | 1 |
Chiaranda, G; Ferlito, S; Gallina, M; Mangiameli, S | 1 |
Alessi, MC; Haverkate, F; Jespersen, J; Juhan-Vague, I; Pyke, SD; Thompson, SG | 1 |
Andreotti, F; Davies, GJ; Haider, AW; Kluft, C; Maseri, A; Thompson, GR | 1 |
Blombäck, M; Fatah, K; Hamsten, A; Karpe, F; Silveira, A; Tornvall, P | 1 |
Apostolopoulos, T; Bosinakou, E; Kyriakides, M; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
Abramov, N; Blieden, LC; Gil-Ad, I; Goez, R; Kuberger, N; Laron, Z; Weizman, A | 1 |
Kántor, M; Lestyán, K; Márk, L; Orosz, I; Wolf, I | 1 |
Cremer, P; Elster, H; Labrot, B; Mann, H; Müller-Berninger, R; Nagel, D; Seidel, D | 1 |
Barradell, LB; Goa, KL; Plosker, GL | 1 |
Eberbach, A; Gardemann, A; Haberbosch, W; Hehrlein, FW; Katz, N; Schwartz, O; Tillmanns, H; Waas, W; Weiss, T | 1 |
Collen, D; De Man, F; Dens, J; Desmet, W; Hermans, L; Kerdsinchai, P; Van de Werf, F; Van den Heuvel, P; Vanderschueren, S; Vrolix, M | 1 |
Carter, AM; Grant, PJ; Ossei-Gerning, N; Wilson, IJ | 1 |
Bach, D; Dieplinger, H; Grabensee, B; Koch, M; Kronenberg, F; Kutkuhn, B; Trenkwalder, E | 1 |
Haas, A; Walzl, B; Walzl, M | 1 |
Lindahl, B; Siegbahn, A; Toss, H; Wallentin, L | 1 |
Amore, C; D'Orazio, A; Di Castelnuovo, A; Donati, MB; Iacoviello, L; Zito, F | 1 |
Bovill, EG; Brown, RG; Cannon, CP; Collen, D; Kleiman, NS; Mahan, E; Mann, KG; Rogers, WJ; Sopko, G; Stump, DC; Thompson, B; Tracy, RP; Williams, DO; Zaret, BL | 1 |
Carter, A; Grant, PJ; Kohler, HP; Mikkola, H; Ossei-Gerning, N; Stickland, MH | 1 |
Carter, AM; Grant, PJ; Kohler, HP; Stickland, MH | 1 |
Pileggi, N; Qi Wu, H; Sobel, JH; Trakht, I | 1 |
Bosinakou, E; Davies, G; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
Heidland, UE; Heintzen, MP; Klimek, WJ; Michel, CJ; Strauer, BE; Willers, R | 1 |
Helber, U; Heller, W; Hoffmeister, HM; Jur, M; Ruf-Lehmann, M; Seipel, L | 1 |
Channer, KS; English, KM; Jones, TH; Steeds, R | 1 |
de Zwaan, C; Glatz, JF; Hermens, WT; Mullers-Boumans, ML; Pelsers, MM | 1 |
Baumann, G; Dübel, P; Gliech, V; Grohmann, A; Langel, J; Laule, M; Melzer, C; Stangl, K; Stangl, V; Tenckhoff, B; Wernecke, KD; Ziemer, S | 1 |
Bots, ML; de Jong, PT; de Maat, MP; Grobbee, DE; Haverkate, F; Hofman, A; Kluft, C; van der Bom, JG | 1 |
Gnarpe, H; Gnarpe, J; Lindahl, B; Siegbahn, A; Toss, H; Wallentin, L | 1 |
Danielsen, R; Morrissey, JH; Onundarson, PT; Thors, H; Vidarsson, B | 1 |
Kario, K; Kobayashi, H; Matsuo, M; Matsuo, T; Suzuki, S | 1 |
Craig, BM; Freeburn, JC; Gilmore, WS; Johnson, D; Sinnamon, DG; Strain, JJ; Wallace, JM | 1 |
Carlsson, J; Meierhenrich, R; Neuhaus, KL; Pfarr, E; Seifried, E; Smolarz, A; Tebbe, U | 1 |
Ankri, A; Bastard, JP; Bearez, E; Bigonzi, F; Carayon, A; Carrie, D; Chevrot, M; Dutoit, A; Flammang, D; Jardel, C; Montalescot, G; Philippe, F; Poulard, JE; Thomas, D; Vicaut, E | 1 |
Behar, S; Brunner, D; Goldbourt, U; Reicher-Reiss, H | 1 |
Aillaud, MF; Amouyel, P; Arveiler, D; Evans, A; Ferrières, J; Juhan-Vague, I; Luc, G; Scarabin, PY | 1 |
Boldi, E; Bonandi, L; Curello, S; D'Aloia, A; Dei Cas, L; Giovannini, G; Metra, M; Nodari, S; Zanini, R | 1 |
Aubó, C; Bosch, M; Marrugat, J; Masiá, R; Pavesi, M; Pena, A; Sentí, M | 1 |
Egberg, N; Eriksson, M; Mittleman, MA; Orth-Gomér, K; Schenck-Gustafsson, K; Wamala, S | 1 |
Howard, DB; Schneider, DJ; Sobel, BE; Taatjes, DJ | 1 |
Frojmovic, M; Théroux, P; Xiao, Z | 1 |
Cambien, F | 1 |
Behar, S | 1 |
Hennekens, CH; Ma, J; Ridker, PM; Stampfer, MJ | 1 |
Dernellis, J; Diamantopoulos, L; Stefanadi, E; Stefanadis, C; Toutouzas, K; Toutouzas, P; Tsiamis, E; Vlachopoulos, C | 1 |
Goto, S; Hande, S; Ikeda, Y; Sakai, H | 1 |
Donati, MB; Iacoviello, L | 1 |
Arora, R; Bodenheimer, MM; Brown, MW; Case, RB; Dwyer, EM; Gillespie, JA; Goldstein, RE; Greenberg, H; Hochman, J; Krone, RJ; Liang, CS; Lichstein, E; Little, WC; Marcus, FI; Marder, VJ; Moss, AJ; Oakes, D; Sparks, CE; Van Voorhees, L; Watelet, LF; Weiss, HJ; Zareba, W | 1 |
Michels, HR | 1 |
Titus, K | 1 |
Di Blasio, A; Di Minno, G; Marchioli, R; Maresca, G | 1 |
Maksimenko, AV; Tischenko, EG | 1 |
Greenbaum, AB; Harrington, RA; Hudson, MP; Ohman, EM | 1 |
Ridker, PM | 1 |
Dickinson, RJ; Howard, AN; Palmer, CR; Rajput-Williams, J; Williams, NR | 1 |
de Faire, U; Hallqvist, J; Reuterwall, C; Theorell, T; Tsutsumi, A | 1 |
D'Orazio, A; De Lucia, D; Di Castelnuovo, A; Donati, MB; Iacoviello, L; Negrini, R; Zito, F | 1 |
Bardorfer, I; Gadzijev, A; Keber, D; Keber, I; Vrtovec, B | 1 |
Bode, C; Kohler, B; Kübler, W; Peter, K; Schwarz, M; Straub, A; Volkmann, M | 1 |
Assmann, G; Heinrich, J; Junker, R; Koehler, E; Schulte, H; Tataru, MC; von Eckardstein, A | 1 |
Boon, NA; Newby, DE | 1 |
Bode, C; Kohler, B; Kübler, W; Moser, M; Nordt, T; Peter, K; Ruef, J; Schmittner, M; Smalling, R | 1 |
Aznar, J; Fayos, L; Ferrando, F; Martínez-Sales, V; Reganon, E; Ruano, M; Vila, V | 1 |
Asano, H; Suzuki, M; Tanaka, H; Usuda, S | 1 |
Cappucci, G; Colaizzo, D; Di Minno, G; Grandone, E; Margaglione, M; Vecchione, G | 1 |
Goldkhammer, EI; Kharash, LM | 1 |
Abrignani, MG; Braschi, A; Braschi, GB; Caruso, R; Di Girolamo, A; Novo, G; Novo, S; Strano, A; Tantillo, R | 1 |
Ford, ES; Giles, WH | 1 |
Ek, P; Frithz, G; Haglund, AC; Ronquist, G | 1 |
Applegate, D; Grieninger, G; Hertzberg, KM; Steben, LS | 1 |
Agneskirchner, J; Bode, PA; Reininger, AJ; Spannagl, M; Wurzinger, LJ | 1 |
Botticella, F; Buono, C; Chiariello, M; Cirillo, P; Condorelli, M; Ezban, M; Golino, P; Guarino, A; Lambiase, C; Piro, O; Ragni, M; Ravera, A; Scognamiglio, A | 1 |
Maurer, MC; Trumbo, TA | 1 |
Andreotti, F; Di Sciascio, G; Leone, AM; Manzoli, A; Sperti, G; Zecchi, P | 1 |
Elikowski, W; Grzywacz, A; Psuja, P; Zawilska, K; Zozulińska, M | 1 |
Dagianti, A; Penco, M; Romano, S; Tozzi-Ciancarelli, MG | 1 |
Johnson, TJ | 1 |
Armiger, LC; Norris, RM; White, HD; Woo, KS | 1 |
Iida, M; Imano, H; Iso, H; Kitamura, A; Kiyama, M; Komachi, Y; Naito, Y; Nakagawa, Y; Nakamura, M; Okamura, T; Sato, S; Shimamoto, T | 1 |
Fisher, SD; Hochman, J; Krone, RJ; Liang, C; Marder, VJ; Moss, AJ; Sparks, CE; Zareba, W | 1 |
Lindahl, B; Siegbahn, A; Toss, H; Venge, P; Wallentin, L | 1 |
Caslake, MJ; Cooney, J; Ford, I; Krishna, M; Lowe, GD; Macphee, CH; McMahon, AD; O'Reilly, DS; Packard, CJ; Rumley, A; Suckling, KE; Wilkinson, FE | 1 |
Bertina, RM; Cats, VM; Doggen, CJ; Rosendaal, FR | 1 |
Adamus, J; Gil, M; Olszewski, R; Zarebiński, M | 1 |
Blann, AD; Landray, MJ; Lip, GY; Lydakis, C; Nuttall, SL; Watson, RD | 1 |
Boyle, EM; Erlich, JH; Fearns, C; Kojikawa, O; Kovacich, JC; Labriola, J; Luther, T; Mackman, N; Martin, TR; Morgan, EN; Pohlman, TH; Santucci, RA; Verrier, ED; Yun, W | 1 |
Droullé, C; Garnotel, R; Hézard, N; Metz, D; Nguyen, P; Potron, G | 1 |
Aliberti, G; Corvisieri, P; De Michele, LV; Minisola, S; Proietta, M; Pulignano, I | 1 |
Eriksson, KF; Hedblad, B; Janzon, L; Lind, P; Lindgärde, F; Stavenow, L | 1 |
Ami, RB; Barshtein, G; Berliner, S; Eldor, A; Goldberg, Y; Keren, G; Miller, H; Prochorov, V; Roth, A; Shapira, I; Yedgar, S; Zeltser, D | 1 |
Halinen, M; Kemppainen, A; Koukkunen, H; Penttila, I; Penttilä, K; Pyörälä, K; Rantanen, T | 1 |
Eto, K; Goto, S; Handa, S; Ikeda, Y; Isshiki, T; Ochiai, M; Sato, T; Takeshita, S; Terakura, M | 1 |
Alpsoy, S; Ata, N; Cavusoglu, Y; Gorenek, B; Timuralp, B; Unalir, A | 1 |
Hirano, T; Kazumi, T; Yoshino, G | 1 |
Assmann, G; Heinrich, J; Koehler, E; Schulte, H; Tataru, MC; von Eckardstein, A | 1 |
Aillaud, MF; Amouyel, P; Arveiler, D; Evans, A; Ferrières, J; Juhan-Vague, I; Lacroix, B; Luc, G; Mennen, L; Scarabin, PY | 1 |
Bakken, A; Berg, K; Bohn, M; Erikssen, J; Kierulf, P; Pedersen, JC; Retterstol, L | 1 |
Bogaty, P; Boyer, L; Dagenais, GR; Poirier, P; Simard, S; Solymoss, S | 1 |
De Backer, G; De Buyzere, M; De Pauw, M; De Sutter, J; Dierckx, R; Gheeraert, P; Taeymans, Y; Van de Wiele, C; Voet, J | 1 |
Curran, JM; Fatah-Ardalani, K; Green, FR; Humphries, SE; Tornvall, P | 1 |
Amarenco, P; Arveiler, D; Cambien, F; Elbaz, A; Evans, A; Funke-Kaiser, H; Gautier-Bertrand, M; Herrmann, SM; Kee, F; Morrison, C; Nicaud, V; Orzechowski, HD; Paul, M; Schmidt-Petersen, K | 1 |
Benedetta, M; Castelnuovo, AD; Colombo, M; Gattone, M; Giannuzzi, P; Gramoni, A; Iacoviello, L; Picco, D; Soffiantino, F | 1 |
Behar, S; Benderly, M; Boyko, V; Brunner, D; Goldbourt, U; Graff, E; Mandelzweig, L; Reicher-Reiss, H; Shotan, A; Tanne, D | 1 |
Blake, GJ; Lindpaintner, K; Ridker, PM; Schmitz, C | 1 |
Bijsterveld, NR; Boekholdt, SM; Büller, HR; Levi, M; Moons, AH; Peters, RJ | 1 |
Aznar, J; Martinez, M; Martínez-Sales, V; Palencia, MA; Réganon, E; Vayá, A; Vila, V | 1 |
Barmeyer, J; Bojara, W; Germing, A; Grewe, P; Lawo, T; Lemke, B; Machraoui, A; von Dryander, S | 1 |
Acevedo, M; Foody, JM; Pearce, GL; Sprecher, DL | 1 |
Bakken, A; Berg, K; Bohn, M; Eikvar, L; Erikssen, J; Retterstol, L | 1 |
Donati, MB; Iacoviello, L; Vischetti, M; Zito, F | 1 |
Baker, IA; Bayer, A; Ebrahim, S; Elwood, PC; Pickering, J | 1 |
Ascari, E; Ferrari, R; Galeazzi, G; Portera, C; Raddino, R; Sarasso, L; Scarabelli, TM; Visioli, O | 1 |
Altamura, N; Di Chiara, A; Fioretti, P; Fiotti, N; Giansante, C; Guarnieri, G; Miccio, M | 1 |
Giannitsis, E; Katus, HA; Steen, H | 1 |
Adamus, J; Gil, M; Zarebiński, M | 1 |
do Rosário, HS; e Silva, JM; Monteiro, J; Perdigão, C; Saldanha, C; Sargento, L | 1 |
Egberg, N; Eksborg, S; Eriksson-Berg, M; Schenck-Gustafsson, K | 1 |
Barshtein, G; Ben-Ami, R; Berliner, AS; Eldor, A; Roth, A; Sheinman, G; Yedgar, S | 1 |
Aznar, J; Martínez-Sales, V; Réganon, E; Vaya, A; Vila, V | 1 |
Bigger, JT; Chien, S; Jan, KM | 1 |
Abildgaard, U; Lie, M; Odegard, OR | 1 |
Loo, J | 1 |
Andreenko, GV | 2 |
Alkjaersig, NJ; Etherington, MD; Jamieson, S; Lawford, P; Lincoln, SV; O'Brien, JR | 1 |
Crawford, GP; Ogston, D; Rennie, JA | 1 |
Duckett, K; Fulton, RM | 1 |
Sharp, AA | 1 |
Kher, A | 1 |
Movshovich, BL; Naddachina, TA | 1 |
Fulton, WF; Summer, DJ | 1 |
Gorelova, AM; Guseĭnov, ChS; Likhacheva, ZM | 1 |
Ito, T; Matsui, E; Niwa, T; Sassa, H | 1 |
Gidron, E; Margalit, R; Oliven, A; Shalitin, Y | 1 |
Andreenko, GV; Bessolitsyna, LA; Sargin, KE | 1 |
Blomhoff, JP; Enger, SC; Gjone, E; Ritland, S; Skrede, S | 1 |
Vedin, A; Wilhelmsson, C | 1 |
Lundsgaard-Hansen, P | 1 |
Kakkar, VV | 3 |
Alkjaersig, NK; Fletcher, AP; Ghani, FM; Owens, O; Tulevski, V | 1 |
Belousov, IuB; Liusov, VA; Panchenko, EP; Savenkov, MP; Sidorskiĭ, AL | 1 |
Di Perri, T | 1 |
Davies, MJ; Fulton, WF; Robertson, WB | 1 |
Arnesen, H; Bjerkedal, I; Godal, HC; Skjaeggestad, O | 1 |
Belousov, IuB; Nemiro, VK; Panchenko, EP; Pivovarov, VA | 1 |
Fedorishko, SS; Palamarchuk, VI; Revutskiĭ, EL; Vendt, VP | 1 |
Gupta, B; Kulshrestha, VK; Prasad, DN; Saxena, KK; Srivastava, VK | 1 |
Johnsson, H; Orinius, E; Paul, C | 1 |
Prasad, DN; Saxena, KK; Srivastava, RK | 1 |
Kumar, M; Mehrotra, MP; Misra, SD; Mital, HS; Sondhi, SP | 1 |
Bellotti, G; Décourt, LV; Diamet, J; Lage, SH; Pillegi, F; Ping, WC; Ramires, JA | 1 |
Głuszek, J; Jasiński, K; Krug, H; Smarsz, C | 1 |
Di Perri, T; Forconi, S; Guerrini, M; Pecchi, S; Rossi, C | 1 |
Seth, HN; Sharma, SC | 1 |
Chernysheva, LN; Urbaniuk, KG | 1 |
Bohenszky, G; Fendler, K; Mátrai, A | 1 |
Cherry, GW; Opie, LH | 1 |
Boisseau, M; Bouloumie, J; Bricaud, H; Broustet, JP; Emeriau, JP | 1 |
Heene, DL; Matthias, FR; Reinicke, R | 1 |
Babeau, P; Pras, P | 1 |
Straub, PW | 1 |
Kohlmann, U; Müller, G; Schäbitz, J | 1 |
Caimi, G; La Bruzzo, S; Sarno, A | 1 |
Lasch, HG; Matthias, FR; Reinicke, R | 1 |
Matsuda, T; Murakami, M | 1 |
Amsterdam, EA; Carretta, RF; DeNardo, GL; Kraus, JF; Lies, JE; Mason, DT; Miller, RR; Wampold, DB | 1 |
Erhardt, LR; Sjögren, A | 1 |
Fulton, WF; Sumner, DG | 1 |
Ogston, D; Rennie, JA | 1 |
Braun, P; Gedeon, A; Meskó, E | 1 |
Neugebauer, G | 1 |
Bol'shakova, RM; Dukhina, MA; Furkalo, NK; SolovtsovA, KM | 1 |
Asoskov, VA | 1 |
Arutiunov, GP; Razumov, VB | 1 |
Bartov, E; Cristal, N; Ho, W; Ronen, M; Silverman, C; Stern, J | 1 |
Eger, H; Fiehring, H; Reichelt, D; Reimann, G; Schilling, B; Sedlarik, K; Vollmar, F; Wilde, J | 1 |
Asano, E; Hata, Y; Tsushima, M | 1 |
Chernack, W; Koss, M; McIntosh, R; Nozawa, M; Reemtsma, K; Weber, C; Weil, R | 1 |
Conkie, JA; Davidson, JF; Walker, ID; Young, P | 1 |
Dintenfass, L; Forbes, CD | 3 |
Emerson, PA | 1 |
Bulin, VA; Iliushina, IP; Mazur, NA; Metalitsa, VI; Zhukov, VN | 1 |
Bleifeld, W; Holzhüter, H; Meyer, J; Stühlen, HW; Wende, W; Wenzel, E | 1 |
Niederle, P; Prerovský, I | 1 |
Boman, G; Erhardt, LR; Unge, G | 1 |
Hermes, R; Koehler, M; Miyashita, C; Pindur, G; Schieffer, H; Sen, S; Wenzel, E | 1 |
Mamont, B; Sawicka, B | 1 |
Araújo, A; Ferreira, D; Geraldes, MJ; Monteiro, J; Nunes, V; Pais, F; Perdigão, C; Ribeiro, C; Varela, MG | 1 |
Burr, ML; Fehily, AM; Holliday, RM; Whitehead, PJ | 1 |
Gutteridge, CN; Ranjadayalan, K; Timmis, AD; Umachandran, V | 1 |
Pekkanen, J; Rasi, V; Salomaa, V | 1 |
Gläsle-Schwarz, L; Neuhaus, KL; Seifried, E; Tanswell, P; Tebbe, U; Wojcik, J | 1 |
Blombäck, B; Blombäck, M; Fatah, K; Hamsten, A | 1 |
Bär, F; Meyer, J; Ostermann, H; Schmitz-Huebner, U; van de Loo, J; Windeler, J | 1 |
Badimon, JJ; Badimon, L; Chesebro, JH | 1 |
Cazenave, JP; Grunebaum, L; Mossard, JM; Sacrez, A; Wiesel, ML | 1 |
Hughes, LO; Imeson, J; Kelleher, CC; Martin, JC; Meade, TW; Mitropoulos, KA; Reeves, BE | 1 |
Crook, M; Haq, M; Tutt, P | 1 |
Cerbone, A; Di Minno, G; Grandone, E; Mancini, M; Margaglione, M; Vecchione, G | 1 |
Arnout, J; Collen, D; de Bono, D; Rapold, HJ; Simoons, M; Verstraete, M | 1 |
Boschetti, C; Catalano, M; Cofrancesco, E; Cortellaro, M; de Gaetano, G; Gabrielli, L; Lombardi, B; Specchia, G; Tavazzi, L; Zanussi, C | 2 |
Califf, RM; Ellis, SG; George, BS; Kereiakes, DJ; Samaha, JK; Sigmon, K; Topol, EJ; Wall, TC; Worley, SJ | 1 |
de Faire, U; Hamsten, A; Landou, C; Olsson, G; Perski, A; Theorell, T | 1 |
Arntz, HR; Heitz, J; Perchalla, G; Roll, D; Schäfer, JH; Schröder, R | 1 |
Ernst, E | 2 |
Andreotti, F; Brunelli, C; Buller, N; Caponnetto, S; Foale, R; Fussell, A; Hackett, D; Haider, AW; Lipkin, D; Shahi, M | 1 |
Egashira, K; Kawai, K; Nagano, M; Nakamura, M; Sakuma, A; Tomoike, H | 1 |
Hoegee-de Nobel, H; Nieuwenhuizen, W; Oethinger, M; Seifried, E; Tanswell, P | 1 |
Bath, PM; Burr, ML; Martin, JF | 1 |
Cohen, AF; Kluft, C; Knot, EA; Leebeek, FW; Los, P; Six, AJ | 1 |
Ho, CH; Wang, SP | 1 |
Guriev, SB; Irgashev, SB; Koteliansky, VE; Shekhonin, BV | 1 |
Schelm, JA; Simpson, PJ; Smith, GF | 1 |
Bahr, RD; Braunwald, E; Flaherty, JT; Gurewich, V; Kirshenbaum, JM; Levine, HJ; Loscalzo, J; Schumacher, RR; Topol, EJ; Wahr, DW | 1 |
Chen, J; Gao, R; Kou, W; Lu, Z; Ma, J; Tao, P; Xu, Y; Yao, K; Yu, Q; Zhu, J | 1 |
Enenkel, W; Fischer, M; Fritsch, S; Pollak, H | 1 |
Barbosa, V; Caramelli, B; de Albuquerque, CP; Gebara, O; Maranhão, R; Pileggi, F; Santos Filho, RD; Tranchesi Júnior, B; Vinagre, C | 1 |
Bode, C; Hautmann, M; Kreuzer, J; Kübler, W; Nordt, T; von Hodenberg, E | 1 |
Chamone, DF; Cobbaert, C; Tranchesi, B; Van de Werf, F; Vanhove, P; Verstraete, M | 1 |
Holmbom, B; Lindström, M; Näslund, U; Thornell, LE | 1 |
Jancsó, T; Mihai, K | 1 |
Bonnier, JJ; Hoffmann, JJ | 1 |
Bates, ER; Clair, WK; George, BS; Kereiakes, DJ; Sane, DC; Sigmon, KN; Stack, RS; Stoddard, MF; Stump, DC; Topol, EJ | 1 |
Berke, AD; Bovill, EG; Collen, D; Feit, F; Frederick, M; Gore, JM; Hillis, LD; Lambrew, CT; Stump, DC; Terrin, ML | 1 |
Alexander, HM; Dobson, AJ; Heller, RF; Lloyd, DM | 1 |
Attubato, MJ; Drew, TM; Feit, F; McDonald, MJ; McKendall, GR; Sharaf, BL; Teichman, S; Thomas, ES; Williams, DO | 1 |
Rapold, HJ | 1 |
Hultin, MB | 1 |
Gregor, J; Hamet, A; Malý, J; Pecka, M; Pidrman, V; Siroký, O; Tichý, M; Vodicka, L | 1 |
Eichner, ER | 1 |
Bellotti, G; Caramelli, B; Chamone, D; de Albuquerque, CP; Gebara, OC; Matsumoto, C; Pileggi, F; Santos Filho, RD; Tranchesi Júnior, B | 1 |
Dykun, IaV; Malaia, LT; Shuliak, LN; Topchiĭ, II; Volkov, VI | 1 |
Broadhurst, P; Hughes, L; Imeson, JD; Kelleher, C; Raftery, EB | 1 |
Bogár, L; Jávor, T; Juricskay, I; Simor, T; Tóth, K | 1 |
Goldhaber, SZ; Hirsch, DR | 1 |
Abbate, R; Bonechi, F; Gensini, GF; Prisco, D; Scarti, L; Tramontana, M | 1 |
Follenfant, MJ; Ford, AJ; Hughes, B; Longridge, DJ; Maxwell, MP | 1 |
Hamsten, A; Wiman, B | 1 |
Bette, L; Jung, F; Miyashita, C; Ozbek, C; Pindur, G; Schieffer, H; Schwerdt, H; Sen, C; Wenzel, E | 1 |
Grossman, B; Kudryk, B; Owen, J; Sobel, J | 1 |
Kannel, WB | 1 |
Jávor, T; Juricskay, I; Mezey, B; Simor, T; Tóth, K | 1 |
Brügemann, J; Hillege, H; Lie, KI; Takens, BH; van der Meer, J | 1 |
Agmon, J; Davidson, E; Fuchs, J; Pinhas, A; Rotenberg, Z; Weinberger, I | 1 |
Esparaz, B; Green, D; Kies, M; Kuzel, T | 1 |
Aznar, J; Lacueva, V; Laiz, B; Regañón, E; Ruano, M; Vila, V | 1 |
Jespersen, J; Munkvad, S; Nieuwenhuizen, W | 1 |
Baur, HR; Gallino, A; Haeberli, A; Straub, PW | 1 |
Cassetti, M; Massoli, PD; Materazzi, M; Palazzesi, G | 1 |
Bounameaux, H; Collen, D; De Cock, F; Lijnen, HR; Verstraete, M | 1 |
Hagert, M; Metzner, H; Rode, B | 1 |
Gallino, A; Haeberli, A; Hess, T; Mombelli, G; Straub, PW | 1 |
Tilsner, V | 1 |
Collen, D; de Geest, H; Van de Werf, F; Vanhaecke, J; Verstraete, M | 1 |
Hanssen, M; Monassier, JP | 1 |
Gram, J; Jespersen, J; Kluft, C | 1 |
Bleifeld, W; Diefenbach, C; Erbel, R; Hamm, C; Mathey, D; Meyer, J; Ostermann, H; Pop, T; Schmitz-Hübner, U; Schofer, J | 1 |
Bode, C; Kuebler, W; Schoenermark, S; Schuler, G; Schwarz, F; Zimmermann, R | 1 |
Chen, AB; Collen, D; Hopkins, A; Stump, DC; Topol, EJ | 1 |
Büdinger, M; Heinrich, D; Oehler, G; Schöndorf, T | 1 |
Barthels, M; Daniel, WG; Fischer, K; Gulba, DC; Lichtlen, PR; Polensky, U; Reil, GH; Welzel, D | 1 |
Baur, H; Haeberli, A; Kuemmerli, H; Rapold, HJ; Weiss, M | 1 |
Bennett, KA; Booth, DC; Branco, MC; DeMaria, AN; Grines, CL; Gurley, JC; Nissen, SE | 1 |
Anderson, L; Califf, RM; Collen, D; Masek, R; Sigmon, K; Stump, DC; Thornton, D; Topol, EJ | 1 |
Feuerer, W; Jeep-Tebbe, S; Neuhaus, KL; Niederer, W; Tebbe, U; Vogt, A | 1 |
Barbash, GI; Hod, H; Laniado, S; Miller, HI; Modan, M; Rath, S; Roth, A; Seligsohn, U; Zahav, YH; Zivelin, A | 1 |
Bareiss, P; Cazenave, JP; Drawin, T; Grunebaum, L; Kieny, JR; Mossard, JM; Roul, G; Sacrez, A; Wiesel, ML | 1 |
Chen, ZJ; Tao, SQ; Yao, SK | 2 |
Sha, LR; Song, XH; Xu, NT; Zhang, LP; Zhang, Y | 1 |
Aznar, J; Laiz, B; Regañón, E; Vila, V | 1 |
Cucchi, G; Ferrara, E; Sardeo, C | 1 |
Chamberlain, DA | 1 |
Guriev, SB; Irgashev, ShB; Kotelianskiĭ, VE; Shekhonin, BV | 1 |
Bleifeld, W; Burmester, L; Erlemeier, HH; Mathey, DG; Schofer, J; Zangemeister, W | 1 |
Swahn, E; von Schenck, H; Wallentin, L | 1 |
Blanke, H; Egbring, R; Höffken, H; Joseph, K; Leschke, M; Schmidtsdorff, A; Strauer, BE | 1 |
Fratino, P; Grignani, G; Pacchiarini, L; Salerno, JA; Storti, C; Zucchella, M | 1 |
Kobayashi, N | 1 |
Tulchinsky, M; Wilensky, RL; Wish, M; Zeller, JA | 1 |
Bernard, R; Bory, M; Brower, RW; Collen, D; de Bono, DP; Erbel, R; Huhmann, W; Lennane, RJ; Lubsen, J; Verstraete, M | 1 |
Bleifeld, W; Brower, RW; Charbonnier, B; Collen, D; de Bono, DP; Dunning, AJ; Lennane, RJ; Lubsen, J; Mathey, DG; Verstraete, M | 1 |
Blombäck, M; Dahlén, G; de Faire, U; Hamsten, A; Landou, C; Szamosi, A; Walldius, G; Wiman, B | 1 |
Berglund, U; von Schenck, H; Wallentin, L | 1 |
Alkjaersig, NK; Fletcher, AP | 1 |
Aĭngorn, ED; Andreenko, GV; Belokon', NA; Karabasova, MA; Zabotina, ON | 1 |
Just, H; Kasper, W; Meinertz, T; Schumacher, M | 1 |
Bergentz, SE | 1 |
Collen, D; Nobuhara, M; Van de Werf, F | 1 |
Graor, RA; Hotchkiss, A; Lucas, FV; Robison, AK; Sobel, BE; Tiefenbrunn, AJ | 1 |
Conard, J; Horellou, MH; Nguyen, G; Samama, M | 1 |
Bell, WR; Noe, DA | 1 |
Forman, SA; Mueller, HS; Rao, AK | 1 |
Boissel, JP; Leizorovicz, A; Peyrieux, JC | 1 |
Bell, WR; Berke, A; Jaffe, A; Knatterud, G; Ockene, I; Pratt, C; Rao, AK; Robertson, TL; Schreiber, TL; Terrin, ML | 1 |
Brochier, M; Charbonnier, B; Lang, M | 1 |
Abbottsmith, C; Boswick, JM; Califf, RM; Candela, R; George, BS; Kereiakes, D; Masek, R; O'Neill, WW; Sigmon, KN; Topol, EJ | 1 |
Bonnet, JL; Bory, M; Bouvier, JL; Camilleri, JF; Djiane, P; Levy, G; Serradimigni, A | 1 |
Cooper, B; Gottlich, CM; Hillis, LD; Schumacher, JR | 1 |
Denchev, S; Ivanova, R; Kamenov, V; Tomov, I | 1 |
Amoriello, A; Eliseo, V; Piantadosi, FR; Piccenna, L; Vacca, C | 1 |
Akioka, K; Hirota, K; Itagane, H; Ochi, H; Oku, H; Takeda, T; Takeuchi, K; Teragaki, M; Yasuda, M | 1 |
Bonzel, T; Chen, C; Drexler, H; Hofmann, T; Just, H; Kasper, W; Meinertz, T; Wollschläger, H; Zeiher, A | 1 |
Brochier, ML; Cribier, A; Favier, JP; Kulbertus, H; Letac, B; Materne, P; Monassier, JP; Quilliet, L; Sacrez, A | 1 |
Aleixo, A; Aniceto Silva, J; Crespo, F; Freire, I; Freitas, R; Real, T; Seabra-Gomes, R; Torres, I | 1 |
Brown, MJ; Kinsella, PA; Marder, VJ | 1 |
Blanke, H; Leschke, M; Motz, W; Stellwaag, M; Strauer, BE | 1 |
Balnave, K; Hughes, R; Moriarty, AJ; Nelson, SD | 1 |
Bodzenta, A; Buluk, K; Lussa, A | 1 |
Fitzpatrick, PG; Francis, CW; Marder, VJ; Rothbard, RL | 1 |
Been, M; Boulton, FE; de Bono, DP; Fears, R; Ferres, H; Muir, AL; Standring, R | 1 |
Edwalds, G; Fishbein, MC; Kulber, D; Stancl, M | 1 |
Connaghan, DG; Francis, CW; Marder, VJ | 1 |
Ambrose, JA; Borrico, S; Cohen, M; Fuster, V; Gorlin, R; Hjemdahl-Monsen, C; Sherman, W | 1 |
Connaghan, DG; Francis, CW; Marder, VJ; Scott, WL | 1 |
Dobrovol'skiĭ, AB; Dorogun, BN; Pomerantsev, EV; Smirnov, AA; Staroverov, II | 1 |
Haeberli, A; Mombelli, G; Monotti, R; Straub, PW | 1 |
Bitto, S; Brieda, M; Cassin, M; Charmet, PA; Molaro, G; Rellini, G; Zanuttini, D | 1 |
Cristal, N; Shainkin-Kestenbaum, R; Winikoff, Y | 1 |
Cercek, B; Ganz, W; Hod, H; Lew, AS; Shah, PK | 1 |
Bonnet, JL; Sainsous, J; Serradimigni, A | 2 |
Gopal, R; Gupta, B; Kulshrestha, VK; Prasad, DN; Saxena, KK; Singh, RC; Srivastava, SS | 1 |
Borodkin, VV; Diukov, IV; Dudaev, VA | 1 |
Bhattacharya, SK; Dube, B; Dube, RK; Somani, PN; Tripathi, GK | 1 |
Krebber, HJ; Mathey, D; Rodewald, G | 1 |
Ernst, E; Matrai, A | 1 |
Ovsianko, IuI; Pavlovskiĭ, DP; Shuliarenko, VA | 1 |
Bonnier, JJ; Hoffmann, JJ; Van Rey, FJ | 1 |
Bell, WR; Topol, EJ; Weisfeldt, ML | 1 |
Gangadharan, V; Gordon, S; Hauser, AM; Mammen, EF; Ramos, RG; Stewart, JR; Timmis, GC; Westveer, DC | 1 |
Eisenberg, PR; Jaffe, AS; Perez, J; Schectman, K; Sherman, LA; Sobel, BE | 1 |
Arutiunova, MS; Gogishvili, AV; Kavtaradze, VG; Mamaladze, GT; Takadze, GSh | 1 |
Bachmann, F; Grbic, M; Sigwart, U | 1 |
Al-Yusuf, AR; Bhatnagar, SK; Hudak, A | 1 |
Gallino, A; Haeberli, A; Straub, PW | 1 |
Pope, WT; Walker, AN | 1 |
Gross, LF; Lurie, AA; Rogers, WJ | 1 |
Kurnik, PB; Ludbrook, PA; Robinson, AK; Sobel, BE; Tiefenbrunn, AJ | 1 |
Borer, J; Braunwald, E; Chesebro, JH; Cohen, LS; Dalen, J; Dodge, HT; Francis, CK; Hillis, LD; Knatterud, G; Ludbrook, P | 1 |
Filippova, SB; Ikonnikova, EI; Khalfen, ESh; Voronkova, LI | 1 |
Maurer, BJ; Shillingford, JP; Wray, R | 1 |
Sevitt, S | 1 |
Almer, LO; Hedner, U; Nilsson, IM | 1 |
Chakrabarti, R; Fearnley, GR | 1 |
Erhardt, LR; Lundman, T; Mellstedt, H | 1 |
Baele, G; Mussche, M; Vermeire, P | 1 |
Beattie, AG; Douglas, AS; Kenmure, AC; Ogston, D; Terry, G; Warlow, C | 1 |
Chakrabarti, R | 1 |
Kaiser, R; Mosuni, MS; Spöttl, F | 1 |
Dement'eva, MP | 1 |
Chakrabarti, R; Fearnley, GR; Hocking, ED | 2 |
Bell, WR; Goodwin, JF; Pitney, WR | 1 |
Attwell, TN; Chakrabarti, R; Fearnley, GR; Hocking, ED; Jackson, D; Mann, RD | 1 |
Rex, J | 1 |
Johansson, SA | 1 |
Cox, FC; Lawrie, TD; Lorimer, AR; Murray, TS | 1 |
Baele, G; Mussche, M; Pannier, R; Vermeire, P | 1 |
Hauss, WH; Papavassiliou, K; Schmitt, G; Winter, R | 1 |
Liusov, VA | 1 |
Rachmilewitz, EA; Shahin, W; Zlotnick, A | 1 |
Ol'shevski, V | 1 |
Bloch, KJ; Colman, RW; Myers, AR; Niewiarowski, S; Thomas, DP | 1 |
Hiramaru, M; Manmi, S; Matsuda, T; Murakami, M; Nishio, T | 1 |
Lipinski, B | 1 |
Andreenko, GV; Chazov, EI; Liutova, LV; Mazaev, AV; Sargin, KE | 1 |
Liapina, LA; Panchenko, VM | 1 |
Gritsiuk, AI; Petrus', VG | 1 |
Akhmetov, KZh; Perepelkin, EG; Zaslavskaia, RM | 1 |
Krug, H; Raszeja-Wanic, B; Wochowiak, A | 1 |
Chepelak, V | 1 |
Pavlishchuk, SA; Petrova, TR | 1 |
Woszczyk, J | 1 |
Hampton, JR; Hayes, MJ; Morris, GK | 1 |
Deutsch, E; Deutsch, M; Enenkel, W; Fasching, W; Gellert, J; Lechner, K; Leodolter, S; Navratil, J; Wolner, E | 1 |
Kuller, L | 1 |
Emerson, PA; Fleming, PR; Handley, AJ | 1 |
Davidson, JF; Lochhead, M; McDonald, GA; McNicol, GP | 1 |
Carroll, JJ; Gallus, AS; Hirsh, J; Hudecki, SM; Minden, JH; O'Brien, SE; Trebilcock, R; Tutle, RJ | 1 |
Maurer, B; Shillingford, J; Wray, R | 1 |
Breddin, K; Ehrly, AM; Fechler, L; Frick, D; König, H; Kraft, H; Krause, H; Krzywanek, HJ; Kutschera, J; Lösch, HW; Ludwig, O; Mikat, B; Rausch, F; Rosenthal, P; Sartory, S; Voigt, G; Wylicil, P | 1 |
Feddersen, C; Gormsen, J; Ploug, J; Tidstrom, B | 1 |
Sova, J | 1 |
Dintenfass, L; Forbes, CD; Milton, GW; Stewart, JH | 1 |
Austen, WG; Buckley, MJ; Caulfield, JB; Leinbach, RC; Nyilas, E | 1 |
Chandler, AB; Chapman, I; Erhardt, LR; Ness, PM; Roberts, WC; Schwartz, CJ; Sherry, S; Simon, TL; Sinapius, D; Spain, DM | 1 |
Didisheim, P; Fuster, V; Kazmier, FJ | 1 |
Pitney, WR; Pussell, BA | 1 |
Hampton, JR; Nicholls, DG | 1 |
Baele, G; Barbier, F; Mussche, M; Pannier, R; Vermeire, P | 1 |
Cajzl, L; Holubec, J; Kott, J; Krbec, J; Sova, J; Stanĕk, B | 1 |
Matsuda, T | 1 |
Bolocan, T; Grecu, O; Păunescu-Podeanu, A | 1 |
Krylov, AA | 1 |
Jeyasingh, K; Maurer, B; Wray, R | 1 |
Anderson, ST; Habersberger, PG; Pitt, A | 1 |
Javid, JP; Lackner, H | 1 |
Roberts, BE; Sheppard, MA; Sibbald, R; Simmons, AV; Tate, G | 1 |
Brüschke, G; Schulz, FH; Schulz, J | 1 |
Uspenskaia, VG | 1 |
Ikkala, E; Kotilainen, M; Pyörälä, K; Ristola, P | 1 |
Arnesen, H | 1 |
Arnesen, H; Godal, HC; Kierulf, P | 1 |
Bonardi, G; Coppi, G | 1 |
Benda, L; Klösel, W; Spiess, A; Zenz, W | 1 |
Verstraete, M | 1 |
Andersen, M; Eliasen, B; Eliasen, P; Kirkegard, C | 1 |
Gordon, RJ; Snyder, GK; Taylor, WJ; Tritel, H | 1 |
Nelson, C; Okuno, T | 1 |
Chapman, I | 1 |
Ferguson, EW | 1 |
Erhardt, IR | 1 |
Handley, AJ; Teather, D | 1 |
Emerson, PA; Marks, P | 1 |
Terry, G; Warlow, CP | 1 |
Amery, A; Roeber, G; Vermeulen, HJ; Verstraete, M | 1 |
Biggs, JC; Chesterman, CN | 1 |
Benda, L; Redtenbacher, L; Spiess, A; Steinbach, T | 1 |
Kakkar, V | 1 |
Schulz, FH; Schulz, J | 1 |
Gorokhovskiĭ, BI; Novosel'skaya, VV; Tarasova, VA | 1 |
Drzewiecki, J; Lipiński, B; Nowak, A | 1 |
Johansson, BG; Kindmark, CO; Trell, EY; Wollheim, FA | 1 |
Cox, AF; Sheppard, MA; Simmons, AV | 1 |
Korsan-Bengtsen, K; Tibblin, G; Wilhelmsen, L | 1 |
Shevelev, AT | 1 |
Alkjaersig, N; Fletcher, A; Owens, O; Smith, JR; Wolff, G | 1 |
Alkjaersig, N; Fletcher, A; Jacob, A; Roy, L | 1 |
Trushinskiĭ, ZK | 2 |
Basu, HN; Hussain, Q; Mittal, MM; Sharma, ML | 1 |
Baklaja-Jevremović, R; Bosnjaković, V; Dordević, BS; Nastić, D | 1 |
Kent, SP | 1 |
Mrazek, SA | 1 |
Belousov, IuB; Liusov, VA | 1 |
Parkhotik, II; Sakharchuk, II | 1 |
Gupta, NN; Mehrotra, RM; Mittal, MM | 1 |
Goldstone, J; Schmid-Schönbein, H; Wells, R | 1 |
Hashimoto, Y | 1 |
Chernysheva, GV | 1 |
Buraschi, J; Sack, ES | 1 |
Marcinkowski, A; Olszewski, W | 1 |
Nikitin, GA | 1 |
Bosisio, P; Lolli, G | 1 |
Medvedeva, ZF; Shishkova, TV; Vorob'ev, AI | 1 |
Inmon, TW; Langsjoen, PH | 1 |
Burckhardt, D; LaDue, JS; Vera, CA | 1 |
Borisenko, AP; Moiseev, SG | 1 |
Deriagina, GP; Komarova, IN | 1 |
Sitar, J | 1 |
Jeziorny, J; Kogucki, S; Laskowski, S; Olszewski, W | 1 |
Matsuoka, M | 1 |
Caroli, RK; Lal, HB | 1 |
Pavlishchuk, SA; Petrova, TP | 1 |
Allan, AG; Cash, JD; Das, PC; Woodfield, DG | 1 |
Gayer, J; Schürholz, J; Voss, D | 1 |
Ogston, CM; Ogston, D | 1 |
Vykouril, J | 1 |
Mikhalev, ID | 1 |
63 review(s) available for fibrinogen and Cardiovascular Stroke
Article | Year |
---|---|
Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.
Topics: Arthroplasty, Replacement; Fibrinogen; Fractures, Bone; Hemorrhage; Hemostatics; Humans; Myocardial Infarction; Pulmonary Embolism; Stroke; Tranexamic Acid; Transfusion Reaction; Venous Thrombosis | 2023 |
Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black People; Cardiovascular Diseases; Coronary Artery Disease; Female; Fibrinogen; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Hispanic or Latino; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Factors; Stroke; Venous Thromboembolism; White People; Young Adult | 2013 |
Influence of the β-fibrinogen-455G/A polymorphism on development of ischemic stroke and coronary heart disease.
Topics: Case-Control Studies; Coronary Artery Disease; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Assessment; Stroke | 2014 |
Fibrinogen and cardiovascular disease: genetics and biomarkers.
Topics: Animals; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Polymorphism, Genetic | 2011 |
Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
Topics: Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Plasminogen; Thrombolytic Therapy | 2002 |
The genetics of atherothrombotic disorders: a clinician's view.
Topics: Cholesterol; Cholesterol, LDL; Coronary Artery Disease; Diabetes Complications; Factor VII; Factor XII; Fibrinogen; Humans; Hyperinsulinism; Hypertension; Inflammation; Insulin Resistance; Models, Biological; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator; Triglycerides | 2003 |
The HELP system for the treatment of atherothrombotic disorders: a review.
Topics: Chemical Precipitation; Coronary Artery Disease; Extracorporeal Circulation; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Lipoproteins, LDL; Male; Myocardial Infarction; Plasmapheresis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Stroke; Treatment Outcome | 2003 |
PATHOPHYSIOLOGY AND MANAGEMENT OF PERICARDITIS.
Topics: Antistreptolysin; Blood Sedimentation; Diagnosis, Differential; Electrocardiography; Fibrinogen; Humans; Myocardial Infarction; Pericarditis; Pericarditis, Constrictive; Phonocardiography; Physiology | 1963 |
[Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Arteriosclerosis; Blood Component Removal; Coronary Restenosis; Female; Fibrinogen; Fibrinolytic Agents; Humans; Hypolipidemic Agents; Male; Meta-Analysis as Topic; Myocardial Infarction; Predictive Value of Tests; Primary Prevention; Prospective Studies; Risk Factors; Stents; Stroke; Syndrome; Thrombosis | 2003 |
Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Animals; Antibodies, Monoclonal; Antibody Specificity; Clinical Trials as Topic; Epitopes; Eptifibatide; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Mice; Myocardial Infarction; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Fusion Proteins; Thrombocytopenia; Tirofiban; Tyrosine | 2004 |
Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease.
Topics: Aged; Angina Pectoris; Antigens, CD; Antigens, Surface; Arterial Occlusive Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Intermittent Claudication; Lectins, C-Type; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; NK Cell Lectin-Like Receptor Subfamily B; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Risk Factors; Scotland; Smoking | 2003 |
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
Topics: Adult; Aged; Cause of Death; Coronary Disease; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Stroke; Vascular Diseases | 2005 |
Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium | 2006 |
The fibrinolytic system in man.
Topics: alpha 1-Antitrypsin; alpha-2-Antiplasmin; alpha-Macroglobulins; Antifibrinolytic Agents; Antithrombin III; Arterial Occlusive Diseases; Arteriosclerosis; Complement C1 Inactivator Proteins; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; Kidney Diseases; Liver Diseases; Myocardial Infarction; Neoplasms; Plasminogen; Pulmonary Embolism; Thrombophlebitis | 1984 |
Hemorrheologic changes following acute myocardial infarction.
Topics: Alpha-Globulins; Blood Viscosity; Erythrocyte Aggregation; Erythrocytes; Fibrinogen; Hematocrit; Humans; Myocardial Infarction; Rheology | 1982 |
Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Factors; Factor V Deficiency; Factor X Deficiency; Factor XI Deficiency; Factor XII Deficiency; Female; Fibrinogen; Hemophilia A; Hemophilia B; Humans; Kininogens; Male; Middle Aged; Myocardial Infarction; Ohio; Prekallikrein; Thrombocytopenia; Thrombosis; von Willebrand Diseases | 1983 |
[The influence of hemorrheology on the practice of clinical medicine].
Topics: Adult; Age Factors; Aged; Arterial Occlusive Diseases; Blood Physiological Phenomena; Blood Viscosity; Diabetic Angiopathies; Erythrocytes; Female; Fibrinogen; Hematocrit; Hemodilution; Hemodynamics; Hemoglobins; Humans; Hypertension; Male; Middle Aged; Models, Biological; Myocardial Infarction; Oxygen Consumption; Phlebitis; Plasmapheresis; Preoperative Care; Raynaud Disease; Rheology | 1983 |
Diagnostic methods of deep vein thrombosis.
Topics: Blood Volume Determination; Fibrinogen; Humans; Iodine Radioisotopes; Myocardial Infarction; Phlebography; Plethysmography; Posture; Pulmonary Embolism; Thermography; Thrombophlebitis; Ultrasonography | 1983 |
Haemorheological aspects of thrombosis.
Topics: Adenosine Diphosphate; Arteries; Blood Flow Velocity; Blood Viscosity; Erythrocytes; Fibrinogen; Hematocrit; Humans; Myocardial Infarction; Platelet Aggregation; Thrombosis | 1980 |
[Hyperfibrinogenemia and cardiovascular risk--epiphenomenon or causal relationship?].
Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Fibrinogen; Humans; Myocardial Infarction; Risk Factors; Survival Rate | 1995 |
[Clinical significance of the cardiovascular risk factor fibrinogen in secondary prevention].
Topics: Adult; Aged; Cerebrovascular Disorders; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Reference Values; Risk Factors | 1995 |
Fibrinogen in ischaemic heart disease.
Topics: Blood Viscosity; Cholesterol; Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Fibrinogen; Humans; Myocardial Infarction; Platelet Aggregation; Prospective Studies; Recurrence; Risk Factors | 1995 |
Fibrinogen and cardiovascular disease in clinical practice.
Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Disease; Fibrinogen; Humans; Lipoproteins; Myocardial Infarction; Prospective Studies; Reference Values; Risk Factors | 1995 |
Beyond thrombolysis: other effects of thrombolytic drugs.
Topics: Animals; Anistreplase; Blood Coagulation; Blood Platelets; Blood Viscosity; Complement System Proteins; Fibrinogen; Humans; Myocardial Infarction; Neutrophils; Reperfusion Injury; Streptokinase; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator | 1994 |
The contribution of thrombosis to the clinical expression of coronary atherosclerosis.
Topics: Animals; Blood Coagulation Factors; Circadian Rhythm; Coronary Artery Disease; Disease Models, Animal; Endopeptidases; Endothelium, Vascular; Fibrinogen; History, 19th Century; History, 20th Century; Humans; Myocardial Infarction; Myocardial Ischemia; Thrombosis | 1996 |
[Lipid, apoprotein and fibrinogen levels in the blood of male patients following myocardial infarct and the effect of diet on these parameters in ischemic heart disease].
Topics: Apolipoproteins; Body Mass Index; Cholesterol; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Sex Factors | 1996 |
Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
Topics: Angina Pectoris; Apolipoproteins; Apolipoproteins A; Bezafibrate; Diabetes Complications; Drug Tolerance; Fibrinogen; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipoproteins; Male; Myocardial Infarction | 1996 |
Testosterone and coronary heart disease: is there a link?
Topics: Coronary Disease; Female; Fibrinogen; Fibrinolysis; Humans; Hyperinsulinism; Male; Myocardial Infarction; Obesity; Risk Factors; Smoking; Testosterone | 1997 |
Genetic prediction of myocardial infarction.
Topics: Alleles; Angiotensinogen; Apolipoproteins; Aryldialkylphosphatase; Carrier Proteins; Cholesterol Ester Transfer Proteins; Esterases; Fibrinogen; Glycoproteins; Humans; Lipoprotein Lipase; Myocardial Infarction; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Selectins | 1999 |
Gene-environment interactions: implications for cardiovascular disease.
Topics: Cardiovascular Diseases; Environment; Factor VII; Female; Fibrinogen; Genetic Variation; Genotype; Hemostasis; Humans; Male; Myocardial Infarction; Polymorphism, Genetic; Risk Factors | 1999 |
A panorama of cardiac risk.
Topics: Adult; Aged; Amyloid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prospective Studies; Research; Retrospective Studies; Risk Factors; Time Factors; Triglycerides; Vitamin E | 1999 |
Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update.
Topics: Cerebrovascular Disorders; Fibrinogen; Humans; Myocardial Infarction; Risk Factors | 1999 |
New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.
Topics: Animals; Dogs; Drug Combinations; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1999 |
Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction.
Topics: Abciximab; Acetates; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eptifibatide; Fibrinogen; Fibrinolytic Agents; Forecasting; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Pilot Projects; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Tyrosine | 1999 |
Evaluating novel cardiovascular risk factors: can we better predict heart attacks?
Topics: Biomarkers; C-Reactive Protein; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Myocardial Infarction; Reproducibility of Results; Risk Factors; Tissue Plasminogen Activator | 1999 |
Vascular and haemostatic gene polymorphisms associated with non-fatal myocardial infarction: a critical review.
Topics: Angiotensinogen; Blood Coagulation Factors; Blood Platelets; Factor VII; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Receptors, Angiotensin | 2000 |
TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
Topics: Drug Evaluation; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Myocardial Infarction; Plasminogen; Randomized Controlled Trials as Topic; Safety; Tenecteplase; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2000 |
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
Topics: Abciximab; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Platelets; CD18 Antigens; Chemotaxis, Leukocyte; Coronary Artery Bypass; Coronary Disease; Cytokines; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Leukocytes; Ligands; Macrophage-1 Antigen; Membrane Glycoproteins; Models, Biological; Myocardial Infarction; Neutrophils; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombospondins; Tirofiban; Tyrosine | 2000 |
[BECAIT [Bezafibrate Coronary Atherosclerosis Intervention Trial]].
Topics: Bezafibrate; Cholesterol, HDL; Coronary Artery Disease; Fibrinogen; Follow-Up Studies; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Triglycerides | 2001 |
Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review.
Topics: Blood Coagulation Factors; Factor V; Fibrinogen; Genetic Variation; Humans; Mutation; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Protein Subunits; Prothrombin | 2001 |
Analysis of gene-environment interaction in coronary heart disease: fibrinogen polymorphisms as an example.
Topics: Coronary Artery Disease; Environmental Exposure; Exercise; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Male; Molecular Biology; Myocardial Infarction; Polymorphism, Genetic; Risk Factors; Sex Factors | 2002 |
[Clinical implications of rheology in cardiovascular diseases].
Topics: Adult; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cerebrovascular Disorders; Child; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Leukemia; Leukocytes; Malaria; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Thrombosis | 2002 |
[Urokinase. Biochemical therapeutical and therapeutical data (author's transl)].
Topics: alpha-Macroglobulins; Animals; Arteriovenous Shunt, Surgical; Chemical Phenomena; Chemistry; Coagulants; Endopeptidases; Enzyme Activation; Fibrinogen; Fibrinolysis; Humans; Hyphema; Intracranial Embolism and Thrombosis; Myocardial Infarction; Plasminogen Activators; Pulmonary Embolism; Retinal Vein; Thrombophlebitis; Thrombosis; Urokinase-Type Plasminogen Activator | 1976 |
[Age, constitutional and genetic characteristics of the fibrinolysis system].
Topics: Adolescent; Adult; Aged; Aging; alpha-Macroglobulins; Animals; Arteriosclerosis; Blood Coagulation; Blood Coagulation Disorders; Body Constitution; Child; Cholesterol; Ethnicity; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Molecular Biology; Myocardial Infarction; Peptide Hydrolases; Physical Exertion; Racial Groups | 1979 |
Fibrinogen uptake test for detection of deep vein thrombosis--a review of current practice.
Topics: Cerebrovascular Disorders; Female; Femoral Neck Fractures; Fibrinogen; Fibrinolytic Agents; Humans; Iodine Radioisotopes; Isotope Labeling; Leg; Maternal-Fetal Exchange; Milk, Human; Myocardial Infarction; Postoperative Complications; Postpartum Period; Pregnancy; Pulmonary Embolism; Radiation Dosage; Thrombophlebitis | 1977 |
[Coagulation factors, platelets and coronary heart disease].
Topics: Blood Coagulation Factors; Coronary Disease; Factor VII; Female; Fibrinogen; Humans; Male; Myocardial Infarction; Platelet Aggregation; Recurrence; Tissue Plasminogen Activator | 1991 |
Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi.
Topics: Angina, Unstable; Blood Platelets; Coronary Artery Disease; Coronary Thrombosis; Fibrinogen; Humans; Myocardial Infarction; Nitric Oxide; Perfusion; Platelet Adhesiveness; Platelet Aggregation; Platelet Membrane Glycoproteins; Rupture, Spontaneous; Stress, Mechanical; Vasoconstriction; von Willebrand Factor | 1992 |
Fibrinogen and mechanisms of thrombosis. A difficult link.
Topics: Blood Viscosity; Coronary Artery Disease; Coronary Thrombosis; Fibrinogen; Humans; Intracranial Arteriosclerosis; Intracranial Embolism and Thrombosis; Myocardial Infarction; Platelet Aggregation; Prognosis; Risk Factors | 1992 |
[Correlation between juvenile myocardial infarct in parents and plasma fibrinogen levels in their offspring].
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Coronary Disease; Female; Fibrinogen; Humans; Male; Myocardial Infarction; Risk Factors | 1991 |
Fibrinogen and factor VII as risk factors in vascular disease.
Topics: Adult; Aged; Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Cohort Studies; Cross-Sectional Studies; Epidemiologic Methods; Europe; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Thromboplastin; Triglycerides; United States | 1991 |
Exercise and arthritis. The hematology of inactivity.
Topics: Arthritis; Arthritis, Rheumatoid; Blood Platelets; Exercise; Fibrinogen; Fibrinolysis; Hematocrit; Humans; Longevity; Myocardial Infarction; Physical Fitness | 1990 |
[Hemorrheologic parameters in myocardial infarct during the hospitalization phase].
Topics: Blood Viscosity; Diuretics; Dose-Response Relationship, Drug; Erythrocyte Count; Female; Fibrinogen; Hematocrit; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Rheology | 1990 |
[Hemorheologic parameters during the 6 months following myocardial infarct].
Topics: Blood Flow Velocity; Blood Viscosity; Blood Volume; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction | 1990 |
Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction.
Topics: Adult; Aged; alpha-2-Antiplasmin; Clinical Trials as Topic; Coronary Circulation; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hemostasis; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators; Recombinant Proteins; Time Factors; Urokinase-Type Plasminogen Activator; Vascular Patency | 1988 |
Unanswered questions in thrombolysis.
Topics: Animals; Blood Coagulation; Blood Platelets; Drug Therapy, Combination; Fibrinogen; Fibrinolytic Agents; Humans; Myocardial Infarction; Vascular Patency | 1989 |
The hematologic consequences of thrombolytic therapy.
Topics: Animals; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Drug Evaluation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Plasminogen Activators; Streptokinase; Thrombin; Thromboembolism | 1986 |
Incidence of thromboembolism in association with surgical and medical diseases.
Topics: Cerebrovascular Disorders; Cohort Studies; Fibrinogen; Humans; Iodine Radioisotopes; Myocardial Infarction; Phlebography; Postoperative Complications; Pulmonary Embolism; Risk Factors; Thromboembolism; Thrombophlebitis | 1988 |
[New thrombolytic agents in myocardial infarction].
Topics: Anistreplase; Coronary Thrombosis; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Injections, Intravenous; Myocardial Infarction; Plasminogen; Plasminogen Activators; Streptokinase; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1987 |
[Blood rheology as a risk indicator in cardiovascular diseases?].
Topics: Blood Sedimentation; Cardiovascular Diseases; Fibrinogen; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Retrospective Studies; Rheology; Risk | 1985 |
The relation of thromboembolic disease to cardiovascular disease.
Topics: Autopsy; Blood Group Antigens; Cardiovascular Diseases; Environment; Fibrinogen; Humans; Iodine Radioisotopes; Myocardial Infarction; Obesity; Posture; Pulmonary Embolism; Stress, Physiological; Thromboembolism; Thrombophlebitis | 1972 |
[Role of changes in the state of the blood coagulation and fibrinolysis system in the pathogenesis of myocardial infarct and atherosclerosis].
Topics: Animals; Antifibrinolytic Agents; Arteriosclerosis; Blood Coagulation Disorders; Blood Platelets; Chromatography; Electrophoresis; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Myocardial Infarction; Platelet Aggregation; Rats | 1974 |
Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction.
Topics: Adult; Aged; Arteries; Arteriosclerosis; Coronary Disease; Coronary Vessels; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Necrosis; Thrombosis; Time Factors | 1974 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamole; Fibrinogen; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Iodine Radioisotopes; Molecular Weight; Myocardial Infarction; Phlebography; Renal Dialysis; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1974 |
111 trial(s) available for fibrinogen and Cardiovascular Stroke
Article | Year |
---|---|
Impact of preoperative fibrinogen concentration on postoperative outcome in patients who received dual antiplatelet therapy in proximity to off-pump coronary bypass surgery.
Topics: Aged; Blood Loss, Surgical; Clopidogrel; Coronary Artery Bypass, Off-Pump; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Preoperative Care; Preoperative Period; Retrospective Studies; Risk Factors; Ticlopidine | 2014 |
Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial.
Topics: Aged; Aorta; Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coagulants; Double-Blind Method; Elective Surgical Procedures; Female; Fibrinogen; Heart Valve Prosthesis Implantation; Humans; Intraoperative Complications; Ischemic Attack, Transient; Male; Myocardial Infarction; Netherlands; Operative Time; Prospective Studies; Renal Insufficiency; Risk; Sample Size; Stroke | 2017 |
Thoracic epidural anesthesia decreases C-reactive protein levels in patients undergoing elective coronary artery bypass graft surgery with cardiopulmonary bypass.
Topics: Aged; Analgesia, Epidural; Anesthesia Recovery Period; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Local; Bupivacaine; C-Reactive Protein; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; Fentanyl; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Pain, Postoperative; Postoperative Complications; Prospective Studies; Systemic Inflammatory Response Syndrome; Troponin I | 2008 |
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Kaplan-Meier Estimate; Male; Myocardial Infarction; Pravastatin; Risk Factors; Stroke | 2009 |
Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Azetidines; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Cholesterol; Cholesterol, HDL; Drug Combinations; Ezetimibe, Simvastatin Drug Combination; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Inflammation Mediators; Italy; Male; Middle Aged; Myocardial Infarction; Primary Prevention; Secondary Prevention; Simvastatin; Time Factors; Treatment Outcome; Triglycerides; Ultrasonography | 2010 |
[Prognostic value of fibrinogen in patients admitted with suspected unstable angina and non-q-wave myocardial infarction].
Topics: Aged; Angina, Unstable; Biomarkers; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis | 2002 |
Correlation between ST-T-segment changes with markers of hemostasis in patients with acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Apolipoproteins; Biomarkers; C-Reactive Protein; Coronary Disease; Coronary Vessels; Electrocardiography; Female; Fibrinogen; Follow-Up Studies; Germany; Hemostasis; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Myocardial Infarction; Patient Admission; Predictive Value of Tests; Risk Factors; Serum Amyloid A Protein; Statistics as Topic; Survival Analysis; Syndrome; Tissue Plasminogen Activator; Vascular Cell Adhesion Molecule-1 | 2002 |
[Pharmacodynamics, safety, and clinical effects of a novel glycoprotein IIb/IIIa antagonist framon during high risk coronary angioplasty].
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Female; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Integrin beta3; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Membrane Glycoprotein IIb; Receptors, Immunologic; Risk Factors | 2002 |
Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.
Topics: Adult; Coronary Stenosis; Factor V; Female; Fibrinogen; Gene Frequency; Humans; Male; Middle Aged; Mutation; Myocardial Infarction; Polymorphism, Genetic; Risk Factors; Thrombophilia | 2003 |
Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Glycine; Humans; Male; Middle Aged; Myocardial Infarction; Myocarditis; Piperidines; Survival Analysis; Troponin T | 2003 |
Myocardial infarction in patients aged less than 40 years. Frequency of BclI polymorphism in the fibrinogen beta-chain gene and plasma fibrinogen.
Topics: Adult; Case-Control Studies; Fibrinogen; Genes, bcl-1; Humans; Male; Middle Aged; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic | 2003 |
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel
Topics: Aged; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Treatment Outcome | 2004 |
Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Case-Control Studies; Coronary Disease; Factor VII; Factor XIIa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Incidence; Inflammation; Interleukin-6; Male; Middle Aged; Monocytes; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Predictive Value of Tests; Risk Factors; Scotland; Thrombophilia; Triglycerides | 2004 |
Rovamycine as add-on treatment in unstable angina and 4 year evolution with major cardiovascular events.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Anti-Bacterial Agents; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Spiramycin; Treatment Outcome | 2003 |
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Heart Diseases; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Predictive Value of Tests; Ramipril; Risk Factors; Vitamin E | 2006 |
Effects of an expanded cardiac rehabilitation programme in patients treated for an acute myocardial infarction or a coronary artery by-pass graft operation.
Topics: Aged; Analysis of Variance; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Coronary Artery Bypass; Diet; Exercise Test; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Smoking; Stress, Psychological | 2008 |
[Coagulation studies and rheological measurements during streptokinase therapy of myocardial infarction (author's transl)].
Topics: Acute Disease; alpha-Macroglobulins; Blood Coagulation; Blood Viscosity; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Myocardial Infarction; Serum Globulins; Streptokinase | 1980 |
Intracoronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase with streptokinase.
Topics: Adult; Aged; Coronary Artery Bypass; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Streptokinase; Urokinase-Type Plasminogen Activator | 1984 |
Fibrinogen as a risk factor for stroke and myocardial infarction.
Topics: Blood Coagulation Factors; Blood Pressure; Cerebrovascular Disorders; Cholesterol; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk; Sweden | 1984 |
The incidence of deep venous thrombosis in patients with an acute myocardial infarction treated with acenocoumarol or indobufen.
Topics: Acenocoumarol; Aged; Antithrombin III; Female; Fibrinogen; Humans; Isoindoles; Leg; Male; Middle Aged; Myocardial Infarction; Phenylbutyrates; Platelet Count; Plethysmography, Impedance; Radionuclide Imaging; Thrombophlebitis | 1982 |
Pharmacokinetics and pharmacodynamics of saruplase, an unglycosylated single-chain urokinase-type plasminogen activator, in patients with acute myocardial infarction.
Topics: Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Glycosylation; Hemostasis; Humans; Middle Aged; Myocardial Infarction; Peptide Hydrolases; Recombinant Proteins; Urokinase-Type Plasminogen Activator | 1994 |
A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Vessels; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Metalloendopeptidases; Middle Aged; Myocardial Infarction; Prospective Studies; Recombinant Proteins; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Vascular Patency | 1995 |
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study.
Topics: Age Factors; Aged; Bezafibrate; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Israel; Male; Middle Aged; Motor Activity; Multivariate Analysis; Myocardial Infarction; Risk Factors; Sex Factors; Smoking; Triglycerides | 1995 |
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
Topics: Adult; Aged; Angina Pectoris; Blood Coagulation Factors; C-Reactive Protein; Death, Sudden, Cardiac; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Regression Analysis; Risk Factors; Tissue Plasminogen Activator; von Willebrand Factor | 1995 |
Artificial ultraviolet whole-body radiation does not modify serum lipoprotein, plasma fibrinogen, plasminogen or antithrombin III concentrations in post-myocardial infarction patients.
Topics: Antithrombin III; Female; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Plasminogen; Prothrombin Time; Thrombin Time; Ultraviolet Rays; Ultraviolet Therapy; Whole-Body Irradiation | 1994 |
[Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
Topics: Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Viscosity; Cerebrovascular Disorders; Chemical Precipitation; Cholesterol; Coronary Disease; Extracorporeal Circulation; Female; Fibrinogen; Heparin; Humans; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Rheology; Triglycerides | 1993 |
Prostaglandin E1 does not accelerate rTPA-induced thrombolysis in acute myocardial infarction.
Topics: Alprostadil; Drug Synergism; Drug Therapy, Combination; Female; Fibrinogen; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 1994 |
Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.
Topics: Adult; Female; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Kinetics; Male; Middle Aged; Myocardial Infarction; Phosphorylation; Streptokinase | 1993 |
Effects of lipoprotein(a) on thrombolysis.
Topics: alpha-2-Antiplasmin; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolysis; Humans; Lipoprotein(a); Male; Myocardial Infarction; Plasminogen; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1994 |
Streptokinase, but not tissue plasminogen activator, attenuates platelet aggregation in patients with acute myocardial infarction.
Topics: Aged; Chi-Square Distribution; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Neutrophils; Platelet Aggregation; Streptokinase; Tissue Plasminogen Activator; Treatment Outcome | 1993 |
Relation of reperfusion success with anistreplase or alteplase in acute myocardial infarction to body weight. The TEAM-3 investigators.
Topics: Anistreplase; Body Weight; Coronary Angiography; Double-Blind Method; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prospective Studies; Tissue Plasminogen Activator; Treatment Outcome | 1994 |
The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents--lack of relationship to pretreatment streptokinase resistance.
Topics: Anistreplase; Blood Pressure; Blood Viscosity; Double-Blind Method; Drug Resistance; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypotension; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy | 1993 |
Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction.
Topics: Anistreplase; Coronary Angiography; Creatine Kinase; Double-Blind Method; Electrocardiography; Female; Fibrinogen; Hematocrit; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Regression Analysis; Smoking; Streptokinase; Thrombolytic Therapy; Treatment Outcome; Vascular Patency | 1993 |
Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator.
Topics: Antithrombins; Collagen; Coronary Thrombosis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Heart Rupture, Post-Infarction; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Plasminogen Activators; Procollagen; Recurrence; Streptokinase; Tissue Plasminogen Activator | 1996 |
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients.
Topics: Adult; Apolipoproteins; Bezafibrate; Cholesterol; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Feasibility Studies; Fibrinogen; Humans; Hypolipidemic Agents; Male; Myocardial Infarction; Risk Factors; Time Factors; Triglycerides | 1996 |
[Evaluation of lipoprotein (a) and fibrinogen levels in men after premature myocardial infarction and in their sons].
Topics: Adolescent; Adult; Child; Child, Preschool; Fibrinogen; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Risk Factors | 1996 |
Platelet and leukocyte activation after myocardial infarction. Influence of enalapril.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Double-Blind Method; Enalapril; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Pancreatic Elastase; Peptide Fragments; Platelet Activation; Platelet Aggregation; Risk Factors; Survival Rate | 1995 |
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)
Topics: Angina, Unstable; Fibrinogen; Humans; Myocardial Infarction; Prognosis; Prospective Studies; Thrombolytic Therapy; Tissue Plasminogen Activator | 1996 |
Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
Topics: Aged; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Streptokinase; Thrombolytic Therapy; Time Factors; Urokinase-Type Plasminogen Activator | 1996 |
Relationship between intracoronary thrombolysis and fibrino-coagulation--special reference to TAT/PIC and FPA/PIC.
Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Hydrolases; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity; Thrombolytic Therapy | 1996 |
[Lactovegetarian diet: effect on changes in body weight, lipid status, fibrinogen and lipoprotein (a) in cardiovascular patients during inpatient rehabilitation treatment].
Topics: Adult; Aged; Body Weight; Cardiac Rehabilitation; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Coronary Disease; Diet, Fat-Restricted; Diet, Reducing; Diet, Vegetarian; Female; Fibrinogen; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Patient Admission; Rehabilitation Centers; Treatment Outcome; Uric Acid | 1996 |
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.
Topics: Adult; Angina Pectoris; Biomarkers; Death, Sudden; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Tissue Polypeptide Antigen; von Willebrand Factor | 1996 |
Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age.
Topics: Adult; Fibrin; Fibrinogen; Fibrinolysis; Gels; Humans; Lipoproteins; Logistic Models; Male; Multivariate Analysis; Myocardial Infarction; Plasminogen Activator Inhibitor 1 | 1996 |
[Lipid, apoprotein and fibrinogen levels in the blood of male patients following myocardial infarct and the effect of diet on these parameters in ischemic heart disease].
Topics: Apolipoproteins; Body Mass Index; Cholesterol; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Sex Factors | 1996 |
Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction.
Topics: Female; Fibrinogen; Fibrinolytic Agents; Humans; Injections, Intravenous; Male; Metalloendopeptidases; Middle Aged; Myocardial Infarction; Plasminogen Activators; Prospective Studies; Recombinant Proteins; Tissue Plasminogen Activator; Vascular Patency | 1997 |
Heparin-induced extracorporeal fibrinogen/LDL precipitation (HELP): a promising regimen for the treatment of vascular diseases.
Topics: Acute Disease; Cerebrovascular Disorders; Extracorporeal Circulation; Female; Fibrinogen; Fibrinolytic Agents; Fractional Precipitation; Hemodilution; Hemorheology; Heparin; Humans; Lipoproteins, LDL; Male; Myocardial Infarction; Optic Neuropathy, Ischemic; Prospective Studies; Thromboembolism; Visual Acuity; Visual Fields | 1997 |
Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
Topics: Aged; Angina, Unstable; C-Reactive Protein; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Regression Analysis; Risk Factors; Survival Analysis; Troponin; Troponin T | 1997 |
Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial.
Topics: Fibrinogen; Humans; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1998 |
Relation of von Willebrand factor to occurrence of Q waves and thrombolytic treatment in acute myocardial infarction.
Topics: Adult; Aged; Electrocardiography; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Tissue Plasminogen Activator; von Willebrand Factor | 1998 |
Combined use of markers of muscle necrosis and fibrinogen conversion in the early differentiation of myocardial infarction and unstable angina.
Topics: Adult; Aged; Angina, Unstable; Biomarkers; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis | 1998 |
Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiac Catheterization; Cholesterol; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Disease Progression; Factor VII; Factor VIIa; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prospective Studies; Regression Analysis; Risk Assessment; Sex Characteristics; Triglycerides | 1998 |
Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patency.
Topics: alpha-2-Antiplasmin; Clinical Trials, Phase II as Topic; Coronary Vessels; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Humans; Multicenter Studies as Topic; Myocardial Infarction; Plasminogen; Plasminogen Activators; Recombinant Proteins; Tissue Plasminogen Activator; Vascular Patency | 1998 |
Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial.
Topics: Aged; Angina, Unstable; Anticoagulants; C-Reactive Protein; Enoxaparin; Female; Fibrinogen; Heparin; Humans; International Cooperation; Male; Myocardial Infarction; Predictive Value of Tests; Prognosis; Prospective Studies; Treatment Outcome; von Willebrand Factor | 1998 |
Baseline characteristics of patients participating in the Bezafibrate Infarction Prevention (BIP) Study.
Topics: Adult; Aged; Bezafibrate; Cholesterol; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Treatment Outcome; Triglycerides | 1998 |
Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
Topics: Aged; Amino Acid Sequence; Angina, Unstable; Blood Platelets; Cell Aggregation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fibrinogen; Flow Cytometry; Heparin; Humans; Male; Middle Aged; Molecular Sequence Data; Myocardial Infarction; Neutrophils; P-Selectin; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Receptors, Thrombin; Tirofiban; Tyrosine | 1999 |
Lowering fibrinogen levels: clinical update. BIP Study Group. Bezafibrate Infarction Prevention.
Topics: Aged; Bezafibrate; Coronary Disease; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 1999 |
A double-blind randomised dose-effect trial of anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction. The APSAC Research Group.
Topics: Anistreplase; Blood Pressure; Coronary Angiography; Coronary Circulation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibrinogen; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Recurrence; Safety; Thrombolytic Therapy; Treatment Outcome; Vascular Patency | 1993 |
A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Cholesterol, HDL; Double-Blind Method; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Physicians; Prospective Studies; Reference Values; Risk Factors | 1999 |
Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase.
Topics: Double-Blind Method; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator | 1999 |
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
Topics: Age Factors; Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Multivariate Analysis; Myocardial Infarction; Risk Factors; Troponin T | 2000 |
[Fibrinogen serum levels in patients with stable coronary artery disease and acute coronary syndrome].
Topics: Aged; Angina, Unstable; Chi-Square Distribution; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Recurrence | 2000 |
A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study.
Topics: Aged; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk; Severity of Illness Index; Stroke; Triglycerides | 2001 |
Thrombolytic therapy reduces red blood cell aggregation in plasma without affecting intrinsic aggregability.
Topics: Aged; Aspirin; Dextrans; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Plasma; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator | 2002 |
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy; Early Ambulation; Exercise Therapy; Fibrinogen; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Physical Therapy Modalities; Platelet Aggregation; Postoperative Complications; Posture; Pulmonary Embolism; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombosis | 1975 |
Laboratory analyses during two years' treatment with alprenolol in patients with myocardial infarction.
Topics: Aged; Alanine Transaminase; Alprenolol; Aspartate Aminotransferases; Bilirubin; Blood Proteins; Cholesterol; Clinical Trials as Topic; Creatinine; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Myocardial Infarction; Phosphoric Monoester Hydrolases; Placebos; Potassium; Thymol; Triglycerides | 1975 |
Plasma free-fatty-acids and small doses of subcutaneous heparin in acute myocardial infarction.
Topics: Aged; Blood Coagulation Tests; Fatty Acids, Nonesterified; Female; Fibrinogen; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Triglycerides; Warfarin | 1979 |
Prevention of lower extremity venous thrombosis by early mobilization. Confirmation in patients with acute myocardial infarction by 125I-fibrinogen uptake and venography.
Topics: Acute Disease; Adult; Aged; Early Ambulation; Female; Fibrinogen; Heart Failure; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Phlebography; Thrombophlebitis; Time Factors | 1976 |
Primary prevention of atherosclerotic vascular disease with ethylnandrol. An interim report of four-year observations.
Topics: Adult; Aged; Arteriosclerosis; Aspartate Aminotransferases; Blood Pressure; Cholesterol; Clinical Trials as Topic; Ethylestrenol; Fibrinogen; Humans; Intracranial Embolism and Thrombosis; Japan; Male; Middle Aged; Myocardial Infarction; Placebos; Serum Globulins; Solubility; Triglycerides | 1975 |
Plasma fibrinolytic activity following oral anabolic steroid therapy.
Topics: Adult; Aged; Anabolic Agents; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Clot Retraction; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Liver Function Tests; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators | 1975 |
Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART).
Topics: Blood Viscosity; Dietary Fats; Dietary Fiber; Fibrinogen; Fish Oils; Follow-Up Studies; Hemoglobinometry; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Platelet Count; Recurrence; Smoking; Smoking Cessation; Survival Rate | 1992 |
Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial.
Topics: Blood Coagulation Tests; Coronary Circulation; Coronary Thrombosis; Double-Blind Method; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemostasis; Humans; Myocardial Infarction; Recombinant Proteins; Recurrence; Streptokinase; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Vascular Patency | 1992 |
Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).
Topics: Adult; Aged; Blood Coagulation; Coronary Vessels; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1992 |
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.
Topics: Aged; Angina Pectoris; Arteriosclerosis; Factor VII; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Ischemia; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Thrombosis; Vascular Diseases | 1992 |
Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Recurrence; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Urokinase-Type Plasminogen Activator; Vascular Patency; Ventricular Function, Left | 1992 |
Blood rheology in acute myocardial infarction: effects of high-dose i.v. streptokinase compared to placebo.
Topics: Adult; Aged; Blood Flow Velocity; Blood Viscosity; Dose-Response Relationship, Drug; Electrocardiography; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Streptokinase | 1992 |
Recombinant tissue-type plasminogen activator ameliorates ischemic derangements induced by thrombotic occlusion in closed chest anesthetized dogs.
Topics: alpha-2-Antiplasmin; Anesthesia; Animals; Dogs; Female; Fibrinogen; Hemodynamics; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Plasminogen; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Ventricular Function, Left | 1992 |
Influence of platelet size on outcome after myocardial infarction.
Topics: Aged; Blood Viscosity; Blood Volume; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Leukocyte Count; Male; Megakaryocytes; Myocardial Infarction; Platelet Count; Prognosis; Recurrence; Risk Factors; Time Factors | 1991 |
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group.
Topics: Adult; Aged; Coronary Angiography; Coronary Thrombosis; Drug Combinations; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recombinant Proteins; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Vascular Patency | 1991 |
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients.
Topics: Aged; Antithrombin III; Arteriosclerosis; Blood Coagulation Factors; Electrocardiography; Female; Fibrinogen; Hemostasis; Humans; Intracranial Arteriosclerosis; Lipids; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Protein C; Risk Factors; Smoking | 1991 |
Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial infarction.
Topics: Adult; Aged; Coronary Angiography; Female; Fibrinogen; Humans; Injections, Intravenous; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator | 1991 |
Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
Topics: Black People; Blood Transfusion; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator; White People | 1991 |
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
Topics: Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Metoprolol; Myocardial Infarction; Plasminogen; Recombinant Proteins; Statistics as Topic; Thrombolytic Therapy; Tissue Plasminogen Activator | 1991 |
Safety and efficacy of a new regimen of intravenous recombinant tissue-type plasminogen activator potentially suitable for either prehospital or in-hospital administration.
Topics: Adult; Clinical Protocols; Coronary Angiography; Emergency Medical Services; Female; Fibrinogen; Hemorrhage; Hospitalization; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; New York City; Recurrence; Rhode Island; Tissue Plasminogen Activator; Vascular Patency | 1991 |
Modern strategies for treatment of acute myocardial infarction: significance of haemostaseological and rheological findings.
Topics: Anistreplase; Blood Viscosity; Drug Therapy, Combination; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Myocardial Infarction; Plasminogen Activators; Streptokinase; Urokinase-Type Plasminogen Activator | 1990 |
Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.
Topics: alpha-2-Antiplasmin; Blood Coagulation; Factor V; Fibrinogen; Fibrinolysis; Humans; Infusions, Parenteral; Myocardial Infarction; Recombinant Proteins; Streptokinase; Tissue Plasminogen Activator | 1986 |
Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Topics: Aged; Beta-Globulins; beta-Thromboglobulin; Blood Coagulation Tests; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Infusions, Parenteral; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Factor 4; Time Factors | 1986 |
Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
Topics: alpha-2-Antiplasmin; Anistreplase; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Myocardial Infarction; Plasminogen; Prothrombin Time; Streptokinase; Thrombin Time | 1987 |
Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction.
Topics: Adult; Aged; alpha-2-Antiplasmin; Clinical Trials as Topic; Coronary Circulation; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hemostasis; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators; Recombinant Proteins; Time Factors; Urokinase-Type Plasminogen Activator; Vascular Patency | 1988 |
Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction.
Topics: alpha-2-Antiplasmin; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Glycosylation; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Plasminogen; Plasminogen Activators; Time Factors; Urokinase-Type Plasminogen Activator; Vascular Patency | 1988 |
Randomised double-blind trial of recombinant pro-urokinase against streptokinase in acute myocardial infarction. PRIMI Trial Study Group.
Topics: Adult; Aged; Blood Flow Velocity; Double-Blind Method; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Plasminogen Activators; Radiography; Random Allocation; Recombinant Proteins; Streptokinase; Time Factors; Urokinase-Type Plasminogen Activator; Vascular Patency | 1989 |
Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator.
Topics: Adult; Aged; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Radiography; Streptokinase | 1985 |
Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction.
Topics: Adult; Aged; Angioplasty, Balloon; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypass; Double-Blind Method; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Random Allocation; Tissue Plasminogen Activator | 1985 |
The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction.
Topics: Anistreplase; Arteries; Clinical Trials as Topic; Coronary Vessels; Creatine Kinase; Fibrinogen; Heart; Heart Ventricles; Heparin; Humans; Myocardial Infarction; Plasminogen; Streptokinase; Vascular Patency | 1988 |
A kinetic analysis of fibrinogenolysis during plasminogen activator therapy.
Topics: Clinical Trials as Topic; Computer Simulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Fibrinogen; Humans; Infusions, Intravenous; Kinetics; Models, Biological; Myocardial Infarction; Plasminogen; Prospective Studies; Random Allocation; Tissue Plasminogen Activator | 1987 |
Dose-effect relationship estimation for thrombolytic therapy in acute myocardial infarction.
Topics: Angiography; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fibrinogen; Fibrinolytic Agents; Humans; Myocardial Infarction; Recombinant Proteins; Research Design; Streptokinase; Tissue Plasminogen Activator | 1987 |
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
Topics: Clinical Trials as Topic; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Myocardial Infarction; Random Allocation; Recombinant Proteins; Streptokinase; Thrombocytopenia; Tissue Plasminogen Activator | 1988 |
Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
Topics: Adult; Aged; Anistreplase; Clinical Trials as Topic; Coronary Angiography; Coronary Circulation; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase; Vascular Patency | 1987 |
Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
Topics: Adult; Aged; Anistreplase; Fibrinogen; Fibrinolytic Agents; Heart Ventricles; Humans; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Myocardial Infarction; Plasminogen; Random Allocation; Streptokinase; Vascular Patency | 1987 |
Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
Topics: Aged; Anistreplase; Coronary Angiography; Creatine Kinase; Electrocardiography; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Random Allocation; Streptokinase; Vascular Patency | 1987 |
Intravenous streptokinase versus heparin in the acute stage of myocardial infarction. A prospective randomised trial in south-east France.
Topics: Adult; Coronary Angiography; Creatine Kinase; Electrocardiography; Female; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Random Allocation; Recurrence; Streptokinase | 1986 |
[Intravenous streptokinase versus heparin in the acute phase of myocardial infarction. Randomized prospective study in southeast France].
Topics: Aged; Angiography; Electrocardiography; Female; Fibrinogen; France; Heart Ventricles; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Random Allocation; Streptokinase | 1986 |
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Electrocardiography; Female; Fibrinogen; Heparin; Humans; Hypercholesterolemia; Informed Consent; Injections, Subcutaneous; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Tachycardia; Thrombophlebitis; Time Factors | 1973 |
Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
Topics: Adult; Aged; Angina Pectoris; Biguanides; Blood Coagulation Tests; Cholesterol; Ethylestrenol; Female; Fibrinogen; Humans; Intermittent Claudication; Male; Metformin; Middle Aged; Myocardial Infarction; Phenformin; Placebos; Vascular Diseases | 1967 |
Heparin in the prevention of deep vein thrombosis after myocardial infarction.
Topics: Aged; Clinical Trials as Topic; Female; Fibrinogen; Heparin; Humans; Injections, Intravenous; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Thrombophlebitis | 1972 |
Fibrinolytic enhancement by stanozolol: a double blind trial.
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Stanozolol | 1972 |
Small subcutaneous doses of heparin in prevention of venous thrombosis.
Topics: Adult; Aged; Blood Coagulation Tests; Blood Transfusion; Clinical Trials as Topic; Female; Femoral Fractures; Femoral Vein; Fibrinogen; Hematocrit; Heparin; Hip; Humans; Injections, Subcutaneous; Iodine Isotopes; Male; Middle Aged; Myocardial Infarction; Phlebography; Popliteal Vein; Postoperative Complications; Prospective Studies; Radionuclide Imaging; Thrombophlebitis; Thromboplastin; Thrombosis | 1973 |
Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction.
Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Clinical Trials as Topic; Exercise Therapy; Fibrinogen; Heparin; Humans; Infusions, Parenteral; Iodine Isotopes; Leg; Movement; Myocardial Infarction; Prognosis; Thrombophlebitis; Time Factors; Warfarin | 1973 |
[Short-term fibrinolytic treatment in acute myocardial infarction].
Topics: Acute Disease; Adult; Aged; Anticoagulants; Benzyl Compounds; Blood Viscosity; Clinical Trials as Topic; Coumarins; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Placebos; Streptokinase; Time Factors | 1973 |
Biochemical evaluation of low dose of urokinase in acute myocardial infarction. A double-blind study.
Topics: Acute Disease; alpha 1-Antitrypsin; Blood Coagulation; Clinical Trials as Topic; Clot Retraction; Depression, Chemical; Drug Evaluation; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Injections, Intravenous; Macroglobulins; Male; Myocardial Infarction; Placebos; Plasminogen; Platelet Adhesiveness; Prothrombin Time; Serum Globulins; Stimulation, Chemical; Time Factors | 1973 |
Evaluation of hematologic effects of intra-aortic balloon assistance in man.
Topics: Anticoagulants; Aorta; Assisted Circulation; Blood Cell Count; Blood Platelets; Blood Transfusion; Cardiac Surgical Procedures; Clinical Trials as Topic; Fibrinogen; Hemoglobins; Humans; Microscopy, Electron, Scanning; Myocardial Infarction; Preoperative Care; Shock, Cardiogenic | 1972 |
Single-blind randomised multicentre trial comparing heparin and streptokinase treatment in recent myocardial infarction.
Topics: Acute Disease; Aspartate Aminotransferases; Blood Coagulation Tests; Blood Sedimentation; Clinical Trials as Topic; Coumarins; Creatine Kinase; Electrocardiography; Erythrocytes; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Heparin; Humans; Injections, Intravenous; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Prednisolone; Streptokinase | 1969 |
698 other study(ies) available for fibrinogen and Cardiovascular Stroke
Article | Year |
---|---|
Association between fibrinogen-to-albumin ratio and the presence and severity of coronary artery disease in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Patient Acuity; Predictive Value of Tests; Risk Assessment; Risk Factors; Serum Albumin, Human | 2021 |
The Correlation between the Triglyceride-Glucose Index and Coagulation Markers in Patients with Recent Acute Myocardial Infarction.
Topics: Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Female; Fibrinogen; Glucose; Hemostatics; Humans; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Risk Assessment; Risk Factors; Thrombophilia; Triglycerides | 2022 |
Synergistic role of circulating CD14++CD16+ monocytes and fibrinogen in predicting the cardiovascular events after myocardial infarction.
Topics: Fibrinogen; Flow Cytometry; Humans; Monocytes; Myocardial Infarction | 2023 |
The Fibrinogen-to-Albumin Ratio Is Associated with Poor Prognosis in Patients with Coronary Artery Disease: Findings from a Large Cohort.
Topics: Albumins; Coronary Artery Disease; Fibrinogen; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Prospective Studies; Risk Factors | 2023 |
Predictive Biochemical Model of Frailty and Mortality After Acute Myocardial Infarction.
Topics: Acute Coronary Syndrome; Aged; Fibrinogen; Frailty; Growth Differentiation Factor 15; Humans; Myocardial Infarction | 2023 |
Serum fibrinogen-to-albumin ratio predicts new-onset atrial fibrillation risk during hospitalization in patients with acute myocardial infarction after percutaneous coronary intervention: a retrospective study.
Topics: Albumins; Atrial Fibrillation; Fibrinogen; Hospitalization; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Retrospective Studies | 2023 |
Human endurance and AI: Audentes Fortna Iuvat - fortune favours the bold.
Topics: Achievement; Artificial Intelligence; Cardiopulmonary Bypass; Extracorporeal Membrane Oxygenation; Fibrinogen; Humans; Interleukins; Lactic Acid; Myocardial Infarction; Physical Endurance; Postoperative Hemorrhage; Running | 2019 |
Uncovering the protective mechanism of Huoxue Anxin Recipe against coronary heart disease by network analysis and experimental validation.
Topics: Animals; Apolipoprotein A-I; Blood Coagulation; Collagen; Complement C3; Coronary Disease; Down-Regulation; Drugs, Chinese Herbal; Fibrinogen; Inflammation; Interleukin-16; Male; Myocardial Infarction; Myocardium; Protective Agents; Rats; Rats, Sprague-Dawley | 2020 |
Comparison of prognostic significance between serum fibrinogen and Global Registry of Acute Coronary Events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Age Factors; Aged; Angina, Unstable; Blood Pressure; Cohort Studies; Creatinine; Electrocardiography; Female; Fibrinogen; Heart Arrest; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve | 2020 |
Analysis of L-arginine:glycine amidinotransferase-, creatine- and homoarginine-dependent gene regulation in the murine heart.
Topics: Amidinotransferases; Animals; Arginine; Connective Tissue Growth Factor; Creatine; Desmocollins; Disease Models, Animal; Energy Metabolism; Fibrinogen; Gene Expression Regulation; Genetic Association Studies; Homoarginine; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Mice, Transgenic; Myocardial Infarction; Myocardium; Potassium Channels; Transcriptome | 2020 |
Management of Myocardial Infarction in Children with Giant Coronary Artery Aneurysms after Kawasaki Disease.
Topics: Anticoagulants; Antithrombin III; Antithrombins; Biomarkers; Child; Clinical Decision-Making; Clinical Protocols; Coronary Aneurysm; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Mucocutaneous Lymph Node Syndrome; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Tissue Plasminogen Activator | 2020 |
Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic Stroke.
Topics: Aged; Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Cluster Analysis; COVID-19; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Humans; Inflammation; Interleukin-6; Ischemic Stroke; L-Lactate Dehydrogenase; Leukocyte Count; Logistic Models; Machine Learning; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Pulmonary Embolism; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Thrombophilia; Venous Thrombosis | 2021 |
Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study.
Topics: Aged; Beijing; C-Reactive Protein; Comorbidity; Coronary Artery Bypass; Coronary Artery Disease; Death; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Stroke; Stroke Volume | 2017 |
Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples.
Topics: Antineoplastic Agents, Hormonal; Cardiovascular Diseases; Clinical Trials as Topic; Endometrial Neoplasms; Female; Fibrinogen; Humans; Multivariate Analysis; Myocardial Infarction; Network Meta-Analysis; Progesterone; Thrombolytic Therapy; Treatment Outcome | 2017 |
Coagulation F13A1 V34L, fibrinogen and homocysteine versus conventional risk factors in the pathogenesis of MI in young persons.
Topics: Adolescent; Adult; Blood Coagulation; DNA; Factor XIIIa; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genotype; Homocysteine; Humans; Male; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Retrospective Studies; Risk Factors; Young Adult | 2018 |
Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
Topics: Alleles; Case-Control Studies; Egypt; Factor XIII; Female; Fibrinogen; Genotype; Hemostasis; Heterozygote; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Prothrombin; Risk | 2018 |
Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease.
Topics: Aged; Ambulatory Care; Amputation, Surgical; Brain Ischemia; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Registries; Risk Factors; Spain; Stroke | 2018 |
Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease.
Topics: Aged; Biomarkers; Cohort Studies; Coronary Artery Disease; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Neopterin; Prognosis; Proportional Hazards Models; Prospective Studies; Risk; Smoking; Troponin T | 2018 |
Is a variability of platelet inhibitory effect of anti-platelet agents important for predicting new lesion in atherothrombotic stroke?
Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Diffusion Magnetic Resonance Imaging; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Thrombosis | 2018 |
Biomarkers of vascular injury in relation to myocardial infarction risk: A population-based study.
Topics: Adult; Biomarkers; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Vascular Diseases | 2019 |
Digit ratio (2D:4D), myocardial infarction and fibrinogen in men.
Topics: Aged; Blood Viscosity; Fibrinogen; Fingers; Humans; Male; Middle Aged; Myocardial Infarction | 2019 |
Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.
Topics: Alleles; Coronary Disease; Fibrinogen; Genetic Pleiotropy; Genetic Variation; Genome-Wide Association Study; Humans; Incidence; Mendelian Randomization Analysis; Models, Genetic; Multivariate Analysis; Myocardial Infarction; Odds Ratio | 2019 |
Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.
Topics: ABO Blood-Group System; Adult; Aged; Case-Control Studies; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Norway; Pedigree; Polymorphism, Single Nucleotide; Prothrombin; Risk Assessment; Risk Factors; Venous Thromboembolism | 2019 |
Role of relationship between HbA1c, fibrinogen and HDL-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus.
Topics: Aged; Atherosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Risk Factors | 2013 |
Early pseudoaneurysm formation after the sutureless technique for left ventricular rupture due to acute myocardial infarction.
Topics: Administration, Topical; Aged; Aneurysm, False; Aprotinin; Cardiac Tamponade; Drug Combinations; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Hemostatics; Humans; Male; Myocardial Infarction; Reoperation; Suture Techniques; Thrombin; Time Factors; Ventricular Septal Rupture | 2014 |
Relationship between inflammatory markers and new cardiovascular events in patients with acute myocardial infarction who underwent primary angioplasty.
Topics: Acute Disease; Age Factors; Angioplasty; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cardiovascular Agents; Cardiovascular Diseases; Electrocardiography; Fibrinogen; Humans; Inflammation Mediators; Myocardial Infarction; Socioeconomic Factors | 2013 |
Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina.
Topics: Aged; Angina, Unstable; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Male; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Saudi Arabia; Tissue Plasminogen Activator | 2012 |
Enhanced infarct stabilization and neovascularization mediated by VEGF-loaded PEGylated fibrinogen hydrogel in a rodent myocardial infarction model.
Topics: Cell Movement; Cell Proliferation; Cells, Cultured; Echocardiography; Fibrinogen; Hemodynamics; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Myocardial Infarction; Polyethylene Glycols; Vascular Endothelial Growth Factor A | 2013 |
Oral health status and the occurrence and clinical course of myocardial infarction in hospital phase: a case-control study.
Topics: Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Dental Plaque Index; Fibrinogen; Health Status; Hospitalization; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Mouth, Edentulous; Myocardial Infarction; Oral Health; Periodontal Diseases; Periodontal Index; Plaque, Atherosclerotic; Predictive Value of Tests; Prevalence; Risk Factors; Stroke Volume; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2013 |
High-molecular-weight kininogen and the intrinsic coagulation pathway in patients with de novo acute myocardial infarction.
Topics: Acute Disease; Aged; Blood Coagulation; Computational Biology; Factor XI; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Kininogen, High-Molecular-Weight; Male; Middle Aged; Myocardial Infarction; Proteomics; Systems Biology | 2013 |
Blunted inflammatory response in STEMI patients timely reperfused.
Topics: Aged; Biomarkers; Blood Sedimentation; C-Reactive Protein; Coronary Angiography; Female; Fibrinogen; Fibrinolytic Agents; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Risk Factors; Tenecteplase; Thrombolytic Therapy; Time Factors; Time-to-Treatment; Tissue Plasminogen Activator; Treatment Outcome | 2014 |
PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium.
Topics: Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Female; Fibrinogen; Genetic Engineering; Hemodynamics; Human Umbilical Vein Endothelial Cells; Humans; Induced Pluripotent Stem Cells; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred NOD; Mice, SCID; Myocardial Contraction; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Neovascularization, Physiologic; Placenta Growth Factor; Polyethylene Glycols; Pregnancy Proteins; Recovery of Function; Regeneration; Time Factors; Tissue Engineering; Tissue Scaffolds; Transduction, Genetic; Transfection | 2014 |
The roles of a novel anti-inflammatory factor, milk fat globule-epidermal growth factor 8, in patients with coronary atherosclerotic heart disease.
Topics: Angina Pectoris; Angina, Unstable; Antigens, Surface; C-Reactive Protein; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Milk Proteins; Myocardial Infarction; Risk Factors; Severity of Illness Index; Sex Factors; Smoking; Triglycerides | 2014 |
Hemostatic status of pre and post intracoronary injection of peripheral blood stem cells in patients with recent myocardial infarction.
Topics: Adult; Aged; Blood Viscosity; C-Reactive Protein; Drug-Eluting Stents; Erythropoietin; Female; Fibrinogen; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Percutaneous Coronary Intervention; Peripheral Blood Stem Cell Transplantation; Platelet Aggregation; Prothrombin Time; Transplantation, Autologous | 2014 |
Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction.
Topics: Aged; Blood Coagulation; Case-Control Studies; Circular Dichroism; Female; Fibrinogen; Fibrinolysis; Humans; Male; Microscopy, Electron, Transmission; Microscopy, Interference; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Oxidative Stress; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Protein Carbonylation; Protein Structure, Secondary; Structure-Activity Relationship; Time Factors | 2014 |
Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events.
Topics: Adipokines; Aged; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Chitinase-3-Like Protein 1; Cholesterol, LDL; Female; Fibrinogen; Genome-Wide Association Study; Humans; Incidence; Intercellular Adhesion Molecule-1; Lectins; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Prospective Studies; Stroke | 2014 |
Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; alpha-Macroglobulins; Biomarkers; Coronary Artery Disease; Electrophoresis, Gel, Two-Dimensional; Female; Fibrinogen; Humans; Image Processing, Computer-Assisted; Male; Mass Spectrometry; Middle Aged; Myocardial Infarction; Open Reading Frames; Oxidoreductases Acting on CH-CH Group Donors; Protein Interaction Mapping; Proteins; Proteome; Proteomics; Systems Biology | 2014 |
Changes in thrombus composition and profilin-1 release in acute myocardial infarction.
Topics: Analysis of Variance; Blood Platelets; Clopidogrel; Coronary Thrombosis; Female; Fibrinogen; Humans; Leukocytes; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Profilins; Thrombectomy; Thrombin; Ticlopidine; Time-to-Treatment | 2015 |
Analysis of risk factors of ST-segment elevation myocardial infarction in young patients.
Topics: Adult; Age Factors; Aged; Biomarkers; Female; Fibrinogen; Genetic Predisposition to Disease; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Sex Factors; Smoking | 2014 |
Factor XIII B subunit polymorphisms and the risk of coronary artery disease.
Topics: Aged; Alleles; Case-Control Studies; Coronary Artery Disease; Factor XIII; Factor XIIIa; Female; Fibrinogen; Genotype; Heterozygote; Humans; Introns; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors | 2015 |
Experimental and imaging techniques for examining fibrin clot structures in normal and diseased states.
Topics: Anemia, Sickle Cell; Blood Chemical Analysis; Factor XIIIa; Fibrin; Fibrinogen; Fibrinolysis; Humans; Microscopy, Confocal; Myocardial Infarction; Myocardial Ischemia; Stroke; Thrombin; Thrombosis | 2015 |
A Risk Score Derived from the Analysis of a Cluster of 27 Serum Inflammatory Cytokines to Predict Long Term Outcome in Patients with Acute Myocardial Infarction: a Pilot Study.
Topics: Acute Disease; Aged; Aged, 80 and over; Cholesterol; Cytokines; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Risk Factors; Statistics, Nonparametric | 2015 |
Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Blood Coagulation; Cytokines; Disease Models, Animal; Eugenol; Fibrinogen; Fibrinolytic Agents; Hemodynamics; Inflammation Mediators; Isoproterenol; Kidney; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Necrosis; Oxidative Stress; Peptidyl-Dipeptidase A; Rats, Wistar; Renin-Angiotensin System; Ventricular Remodeling | 2016 |
Variants of the Coagulation and Inflammation Genes Are Replicably Associated with Myocardial Infarction and Epistatically Interact in Russians.
Topics: Adult; Aged; Alleles; Blood Coagulation; C-Reactive Protein; Cyclooxygenase 1; Female; Fibrinogen; Genetic Association Studies; Genetic Markers; Genotype; Humans; Inflammation; Interferon-gamma; Linkage Disequilibrium; Logistic Models; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Factors; Russia; Transforming Growth Factor beta1 | 2015 |
Influence of pre-existing inflammation on the outcome of acute coronary syndrome: a cross-sectional study.
Topics: Acute Coronary Syndrome; Adult; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Platelet Count; Risk Factors; Serum Amyloid A Protein | 2016 |
Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention.
Topics: Acute Coronary Syndrome; Aged; California; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Humans; Incidence; Male; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Postoperative Hemorrhage; Prognosis; Prosthesis Design; Retrospective Studies; Stents; Survival Rate; Thrombolytic Therapy; Time Factors | 2016 |
Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury.
Topics: Aged; Angina, Stable; Biomarkers; Chromatography, Liquid; Extracellular Vesicles; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Proteomics; Tandem Mass Spectrometry; Up-Regulation | 2016 |
Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study.
Topics: Acute Coronary Syndrome; Angina Pectoris; Biomarkers; Epidemiologic Methods; Fibrin Fibrinogen Degradation Products; Fibrinogen; France; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Northern Ireland; von Willebrand Factor | 2008 |
Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Artery Bypass; Female; Fibrinogen; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Prognosis; Proportional Hazards Models; Prothrombin Time; Recurrence; Retrospective Studies; Risk Assessment; Stents | 2008 |
Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.
Topics: Blood Platelets; Clopidogrel; Dose-Response Relationship, Drug; Electrocardiography; Female; Fibrinogen; Flow Cytometry; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Treatment Outcome | 2008 |
Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study.
Topics: Aged; C-Reactive Protein; Fibrinogen; Genotype; Haplotypes; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; White People | 2008 |
Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction.
Topics: Case-Control Studies; Death, Sudden; Factor XIII; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Prevalence; Prothrombin; Toll-Like Receptor 4; Ventricular Fibrillation | 2008 |
Epidural anesthesia and analgesia in cardiac surgery.
Topics: Analgesia, Epidural; Anesthesia, Epidural; C-Reactive Protein; Cardiac Surgical Procedures; Fibrinogen; Humans; Meta-Analysis as Topic; Myocardial Infarction; Postoperative Complications; Randomized Controlled Trials as Topic; Systemic Inflammatory Response Syndrome | 2008 |
Influence of fibrinogen beta-chain gene variations on risk of myocardial infarction in a Chinese Han population.
Topics: Adult; Aged; China; Female; Fibrinogen; Genetic Variation; Haplotypes; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide | 2008 |
Histopathological study of healing after allogenic mesenchymal stem cell delivery in myocardial infarction in dogs.
Topics: Animals; Collagen; Dogs; Extracellular Matrix; Female; Fibrinogen; Fibronectins; Histological Techniques; Laminin; Male; Mesenchymal Stem Cell Transplantation; Myocardial Infarction; Myocardium; Transplantation, Homologous | 2009 |
Relationship between oxidized fibrinogen and hemostasis disturbances and endothelial dysfunction in myocardial infarction.
Topics: Adult; Aged; Blood Coagulation Disorders; Case-Control Studies; Endothelium, Vascular; Fibrinogen; Hemostasis; Humans; Lipid Peroxidation; Male; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Vascular Diseases | 2008 |
Fibrinogen genes modify the fibrinogen response to ambient particulate matter.
Topics: Adult; Aged; Aged, 80 and over; Environmental Exposure; Europe; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homozygote; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Particulate Matter; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Urban Population | 2009 |
Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke.
Topics: Adolescent; Adult; Alleles; Case-Control Studies; Female; Fibrinogen; Genetic Variation; Genotype; Humans; Middle Aged; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Risk; Stroke; Thrombosis | 2009 |
Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Electrocardiography; Emergency Treatment; Female; Fibrinogen; Humans; Lipids; Macrophage Colony-Stimulating Factor; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Troponin I | 2009 |
Breathe deeply into your genes!: genetic variants and air pollution effects.
Topics: Environmental Exposure; Fibrinogen; Genetic Predisposition to Disease; Humans; Myocardial Infarction; Particulate Matter; Polymorphism, Single Nucleotide; Urban Population | 2009 |
G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece.
Topics: Adult; Age of Onset; Alleles; Coronary Disease; Female; Fibrinogen; Genotype; Greece; Humans; Male; Myocardial Infarction; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Risk; Risk Factors | 2010 |
Prothrombin fragment 1 + 2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; C-Reactive Protein; Carotid Artery, Common; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Plasminogen; Plasminogen Activator Inhibitor 1; Prothrombin; Risk Factors; Tunica Media; Ultrasonography; von Willebrand Factor | 2009 |
Plasma fibrinogen level may predict critical coronary artery stenosis in young adults with myocardial infarction.
Topics: Adult; Antithrombin III; Biomarkers; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Male; Myocardial Infarction; Predictive Value of Tests; Protein C; Protein S; Risk Factors; Smoking | 2009 |
The role of platelets CD40 ligand (CD154) in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Angina, Unstable; Blood Platelets; Case-Control Studies; CD40 Ligand; Female; Fibrinogen; Humans; Lipoproteins, LDL; Male; Middle Aged; Models, Biological; Myocardial Infarction; Nitric Oxide; P-Selectin | 2009 |
Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample.
Topics: Aged; Air Pollutants; Air Pollution; Biomarkers; Blood Coagulation; Case-Control Studies; Environmental Exposure; Environmental Monitoring; Female; Fibrinogen; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Sweden; Urban Health | 2009 |
Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: a case control study.
Topics: Adult; Age of Onset; Asian People; Biomarkers; Case-Control Studies; Fibrinogen; Humans; Iran; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Assessment; Risk Factors; Up-Regulation | 2009 |
Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.
Topics: Acute Coronary Syndrome; Angina Pectoris; Blood Viscosity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hemorheology; Humans; Hypercholesterolemia; Incidence; Myocardial Infarction; Myocardial Revascularization; Plasminogen Inactivators; Risk Factors; Thrombophilia | 2009 |
Modification of the interleukin-6 response to air pollution by interleukin-6 and fibrinogen polymorphisms.
Topics: Aged; Air Pollution; Carbon Monoxide; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Nitrogen Dioxide; Polymorphism, Single Nucleotide | 2009 |
[Oxidized fibrinogen and its relationship with hemostasis disturbances and endothelial dysfunction during coronary heart disease and myocardial infarction].
Topics: Adult; Aged; Blood Coagulation Disorders; Coronary Artery Disease; Endothelium, Vascular; Fibrinogen; Hemostasis; Humans; Lipid Peroxidation; Male; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Platelet Aggregation; Prognosis; Vasodilation | 2009 |
Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort.
Topics: Aged; Atherosclerosis; Biomarkers; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Inflammation; Kaplan-Meier Estimate; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Risk Factors; Serum Albumin; Smoking; United States; von Willebrand Factor | 2009 |
Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Male; Mass Spectrometry; Middle Aged; Myocardial Infarction; Protein Carbonylation; Protein Multimerization; Thrombin; Thrombosis; Tyrosine | 2010 |
Alcohol intake, myocardial infarction, biochemical risk factors, and alcohol dehydrogenase genotypes.
Topics: Adult; Aged; Alcohol Dehydrogenase; Alcohol Drinking; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Denmark; Female; Fibrinogen; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors | 2009 |
Hemostatic gene polymorphisms in young Sardinian with non-fatal acute myocardial infarction.
Topics: Adult; Antigens, Human Platelet; Autoantigens; Factor V; Female; Fibrinogen; Humans; Integrin beta3; Iodide Peroxidase; Iron-Binding Proteins; Italy; Male; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Thrombomodulin; von Willebrand Factor | 2010 |
Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study.
Topics: Aged; Cardiovascular Diseases; Carotid Arteries; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Humans; Interleukin-6; Male; Models, Biological; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk; Stroke | 2010 |
[Relationship between activity of fibrinolysis, parameters of lipid spectrum and carbohydrate metabolism].
Topics: Aged; Angina Pectoris; Atherosclerosis; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Chi-Square Distribution; Cohort Studies; Data Interpretation, Statistical; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension; Insulin; Lipids; Male; Myocardial Infarction; Myocardial Ischemia; Obesity, Abdominal; Prospective Studies; Sex Factors | 2010 |
-94 ins/del ATTG NFKB1 gene variant is associated with lower susceptibility to myocardial infarction.
Topics: Aged; Biomarkers; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; I-kappa B Proteins; Linear Models; Logistic Models; Male; Middle Aged; Myocardial Infarction; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Polymorphism, Genetic | 2011 |
Momentary stress moderates procoagulant reactivity to a trauma-specific interview in patients with posttraumatic stress disorder caused by myocardial infarction.
Topics: Aged; Case-Control Studies; Diagnostic and Statistical Manual of Mental Disorders; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Interview, Psychological; Male; Middle Aged; Myocardial Infarction; Risk Factors; Severity of Illness Index; Stress Disorders, Post-Traumatic; Stress, Psychological; Surveys and Questionnaires | 2010 |
Age-related short-term effect of ramipril on N-terminal pro-brain natriuretic peptide and markers of hemostasis in patients after acute myocardial infarction.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Plasminogen Activator Inhibitor 1; Prospective Studies; Ramipril; Slovenia; von Willebrand Factor | 2010 |
Clinical and laboratory characteristics in patients with acute myocardial infarction due to occlusive vasospasm.
Topics: Adult; Aged; Angina Pectoris, Variant; Biomarkers; C-Reactive Protein; Clinical Laboratory Information Systems; Coronary Stenosis; Coronary Vasospasm; Ergonovine; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction | 2010 |
The development of anemia of inflammation during acute myocardial infarction.
Topics: Aged; Anemia; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Prospective Studies | 2012 |
[To prevent myocardial infarction with a tooth brush?].
Topics: C-Reactive Protein; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Periodontitis; Risk Factors; Scotland; Socioeconomic Factors; Toothbrushing | 2010 |
Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation Mediators; Interleukin-6; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Retrospective Studies; Risk Factors; Stroke | 2011 |
Correlations between abdominal circumference and the breakage resistance of the fibrin clot in patients with diabetes mellitus type 2.
Topics: Aged; Brain Ischemia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Obesity, Abdominal; Platelet Activation; Thrombophilia; Thrombosis; Time; Waist Circumference | 2010 |
A combined cell therapy and in-situ tissue-engineering approach for myocardial repair.
Topics: Animals; Cell- and Tissue-Based Therapy; Cells, Cultured; Echocardiography; Embryonic Stem Cells; Fibrinogen; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Polyethylene Glycols; Rats; Rats, Inbred F344; Tissue Engineering | 2011 |
Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease.
Topics: Adult; Aged; Blood Pressure; C-Reactive Protein; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Fibrinogen; Genotype; Heterozygote; Humans; Ischemia; Lipids; Lipoproteins; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Myocardial Infarction; Pseudoxanthoma Elasticum; Risk Factors; Vascular Diseases | 2011 |
Influence of matrix metalloproteinase-12 on fibrinogen level.
Topics: Animals; Atherosclerosis; England; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Homozygote; Humans; Italy; Linear Models; Linkage Disequilibrium; Logistic Models; Matrix Metalloproteinase 12; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors | 2012 |
Macrophage inflammatory protein-1β and fibrinogen are synergistic predictive markers of prognosis of intermediate coronary artery lesions.
Topics: Aged; Angina Pectoris; Biomarkers; Chemokine CCL4; Coronary Stenosis; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Risk Factors; Survival Analysis | 2012 |
Variability of fibrinogen measurements in post-myocardial infarction patients. Results from the AIRGENE study center Augsburg.
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Europe; Female; Fibrinogen; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Nephelometry and Turbidimetry; Predictive Value of Tests; Reproducibility of Results; Risk Assessment; Risk Factors; Time Factors | 2012 |
Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction.
Topics: Biomarkers; Blood Coagulation Factors; Comorbidity; Coronary Thrombosis; Female; Fibrinogen; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Reproducibility of Results; Sensitivity and Specificity; Spain; Thromboplastin | 2012 |
The prognostic value of plasma fibrinogen concentrations of patients with ST-elevation myocardial infarction and treated by primary percutaneous coronary intervention: a cautionary message.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Proportional Hazards Models; Risk | 2012 |
Multiple gene polymorphisms predisposing to the prothrombotic state in an adolescent with acute myocardial infarction.
Topics: Adolescent; Anticoagulants; Aspirin; Cholesterol Ester Transfer Proteins; Clopidogrel; Coronary Angiography; Electrocardiography; Fibrinogen; Genetic Predisposition to Disease; Heparin; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Thrombosis; Ticlopidine | 2012 |
Fever in myocardial infarction: is it still common, is it still predictive?
Topics: Aged; Biomarkers; Body Temperature Regulation; C-Reactive Protein; Female; Fever; Fibrinogen; Humans; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
[Endogenous sex hormone testosterone and haemostatic factors in young men after myocardial infarction].
Topics: Adult; Age Factors; Blood Coagulation Factors; Blood Coagulation Tests; Estradiol; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Risk Factors; Sex Factors; Statistics as Topic; Testosterone | 2012 |
Renal insufficiency is an independent predictor of in-hospital mortality for patients with acute myocardial infarction receiving primary percutaneous coronary intervention.
Topics: Aged; Dimerization; Electrocardiography; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glomerular Filtration Rate; Hospitalization; Humans; Kidney; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Renal Insufficiency; Retrospective Studies; Treatment Outcome | 2012 |
[Association between gene polymorphisms and myocardial infarction in Han Chinese of Yunnan province].
Topics: Adult; Aged; Aged, 80 and over; China; Factor VII; Factor XII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic | 2012 |
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Forced Expiratory Volume; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pneumonia; Pulmonary Disease, Chronic Obstructive; Risk; Vital Capacity | 2012 |
Increased inflammatory response in patients with the first myocardial infarction and nonsignificant stenosis of infarct-related artery.
Topics: Adult; Aged; Blood Sedimentation; C-Reactive Protein; Coronary Stenosis; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy | 2012 |
IgG, IgM and inflammatory markers serum concentration in patients with acute coronary syndrome: a pilot study.
Topics: Acute Coronary Syndrome; Angina, Unstable; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Myocardial Infarction; Pilot Projects | 2012 |
Myocardial infarction marker levels are influenced by prothrombin and tumor necrosis factor-α gene polymorphisms in young patients.
Topics: Adult; Age Factors; Biomarkers; Creatine Kinase, MB Form; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Prothrombin; Troponin; Tumor Necrosis Factor-alpha; Young Adult | 2013 |
Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention.
Topics: Aged; Blood Platelets; C-Reactive Protein; Clopidogrel; Coronary Artery Disease; Creatine Kinase, MB Form; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Predictive Value of Tests; Premedication; Prospective Studies; ROC Curve; Sensitivity and Specificity; Ticlopidine; Troponin | 2013 |
[Case-cohort surveys].
Topics: Biomarkers; Case-Control Studies; Cohort Studies; Computer Simulation; Epidemiologic Methods; Fibrinogen; France; Humans; Mathematical Computing; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Reproducibility of Results; Risk; Sensitivity and Specificity | 2013 |
Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk.
Topics: Adenosine Diphosphate; Coronary Artery Disease; Female; Fibrinogen; Flow Cytometry; Humans; Kidney Failure, Chronic; Male; Membranes, Artificial; Microscopy, Confocal; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Renal Dialysis; Risk Factors | 2002 |
[Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Death, Sudden, Cardiac; Female; Fibrinogen; Follow-Up Studies; Hospitalization; Humans; Incidence; Inflammation; Leukocyte Count; Life Tables; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Recurrence; Risk Factors; Sensitivity and Specificity | 2002 |
Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference?
Topics: Adult; Age Factors; Aged; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Blotting, Western; Case-Control Studies; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Hyperglycemia; Male; Middle Aged; Myocardial Infarction; Prevalence; Risk Factors; Virulence | 2002 |
[Short-term prognosis of patients admitted for probable acute coronary syndrome without ST-segment elevation. Role of new myocardial damage markers and acute-phase reactants].
Topics: Acute Disease; Acute-Phase Proteins; Adult; Age Factors; Aged; Aged, 80 and over; Angina, Unstable; Biomarkers; C-Reactive Protein; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Electrocardiography; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Syndrome; Time Factors; Troponin I | 2002 |
Smoking, low density lipoprotein cholesterol, fibrinogen and myocardial infarction before 41 years of age: a Danish case-control study.
Topics: Adult; Age Factors; Case-Control Studies; Cholesterol, LDL; Denmark; Female; Fibrinogen; Humans; Hypercholesterolemia; Logistic Models; Male; Middle Aged; Myocardial Infarction; Prevalence; Risk Factors; Smoking; Statistics as Topic; Surveys and Questionnaires | 2002 |
The G-455A polymorphism of the fibrinogen Bbeta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women.
Topics: Age Factors; Aged; Alleles; Chi-Square Distribution; Exercise; Female; Fibrinogen; Genotype; Humans; Hypercholesterolemia; Hypertension; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Risk; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Surveys and Questionnaires | 2002 |
[Blood coagulation in normotensives and hypertensives in relation to their body mass index].
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Blood Pressure; Body Mass Index; Cholesterol, HDL; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Obesity; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Risk Factors; Stroke; Triglycerides | 2002 |
[The relationship of beta-fibrinogen gene polymorphisms and ischaemic cardiocerebral vascular disease].
Topics: Adult; Aged; Aged, 80 and over; Caenorhabditis elegans Proteins; Cerebral Infarction; Female; Fibrinogen; Gene Frequency; Humans; Linkage Disequilibrium; Male; Middle Aged; Muscle Proteins; Myocardial Infarction; Polymorphism, Genetic | 2002 |
Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study.
Topics: Coronary Disease; Factor VII; Fibrinogen; Follow-Up Studies; France; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Prospective Studies; Risk Factors | 2003 |
Correction of haemorheological disturbances in myocardial infarction by diquertin and ascorbic acid.
Topics: Animals; Antioxidants; Ascorbic Acid; Blood Viscosity; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Erythrocyte Aggregation; Fibrinogen; Male; Myocardial Infarction; Phytotherapy; Quercetin; Rats; Rats, Wistar | 2003 |
[The whole blood and plasma viscosity changes in course of acute myocardial infarction].
Topics: Adult; Aged; Blood Coagulation; Blood Viscosity; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Hemorheology; Humans; Male; Middle Aged; Myocardial Infarction; Plasma; Risk Factors; Time Factors; Triglycerides | 2002 |
C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Fibrinogen; France; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Prospective Studies; Risk Factors; Statistics, Nonparametric | 2003 |
Procoagulant effects of thrombolytic therapy in acute myocardial infarction.
Topics: Aged; Antithrombin III; Biomarkers; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Hydrolases; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 2002 |
Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis.
Topics: Aged; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Regression Analysis; Thrombolytic Therapy | 2003 |
Observations on the plasma fibrinogen content after myocardial infarction.
Topics: Coronary Disease; Fibrin; Fibrinogen; Humans; Myocardial Infarction; Plasma | 1952 |
Fibrinogen concentration in acute myocardial infarction; comparison of the clot density determination of fibrinogen with the erythrocyte sedimentation rate.
Topics: Anterior Wall Myocardial Infarction; Blood Sedimentation; Cardiovascular Diseases; Fibrinogen; Hematologic Tests; Humans; Myocardial Infarction | 1954 |
Plasma protein changes after acute myocardial infarction: alpha 2-globulin and fibrinogen.
Topics: Blood Proteins; Blood Sedimentation; Fibrinogen; Globulins; Humans; Myocardial Infarction; Serum Globulins | 1955 |
The clot-density method of determination of fibrinogen in acute myocardial infarction.
Topics: Anterior Wall Myocardial Infarction; Cardiovascular Diseases; Coagulants; Fibrinogen; Humans; Myocardial Infarction | 1956 |
[Prothrombin and fibrinogen levels in myocardial infarct and stenocardia].
Topics: Angina Pectoris; Fibrinogen; Humans; Myocardial Infarction; Prothrombin | 1956 |
Plasma fibrinogen and erythrocyte sedimentation rate in myocardial infarction.
Topics: Blood Sedimentation; Cardiovascular Diseases; Fibrinogen; Hematologic Tests; Humans; Myocardial Infarction; Plasma | 1957 |
The value of estimating fibrinogen and C-reactive-protein levels in myocardial ischaemia.
Topics: Blood Proteins; Coronary Artery Disease; Fibrinogen; Humans; Myocardial Infarction; Myocardial Ischemia | 1957 |
[Protein-bound carbohydrates in plasma & serum in myocardial infarct. II. Hexoses & hexosamine of the fibrinogen fraction & blood mucoprotein].
Topics: Blood Proteins; Fibrinogen; Glucosamine; Hexosamines; Hexoses; Humans; Mucoproteins; Myocardial Infarction | 1957 |
[Comparative studies of the significance of serum transaminase and fibrinogen levels in differential diagnosis and prognosis of myocardial infarct].
Topics: Diagnosis, Differential; Fibrinogen; Humans; Myocardial Infarction; Prognosis; Transaminases | 1958 |
Clinical evaluation of plasma fibrinogen determination in cases of myocardial infarction.
Topics: Cardiovascular Diseases; Fibrinogen; Humans; Myocardial Infarction | 1959 |
[Clinical significance of fibrinogen test in myocardial infarction and stenocardia].
Topics: Angina Pectoris; Cardiovascular Diseases; Coagulants; Fibrinogen; Humans; Myocardial Infarction | 1958 |
[Changes of fibrinogenemia in myocardial infarct and coronary insufficiency].
Topics: Coronary Artery Disease; Coronary Disease; Fibrinogen; Hematologic Diseases; Humans; Myocardial Infarction | 1961 |
[C-Reactive protein and fibrinogen in the blood in patients with myocardial infarct].
Topics: C-Reactive Protein; Coagulants; Fibrinogen; Hemostatics; Humans; Myocardial Infarction | 1961 |
[Studies on fibrinolytic activity and fibrinogen in the blood in atherosclerosis of the coronary vessels, myocardial infarction and during seizures of stenocardia].
Topics: Angina Pectoris; Atherosclerosis; Coronary Disease; Coronary Vessels; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Seizures | 1961 |
[Simplified method for the determination of fibrinogen in the plasma in myocardial infarct and stenocardia].
Topics: Angina Pectoris; Coagulants; Fibrinogen; Hemostatics; Humans; Myocardial Infarction | 1963 |
[THE IMPORTANCE OF INDICES OF PROTEIN AND LIPID METABOLISM FOR THE DIFFERENTIAL DIAGNOSIS OF VARIOUS FORMS OF CORONARY INSUFFICIENCY].
Topics: Angina Pectoris; Blood Protein Electrophoresis; Cholesterol; Coronary Disease; Diagnosis, Differential; Fibrinogen; Glycoproteins; Humans; Lipid Metabolism; Lipids; Lipoproteins; Myocardial Infarction; Phospholipids | 1963 |
ABNORMAL GLOBULINS IN MYOCARDIAL INFARCTION. WITH SPECIAL REFERENCE TO A MATERIAL COATING ERYTHROCYTES AND A COLD-INSOLUBLE PROTEIN.
Topics: Angina Pectoris; Blood Protein Disorders; Blood Protein Electrophoresis; Blood Sedimentation; Capillaries; Conjunctiva; Cryoglobulins; Dextrans; Erythrocyte Aggregation; Erythrocytes; Fibrinogen; Hemagglutination; Humans; Latex Fixation Tests; Microscopy; Myocardial Infarction; Serologic Tests | 1963 |
STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD FOR OBTAINING A THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
Topics: Deoxyribonuclease I; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Geriatrics; Intracranial Embolism; Intracranial Embolism and Thrombosis; Myocardial Infarction; Streptodornase and Streptokinase; Streptokinase; Thromboembolism; Thrombosis | 1963 |
PLASMA-FIBRINOGEN LEVELS IN CORONARY-ARTERY DISEASE.
Topics: Angina Pectoris; Anticoagulants; Arteries; Blood Coagulation Tests; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Pulmonary Edema; Pulmonary Embolism; Thrombophlebitis | 1963 |
[COAGULATION AND ANTICOAGULATION FACTORS IN THE BLOOD AND THEIR ALTERATION IN DISORDERS OF CORONARY CIRCULATION].
Topics: Angina Pectoris; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Coronary Circulation; Coronary Disease; Fibrinogen; Fibrinolysin; Heparin; Humans; Myocardial Infarction; Niacin; Statistics as Topic | 1963 |
[DIAGNOSTIC VALUE OF THE COMPLEX INVESTIGATION OF THE BLOOD ENZYMES AND PROTEINS IN MYOCARDIAL INFARCT].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Protein Disorders; Blood Protein Electrophoresis; Clinical Enzyme Tests; Fibrinogen; Fructose-Bisphosphate Aldolase; Humans; Myocardial Infarction | 1963 |
[COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS].
Topics: Angina Pectoris; Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Circulation; Coronary Disease; Drug Therapy; Factor VII; Fibrinogen; Fibrinolysis; Heparin; Myocardial Infarction; Niacin; Prothrombin Time; Toxicology | 1964 |
THROMBIN GENERATION IN NORMAL SUBJECTS AND CARDIAC PATIENTS.
Topics: Biomedical Research; Blood Coagulation Tests; Ebstein Anomaly; Exercise Test; Fibrinogen; Humans; Myocardial Infarction; Physiology; Rheumatic Heart Disease; Tetralogy of Fallot; Thrombin | 1964 |
EFFECT OF SUDDEN WITHDRAWAL OF LONG-TERM ANTICOAGULANT THERAPY ON THE HEPARIN RESISTANCE AND PLASMA FIBRINOGEN LEVEL.
Topics: Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Electrocardiography; Fibrinogen; Heparin; Heparin Antagonists; Humans; Myocardial Infarction; Phenindione; Prothrombin Time | 1964 |
[DIAGNOSTIC VALUE OF THE DETERMINATION OF BLOOD FIBRINOGEN IN MYOCARDIAL INFARCTION AND ARTERIAL THROMBOSIS].
Topics: Cardiovascular Diseases; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Thrombosis | 1964 |
FIBRINOLYTIC ACTIVITY AND THYROID FUNCTION.
Topics: Aging; Cholesterol; Fibrinogen; Fibrinolysis; Geriatrics; Hyperthyroidism; Hypothyroidism; Iodine Isotopes; Middle Aged; Myocardial Infarction; Sex; Thyroid Function Tests; Thyroxine | 1965 |
PLASMA FIBRINOLYTIC ACTIVITY FOLLOWING RECENT MYOCARDIAL AND CEREBRAL INFARCTION.
Topics: Cerebral Infarction; Fibrinogen; Fibrinolysis; Humans; Intracranial Embolism; Intracranial Embolism and Thrombosis; Myocardial Infarction; Stroke; Thrombolytic Therapy; Thrombosis | 1965 |
Clot density determination of fibrinogen in experimental myocardial infarction.
Topics: Coagulants; Fibrinogen; Hemostatics; Myocardial Infarction; Thrombosis | 1955 |
The pre-existence of an acute coronary event predicts differences in biological parameters and clinical evolution among patients with longstanding stable angina.
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Apolipoprotein A-I; Biomarkers; Blood Glucose; Blood Pressure; Brazil; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Angiography; Coronary Artery Disease; Diastole; Female; Fibrinogen; Humans; Leukocyte Count; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Retrospective Studies; Statistics as Topic; Systole; Triglycerides | 2003 |
Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction.
Topics: Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Risk Factors; Survivors | 2003 |
Fibrinogen B beta polymorphisms do not directly contribute to an altered in vitro clot structure in humans.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation; Case-Control Studies; Female; Fibrin; Fibrinogen; Fibrinolysis; Gene Frequency; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; New Zealand; Permeability; Polymorphism, Genetic; Smoking | 2003 |
Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk.
Topics: Acute-Phase Proteins; alpha 1-Antitrypsin; Cardiovascular Diseases; Ceruloplasmin; Fibrinogen; Haptoglobins; Humans; Incidence; Inflammation; Male; Middle Aged; Myocardial Infarction; Orosomucoid; Risk Factors | 2003 |
Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins.
Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Carboxyhemoglobin; Ceruloplasmin; Cohort Studies; Comorbidity; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Inflammation; Male; Middle Aged; Motor Activity; Myocardial Infarction; Orosomucoid; Prospective Studies; Risk; Smoking; Smoking Cessation; Stroke; Surveys and Questionnaires; Sweden | 2004 |
Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Apolipoproteins; Blood Glucose; Case-Control Studies; Cholesterol; Erythrocyte Aggregation; Erythrocyte Membrane; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; N-Acetylneuraminic Acid; Survivors; Triglycerides | 2004 |
Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.
Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Leukocyte Count; Male; Multivariate Analysis; Myocardial Infarction; Prognosis; Spain; Survival Analysis | 2004 |
Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis - interrelation with traditional cardiovascular risk factors.
Topics: Aged; Apolipoproteins; Arteriosclerosis; Cardiovascular System; Disease-Free Survival; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Risk Factors; Serum Albumin; Serum Amyloid A Protein; Time Factors; Treatment Outcome | 2004 |
4 new tests for heart disease. Here's what your doctor might order in the future.
Topics: Albuminuria; Biomarkers; C-Reactive Protein; Fibrinogen; Humans; Myocardial Infarction; Peroxidase | 2004 |
Statin therapy improves cardiovascular outcome of patients with peripheral artery disease.
Topics: Aged; Apolipoproteins; C-Reactive Protein; Death, Sudden, Cardiac; Disease-Free Survival; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Neutrophils; Peripheral Vascular Diseases; Prospective Studies; Serum Amyloid A Protein; Treatment Outcome | 2004 |
Absolute neutrophil counts and fibrinogen levels as an aid in the early diagnosis of acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Creatine Kinase; Creatine Kinase, MB Form; Electrocardiography; Female; Fibrinogen; Humans; Isoenzymes; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Neutrophils; Predictive Value of Tests; Retrospective Studies; Sex Factors | 2004 |
Effects of flow on solute exchange between fluids and supported biosurfaces.
Topics: Adsorption; Biological Transport; Blood Platelets; Convection; Diffusion; Fibrinogen; Kinetics; Mathematics; Models, Biological; Myocardial Infarction; Rheology; Solutions; Surface Properties; Thrombin | 2004 |
Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes.
Topics: Acute Disease; Angina, Unstable; Biomarkers; C-Reactive Protein; Clinical Trials as Topic; Coronary Thrombosis; Fibrinogen; Genetic Variation; Genotype; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-6; Leukocyte Count; Myocardial Infarction; Polymorphism, Genetic; Recurrence; Risk Factors; Sialoglycoproteins; Syndrome | 2004 |
Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study.
Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Blood Proteins; Body Mass Index; Cardiovascular Diseases; Ceruloplasmin; Cohort Studies; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Hypertension; Incidence; Inflammation; Male; Middle Aged; Motor Activity; Myocardial Infarction; Obesity; Orosomucoid; Predictive Value of Tests; Proportional Hazards Models; Smoking; Stroke; Sweden | 2004 |
Sutureless patch repair for small blowout rupture of the left ventricle after myocardial infarction.
Topics: Aged; Collagen; Fibrinogen; Heart Rupture, Post-Infarction; Hemostatics; Humans; Male; Myocardial Infarction; Prosthesis Implantation; Tissue Adhesives; Treatment Outcome | 2004 |
[Inflammation markers in acute coronary syndrome].
Topics: Angina, Unstable; Biomarkers; Blood Sedimentation; C-Reactive Protein; Fibrinogen; Humans; Inflammation; Interleukin-6; Myocardial Infarction | 2004 |
Erythrocyte aggregation and -455G/A polymorphism of the beta-fibrinogen gene in survivors of acute myocardial infarction.
Topics: Case-Control Studies; Erythrocyte Aggregation; Fibrinogen; Genotype; Humans; Myocardial Infarction; Polymorphism, Genetic | 2004 |
C-reactive protein increase in acute myocardial infarction.
Topics: Acute Disease; Aged; C-Reactive Protein; Chest Pain; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation; Male; Middle Aged; Myocardial Infarction; Observation; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index | 2004 |
A proposed reference method for plasminogen activators that enables calculation of enzyme activities in SI units.
Topics: Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; International System of Units; Kinetics; Laboratories; Models, Chemical; Myocardial Infarction; Plasminogen Activators; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Reference Standards; Reproducibility of Results; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator | 2004 |
Plasma fibrinogen levels are associated with a strong family history of myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Apolipoprotein A-I; Case-Control Studies; Comorbidity; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Parents; Risk Factors; Sampling Studies; Siblings | 2004 |
Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke.
Topics: Aged; Female; Fibrinogen; Humans; Ischemic Attack, Transient; Male; Meta-Analysis as Topic; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke | 2004 |
Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.
Topics: Acute Disease; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Lipids; Male; Myocardial Infarction; Proinsulin; Prospective Studies; Risk Factors; Triglycerides | 2004 |
Combination of thrombophilia markers in acute myocardial infarction of the young.
Topics: Adult; Antithrombin III; Biomarkers; Coronary Angiography; Echocardiography; Electrophoresis, Polyacrylamide Gel; Factor V; Female; Fibrinogen; Homocysteine; Humans; Male; Myocardial Infarction; Point Mutation; Protein C; Risk Factors; Thrombophilia | 2004 |
[Increased platelet aggregation induced activity by anti-glycoprotein IIb/IIIa antibody in patients with acute coronary syndrome].
Topics: Alprostadil; Angina, Unstable; Antibodies, Monoclonal; Blood Platelets; Data Interpretation, Statistical; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2004 |
Proteomic analysis of plasma from patients during an acute coronary syndrome.
Topics: Acute Disease; Aged; alpha 1-Antitrypsin; Angina, Unstable; Apolipoprotein A-I; Blood Proteins; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Protein Isoforms; Proteomics; Reference Values; Risk Factors; Syndrome | 2004 |
[Association of polymorphic marker G(-455)A of gene FGB with coronary artery disease].
Topics: Alleles; Coronary Disease; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Male; Moscow; Myocardial Infarction; Polymorphism, Single Nucleotide | 2004 |
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study.
Topics: Aged; Alleles; Body Mass Index; Case-Control Studies; Environment; Europe; Exons; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Interleukin-6; Introns; Male; Middle Aged; Models, Genetic; Myocardial Infarction; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Regression Analysis; Reverse Transcriptase Polymerase Chain Reaction; Risk; Smoking; Time Factors; Venous Thrombosis | 2004 |
No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors.
Topics: Blood Platelets; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; DNA; Factor V; Factor VII; Factor XIII; Family Health; Fibrinogen; Humans; Integrin alpha2beta1; Integrin beta3; Myocardial Infarction; Odds Ratio; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Risk; Risk Factors; Thrombosis | 2005 |
Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine.
Topics: Aged; C-Reactive Protein; Female; Fibrinogen; Homocysteine; Humans; Male; Myocardial Infarction; Predictive Value of Tests; Prognosis; Risk Assessment; Troponin I | 2005 |
Fibrinogen and other coronary risk factors.
Topics: Adult; Blood Glucose; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cross-Sectional Studies; Denmark; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors; Socioeconomic Factors; Triglycerides | 2005 |
The -455G/A polymorphism of the beta fibrinogen gene and the Bgl II polymorphism of the alpha2beta1 integrin gene and myocardial infarction in patients with type 2 diabetes.
Topics: Bacterial Proteins; Deoxyribonucleases, Type II Site-Specific; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Integrin alpha2beta1; Male; Myocardial Infarction; Polymorphism, Genetic; White People | 2004 |
Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Angiography; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Prognosis; Prospective Studies; Simvastatin; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction.
Topics: Case-Control Studies; Female; Fibrinogen; Gene Frequency; Haplotypes; Humans; Linkage Disequilibrium; Male; Middle Aged; Multigene Family; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk | 2005 |
[Inflammatory, lipid, and metabolic profile in acute ischemic syndrome: correlation with hospital and posthospital events].
Topics: Acute Disease; Aged; Angina, Unstable; Biomarkers; Blood Glucose; C-Reactive Protein; Cohort Studies; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Lipids; Male; Middle Aged; Myocardial Infarction; Risk Factors; Syndrome | 2005 |
Body temperature - a marker of infarct size in the era of early reperfusion.
Topics: Biomarkers; Body Temperature; C-Reactive Protein; Cohort Studies; Creatine Kinase; Echocardiography; Female; Fever; Fibrinogen; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Leukocyte Count; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Prospective Studies; Troponin I; Ventricular Function, Left | 2005 |
Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
Topics: Aged; Analysis of Variance; Angina, Unstable; Biomarkers; C-Reactive Protein; Electrocardiography; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myoglobin; Prognosis; Recurrence; Risk Assessment; Risk Factors; Troponin I | 2005 |
Lipoprotein(a) levels in patients with unstable angina and their relationship with atherothrombosis and myocardial damage.
Topics: Angina, Unstable; Coronary Artery Disease; Coronary Thrombosis; Female; Fibrinogen; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen; Predictive Value of Tests; Risk Factors; Troponin I | 2005 |
Fibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow-up study.
Topics: Adult; Age Factors; Aged; Biomarkers; Blood Chemical Analysis; Cause of Death; Coronary Angiography; Fibrinogen; Follow-Up Studies; Humans; Intensive Care Units; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Probability; Recurrence; Risk Assessment; Severity of Illness Index; Survival Analysis; Time Factors | 2005 |
Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction.
Topics: Analysis of Variance; Body Mass Index; Case-Control Studies; Cohort Studies; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypercholesterolemia; Insulin; Lipids; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Proinsulin; Risk Factors; Tissue Plasminogen Activator; Triglycerides | 2005 |
Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk.
Topics: Adult; Aged; Blood Viscosity; Coronary Artery Disease; Female; Fibrinogen; Hemorheology; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Oxygen; Polysomnography; Risk Factors; Sleep Apnea, Obstructive; Statistics as Topic | 2005 |
Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST-elevation acute myocardial infarction.
Topics: Aged; Biomarkers; C-Reactive Protein; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Serum Amyloid A Protein; Severity of Illness Index; Troponin I | 2005 |
Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men.
Topics: Aged; Alcohol Drinking; Biomarkers; Case-Control Studies; Cholesterol, HDL; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Factors; Sex Distribution | 2005 |
Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
Topics: Apolipoproteins B; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Fibrinogen; Genotype; Humans; Lipoprotein(a); Male; Matrix Metalloproteinase 9; Myocardial Infarction; Point Mutation; Polymorphism, Genetic; Risk Factors | 2005 |
Modeling premature occurrence of acute coronary syndrome with atherogenic and thrombogenic risk factors and gene markers in extended families.
Topics: Age of Onset; Atherosclerosis; Family Health; Female; Fibrinogen; Genetic Markers; Genotype; Homocysteine; Humans; Male; Middle Aged; Models, Statistical; Myocardial Infarction; Pedigree; Risk Factors; Thrombosis | 2005 |
[Predictive value of the markers of inflammation in acute coronary syndromes].
Topics: Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Stenosis; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Severity of Illness Index; Troponin I | 2005 |
Genetic risk factors for arterial thrombosis and inflammation.
Topics: Arteries; Factor V; Factor VIII; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Hemostasis; Humans; Inflammation; Myocardial Infarction; Risk Factors; Stroke; Thrombosis | 2005 |
[Associations of hemostasis factors genes with early development of ischemic heart disease and manifestation of myocardial infarction in young age].
Topics: Adult; Age Factors; Aged; Alleles; Blood Coagulation Factors; Data Interpretation, Statistical; Factor V; Factor VII; Female; Fibrinogen; Genotype; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Polymorphism, Genetic; Risk Factors; Smoking; Tissue Plasminogen Activator | 2005 |
Haplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction.
Topics: Case-Control Studies; Fibrinogen; Haplotypes; Humans; Male; Myocardial Infarction; Netherlands; Polymorphism, Single Nucleotide; Risk Factors | 2006 |
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS).
Topics: Aged; Algorithms; C-Reactive Protein; Cardiomegaly; Cohort Studies; Coronary Disease; Echocardiography; Female; Fibrinogen; Follow-Up Studies; Heart Atria; Heart Failure; Humans; Indians, North American; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors; Stroke; United States | 2006 |
[Specific features of the laboratory diagnosis of myocardial infarction in patients with anemia].
Topics: Adult; Aged; Aged, 80 and over; Anemia; Creatine Kinase; Erythrocyte Count; Female; Fibrinogen; Hemoglobins; Humans; Hydroxybutyrate Dehydrogenase; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Myoglobin | 2005 |
A PEGylated fibrin patch for mesenchymal stem cell delivery.
Topics: Animals; Cell Differentiation; Cells, Cultured; Fibrin; Fibrinogen; Mesenchymal Stem Cells; Myocardial Infarction; Polyethylene Glycols; Stem Cell Transplantation; Swine; Time Factors; Triazoles | 2006 |
Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
Topics: Environment; Epistasis, Genetic; Factor XIII; Fibrin; Fibrinogen; Gels; Genetic Markers; Genetic Predisposition to Disease; Humans; Middle Aged; Models, Genetic; Myocardial Infarction; Polymorphism, Single Nucleotide; Porosity; Risk Factors | 2006 |
Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis.
Topics: Adult; Aged; C-Reactive Protein; Case-Control Studies; Fibrin; Fibrinogen; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction | 2006 |
C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease.
Topics: Aged; Angina Pectoris; Bezafibrate; Brain Ischemia; C-Reactive Protein; Cerebral Infarction; Female; Fibrinogen; Follow-Up Studies; Humans; Hypercholesterolemia; Hypolipidemic Agents; Incidence; Israel; Life Tables; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment | 2006 |
Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
Topics: Aged; Angina Pectoris; Blood Glucose; Body Mass Index; Case-Control Studies; Death, Sudden, Cardiac; Female; Fibrinogen; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Risk Factors; Smoking | 2006 |
Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis.
Topics: Adult; Coronary Artery Disease; Coronary Thrombosis; Elasticity; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Lipoprotein(a); Male; Microscopy, Confocal; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Viscosity; von Willebrand Factor | 2006 |
High baseline fibrinogen concentration as a risk factor of no tissue reperfusion in ST-segment elevation acute myocardial infarction treated with successful primary percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Blood Vessel Prosthesis Implantation; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Risk Factors; Stents; Treatment Outcome | 2006 |
Preoperative serum fibrinogen as a predictor of myocardial infarction in the surgical myocardial revascularization.
Topics: Biomarkers; Cohort Studies; Female; Fibrinogen; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Predictive Value of Tests; Pulmonary Embolism; Retrospective Studies; Stroke | 2006 |
AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults.
Topics: Adult; Coronary Angiography; Female; Fibrinogen; Genotype; Humans; Male; Myocardial Infarction; Nitrates; Nitric Oxide Synthase Type III; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Regional Blood Flow; Risk Factors | 2007 |
Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Stenosis; Disease-Free Survival; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors | 2006 |
The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration.
Topics: Aged; Base Sequence; Blood Coagulation; Case-Control Studies; Chi-Square Distribution; Fibrinogen; Haplotypes; Humans; Interleukin-6; Male; Middle Aged; Molecular Sequence Data; Myocardial Infarction | 2007 |
Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
Topics: Arteriosclerosis; Coronary Artery Disease; Factor XIII; Fibrinogen; Hungary; Molecular Epidemiology; Mutation, Missense; Myocardial Infarction; Polymorphism, Genetic; Protein Subunits; Risk | 2007 |
Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors.
Topics: Female; Fibrin; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Models, Genetic; Myocardial Infarction; Peptide Fragments; Polymorphism, Genetic; Protein Isoforms; Risk; Risk Factors; RNA, Messenger | 2007 |
The amount of fibrinogen-positive platelets predicts the occurrence of in-stent restenosis.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Blood Platelets; Coronary Restenosis; Female; Fibrinogen; Flow Cytometry; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Risk Factors; Stents; Thrombospondins; Ultrasonography, Interventional | 2008 |
Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa.
Topics: Anticoagulants; Cerebral Hemorrhage; Factor VII; Factor VIIa; Factor VIII; Fibrinogen; Humans; Myocardial Infarction; Plasma; Recombinant Proteins; Research Design; Retrospective Studies; Risk; Selection Bias; Troponin; Warfarin | 2007 |
The effects of the fibrin-derived peptide Bbeta(15-42) in acute and chronic rodent models of myocardial ischemia-reperfusion.
Topics: Animals; CD18 Antigens; Cyclic N-Oxides; Disease Models, Animal; Fibrinogen; Free Radical Scavengers; Interleukin-6; Mice; Mice, Inbred BALB C; Models, Biological; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Rats; Reperfusion Injury; Spin Labels | 2007 |
Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart.
Topics: Animals; Cell Movement; Cells, Cultured; Chemokine CXCL12; Chemokines, CXC; Delayed-Action Preparations; Female; Fibrinogen; Mice; Mice, Inbred BALB C; Myocardial Infarction; Myocardium; Proto-Oncogene Proteins c-kit | 2007 |
Coagulation factor VII and inflammatory markers in patients with coronary heart disease.
Topics: Alleles; Amino Acid Substitution; Biomarkers; C-Reactive Protein; Coronary Disease; Factor VIIa; Female; Fibrinogen; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Quantitative Trait Loci | 2007 |
Procoagulant stress reactivity and recovery in apparently healthy men with systolic and diastolic hypertension.
Topics: Adult; Aged; Antigens; Cerebral Infarction; Factor VII; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Reference Values; Risk Factors; Stress, Psychological | 2007 |
Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Topics: Coronary Artery Disease; Coronary Vessels; Factor XIII; Fibrinogen; Genotype; Homozygote; Humans; Myocardial Infarction; Protein Subunits; Sclerosis | 2008 |
Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors.
Topics: Air Pollution; C-Reactive Protein; Fibrinogen; Humans; Inflammation; Interleukin-6; Myocardial Infarction | 2007 |
Diagnostic value of biohumoral markers of necrosis and inflammation in patients with right ventricular myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Creatine Kinase; Electrocardiography; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Necrosis | 2007 |
Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Topics: Analysis of Variance; Angina Pectoris; Biomarkers; Blood Coagulation Factors; Case-Control Studies; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 2007 |
Effect of age and glycaemic control on the association between fibrinogen and risk of acute coronary events after transient ischaemic attack or stroke.
Topics: Age Factors; Aged; Blood Glucose; Cohort Studies; Death, Sudden, Cardiac; Female; Fibrinogen; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Risk Factors; Stroke | 2008 |
Blood fibrinogen in myocardial infarction.
Topics: Blood; Cardiovascular Diseases; Fibrinogen; Heart; Humans; Infarction; Myocardial Infarction | 1948 |
Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Age Factors; Aged; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, HDL; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Risk; Risk Factors; Smoking; Triglycerides; von Willebrand Factor | 2008 |
Fibrinogen genes and myocardial infarction: a haplotype analysis.
Topics: Aged; Alleles; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Variation; Haplotypes; Humans; Linkage Disequilibrium; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Factors | 2008 |
Evidence of major genes effects on serum homocysteine and fibrinogen levels, and premature ischemic heart disease in Italian extended families.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Myocardial Ischemia; Parents; Pedigree; Polymorphism, Single Nucleotide; Risk Factors; Siblings | 2008 |
Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Blood Coagulation; Blood Coagulation Tests; C-Reactive Protein; Case-Control Studies; Chronic Disease; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Thrombin; Time Factors; Up-Regulation | 2008 |
Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study.
Topics: Age Factors; Aged; Black or African American; Brain Ischemia; Cardiovascular Diseases; Carotid Artery Diseases; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Population Surveillance; Proportional Hazards Models; Prospective Studies; Reproducibility of Results; Risk Assessment; Risk Factors; Sex Factors; Stroke; United States; White People | 2008 |
Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction.
Topics: Adult; Aged; Blood Coagulation Factors; Cardiovascular Diseases; Cohort Studies; DNA Mutational Analysis; Fibrinogen; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Recurrence; Risk Factors | 2008 |
Air temperature and inflammatory responses in myocardial infarction survivors.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Europe; Female; Fibrinogen; Health Status Indicators; Humans; Interleukin-6; Longitudinal Studies; Male; Middle Aged; Models, Statistical; Myocardial Infarction; Prospective Studies; Risk Factors; Survivors; Temperature | 2008 |
Haemorheological parameters in young patients with acute myocardial infarction.
Topics: Adult; Blood Viscosity; C-Reactive Protein; Case-Control Studies; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocytes; Female; Fibrinogen; Hemorheology; Humans; Male; Middle Aged; Myocardial Infarction; Risk | 2008 |
Myocardial infarction and whole-blood viscosity.
Topics: Adult; Blood Viscosity; Female; Fibrinogen; Hematocrit; Humans; Male; Myocardial Infarction; Rheology | 1967 |
[Hypofibrinolysis and thrombophilia].
Topics: Adult; Blood Coagulation Tests; Deamino Arginine Vasopressin; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Prognosis; Thrombophlebitis; Thrombosis | 1984 |
Fibrinopeptide A in acute coronary insufficiency.
Topics: Acute Disease; Fibrinogen; Fibrinopeptide A; Humans; Myocardial Infarction | 1981 |
Beta-thromboglobulin levels in relation to myocardial infarction--preliminary observations.
Topics: Adult; Aged; Beta-Globulins; beta-Thromboglobulin; Female; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Thrombophlebitis; Tobacco Use Disorder | 1980 |
beta-Thromboglobulin in acute myocardial infarction.
Topics: Adult; Aged; Beta-Globulins; beta-Thromboglobulin; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Count; Prekallikrein; Time Factors | 1980 |
Rheological and clotting changes in the immediate post-myocardial infarction period.
Topics: Adult; Aged; Antithrombin III; Blood Coagulation Tests; Blood Viscosity; Female; Fibrinogen; Fibrinolysis; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen | 1981 |
Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
Topics: Adult; Aged; Beta-Globulins; beta-Thromboglobulin; Blood Coagulation Factors; Blood Platelets; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Fibrinopeptide A; Heart Aneurysm; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Factor 4 | 1982 |
Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain.
Topics: Adult; Aged; Angina, Unstable; Beta-Globulins; beta-Thromboglobulin; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Pain; Thorax | 1983 |
Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Beta-Globulins; beta-Thromboglobulin; Blood Platelets; Coronary Disease; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Myocardial Infarction; Myocardium; Thrombin; Thrombophlebitis | 1984 |
Haemostatic variables and the outcome of myocardial infarction.
Topics: alpha 1-Antitrypsin; alpha-Macroglobulins; Antigens; Creatine Kinase; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Prognosis; von Willebrand Factor | 1983 |
[Myocardial repair in infarction: parallels of clinico-laboratory indices, morphology and biochemistry of infarcted myocardium].
Topics: Adult; Aged; Blood Sedimentation; Female; Fibrinogen; Glycosaminoglycans; Humans; Hydroxyproline; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Myocardium | 1982 |
Comparative behaviour of the components of the factor VIII complex in acute myocardial infarction.
Topics: Adult; Aged; Antigens; Blood Coagulation Factors; Factor VIII; Female; Fibrinogen; Humans; Immunoelectrophoresis, Two-Dimensional; Male; Middle Aged; Myocardial Infarction; von Willebrand Factor | 1983 |
Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction.
Topics: Aged; Anistreplase; Coronary Vessels; Drug Evaluation; Factor V; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase; Thrombin Time | 1984 |
Quantitation of the three normally-occurring plasma fibrinogens in health and during so-called "acute phase" by SDS electrophoresis of fibrin obtained from EDTA-plasma.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Protein Electrophoresis; Child; Child, Preschool; Edetic Acid; Female; Fibrin; Fibrinogen; Hip Prosthesis; Humans; Infant; Male; Middle Aged; Molecular Weight; Myocardial Infarction; Postoperative Period; Sex Factors | 1984 |
Fibrinogen, factor VIII related antigen, antithrombin III and alpha 2-antiplasmin in peripheral arterial disease.
Topics: alpha-2-Antiplasmin; Antigens; Antithrombin III; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Factor VIII; Fibrinogen; Hemostasis; Humans; Male; Myocardial Infarction; von Willebrand Factor | 1984 |
Intracoronary thrombolysis in evolving myocardial infarction.
Topics: Adult; Animals; Arterial Occlusive Diseases; Coronary Vessels; Creatine Kinase; Dogs; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Nitroglycerin; Plasminogen; Serum Globulins; Streptokinase; Time Factors | 1981 |
[Effect of streptodecase and heparin on the state of hemostasis in patients with acute myocardial infarction].
Topics: Adult; Aged; Blood Coagulation; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Streptokinase | 1984 |
Systemic markers of fibrinolysis after unsuccessful intracoronary streptokinase thrombolysis for acute myocardial infarction. Does nonreperfusion indicate failure to achieve a systemic lytic state?
Topics: Coronary Angiography; Coronary Vessels; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Streptokinase | 1984 |
[Longitudinal studies on the prognostic significance of plasma fibrinogen in diabetes mellitus].
Topics: Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Prognosis | 1984 |
[Prognostic significance of the state of the blood coagulation system for the development of myocardial infarction and sudden death in patients with ischemic heart disease].
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Disorders; Coronary Disease; Death, Sudden; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis | 1984 |
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.
Topics: Aged; alpha-2-Antiplasmin; Coronary Vessels; Drug Evaluation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators; Streptokinase | 1984 |
Coronary thrombolysis with recombinant human tissue-type plasminogen activator.
Topics: alpha-2-Antiplasmin; Animals; Coronary Angiography; Coronary Disease; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Fibrinogen; Fibrinolysis; Myocardial Infarction; Plasminogen; Plasminogen Activators | 1984 |
[Aortocoronary venous bypass in dysfibrinogenemia].
Topics: Blood Coagulation Disorders; Coronary Artery Bypass; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction | 1983 |
Does qualitatively altered fibrinogen contribute to the increased heparin precipitable fraction (HPF) in acute myocardial infarction (AMI)?
Topics: Acute-Phase Proteins; alpha 1-Antitrypsin; Blood Proteins; C-Reactive Protein; Fibrinogen; Fibronectins; Haptoglobins; Heparin; Humans; Myocardial Infarction; Neoplasms; Orosomucoid; Pulmonary Embolism; Sepsis | 1984 |
Haemorheological investigations in patients with chronic ischaemic heart disease and acute myocardial infarction.
Topics: Blood Proteins; Blood Viscosity; Coronary Disease; Female; Fibrinogen; Hematocrit; Humans; Male; Myocardial Infarction | 1983 |
Plasma fibrinogen levels and the clinical course of acute myocardial infarction.
Topics: Adult; Aged; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Thromboembolism | 1983 |
Prognostic value of plasma fibrinogen in myocardial infarction.
Topics: Adult; Aged; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis | 1983 |
[Hemorrheological changes in ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Blood Viscosity; Coronary Disease; Erythrocytes; Exercise Test; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Rheology | 1983 |
[Erythrocyte filtration in acute myocardial infarction].
Topics: Blood Sedimentation; Erythrocytes; Female; Fibrinogen; Humans; Leukocyte Count; Male; Myocardial Infarction; Polycarboxylate Cement; Time Factors; Ultrafiltration | 1983 |
Evaluation of the haemorheological determinants in coronary heart disease.
Topics: Blood Viscosity; Coronary Disease; Fibrinogen; Hematocrit; Humans; Myocardial Infarction; Physical Exertion | 1984 |
Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction.
Topics: Aged; Antithrombin III; Creatine Kinase; Female; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction | 1984 |
Clinical failure of streptokinase due to an unsuspected high titer of antistreptokinase antibody.
Topics: Antibodies, Bacterial; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase | 1984 |
Changes in platelet functions, coagulation and fibrinolysis in uncomplicated cases of acute myocardial infarction.
Topics: Adenosine Diphosphate; Adult; Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation; Blood Platelets; Collagen; Epinephrine; Factor VIII; Factor XIII; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Serotonin; Serum Globulins; Time Factors | 1980 |
Occurrence of soluble very high molecular weight fibrinogen complexes in hypercoagulable states. An in vitro and in vivo study on their features.
Topics: Adolescent; Adult; Animals; Blood Coagulation; Cerebrovascular Disorders; Chromatography, Gel; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Immunodiffusion; Infusions, Parenteral; Male; Molecular Weight; Myocardial Infarction; Polymers; Rabbits; Solubility; Thrombin; Thrombophlebitis | 1980 |
Increased ristocetin-cofactor in acute myocardial infarction: a component of the acute phase reaction.
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Factor VIII; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Pregnancy; von Willebrand Factor | 1980 |
Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency.
Topics: Adult; Aged; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen; Prothrombin Time; Streptokinase; Time Factors | 1983 |
Clinical and laboratory management of pulmonary embolism.
Topics: Anticoagulants; Blood Cell Count; Diagnosis, Differential; Electrocardiography; Fibrinogen; Humans; Iodine Radioisotopes; Lung; Myocardial Infarction; Physical Examination; Platelet Count; Plethysmography, Impedance; Pneumonia; Pulmonary Embolism; Radionuclide Imaging; Thrombosis; Ultrasonography | 1983 |
Heparin effect on plasma fibrinogen in the thrombophilic syndrome.
Topics: Adult; Aged; Angina Pectoris; Blood Viscosity; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Whole Blood Coagulation Time | 1983 |
Plasma hypercoagulability after termination of oral anticoagulants.
Topics: 4-Hydroxycoumarins; Administration, Oral; Aged; Anticoagulants; Blood Coagulation; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Myocardial Infarction; Phenprocoumon; Prothrombin Time; Thromboembolism; Time Factors | 1983 |
Morphological variants of acute myocardial necrosis and their relationship to coronary artery thrombosis.
Topics: Animals; Arteriosclerosis; Coronary Disease; Coronary Vessels; Fibrinogen; Humans; Isoproterenol; Myocardial Infarction; Myocardium; Necrosis; Rats | 1980 |
[Stress-metabolism after myocardial infarction-demonstrated by means of the behaviour of plasma proteins with short half-life (author's transl)].
Topics: Aged; alpha 1-Antitrypsin; Angina Pectoris; Blood Proteins; C-Reactive Protein; Electrocardiography; Female; Fibrinogen; Half-Life; Haptoglobins; Humans; Male; Myocardial Infarction; Prealbumin; Serum Albumin; Stress, Physiological; Transferrin | 1981 |
Blood rheology in acute myocardial infarction.
Topics: Adult; Aged; Blood Viscosity; Diabetes Complications; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Rheology | 1982 |
Plasma fibrinogen levels as an indicator of myocardial necrosis.
Topics: Adult; Aged; Coronary Disease; Diagnosis, Differential; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Necrosis | 1982 |
Association of recurrent myocardial infarction with hemostatic factors: a prospective study.
Topics: Adult; Aged; Cholesterol; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Prospective Studies; Prothrombin; Prothrombin Time; Recurrence | 1982 |
Heparin effect on blood viscosity.
Topics: Adult; Aged; Angina Pectoris; Blood Proteins; Blood Viscosity; Female; Fibrinogen; Hematocrit; Heparin; History, 17th Century; Humans; Male; Myocardial Infarction | 1982 |
[Myocardial infarct: an acute dysmetabolic disease].
Topics: Adult; Antithrombin III; Female; Fibrinogen; Glycosaminoglycans; Heparin; Humans; Injections, Intravenous; Lipoprotein Lipase; Male; Middle Aged; Myocardial Infarction | 1982 |
Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen.
Topics: Animals; Antibodies; Dogs; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Isotope Labeling; Mice; Myocardial Infarction; Myocardium; Myosins; Radionuclide Imaging; Technetium; Tissue Distribution | 1982 |
Plasma fibrinolytic activity and fibrinogen: their relationship in cardiac injury.
Topics: Adult; Aged; Animals; Dogs; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Rats | 1982 |
Fibrinogen derivatives and recurrent myocardial infarction.
Topics: Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Myocardial Infarction; Prospective Studies; Recurrence; Risk | 1982 |
Catabolism and excretion of fibrinopeptide-A.
Topics: Adolescent; Adult; Aged; Animals; Brain Abscess; Burns; Child; Circadian Rhythm; Dogs; False Positive Reactions; Female; Fibrinogen; Fibrinopeptide A; Hemoglobinuria; Humans; Hydrogen-Ion Concentration; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Myocardial Infarction; Neoplasms; Thrombin | 1982 |
[Evaluation of some hemo-rheological factors in a group of subjects with prior myocardial infarct submitted to exercise tests].
Topics: Acid-Base Equilibrium; Adult; Blood Flow Velocity; Blood Viscosity; Exercise Test; Fibrinogen; Heart; Hematocrit; Hemodynamics; Humans; Lactates; Male; Middle Aged; Myocardial Infarction | 1981 |
Measurement of fibrinopeptide A in patients treated with phenprocoumon.
Topics: 4-Hydroxycoumarins; Administration, Oral; Anticoagulants; Blood Coagulation; Fibrinogen; Fibrinopeptide A; Humans; Myocardial Infarction; Partial Thromboplastin Time; Phenprocoumon; Thrombin; Thrombophlebitis | 1981 |
[Changes of fibrinogen concentration and their prognostic value in acute myocardial infarct].
Topics: Acute Disease; Adult; Aged; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk; Thrombosis | 1981 |
Practical impact of hemorheology on the treatment of chronic peripheral ischemia.
Topics: Ancrod; Aspirin; Blood Viscosity; Chronic Disease; Erythrocyte Count; Fibrinogen; Humans; Intermittent Claudication; Ischemia; Lipid Metabolism; Myocardial Infarction; Plasma Exchange; Rheology; Vascular Diseases; Vasodilator Agents | 1981 |
[Lipid binding in blood clots in acute myocardial infarct].
Topics: Adult; Binding Sites; Blood Coagulation; Blood Platelets; Cholesterol; Cholesterol, HDL; Fibrinogen; Humans; Lipids; Lipoproteins, HDL; Male; Middle Aged; Myocardial Infarction; Phospholipids; Triglycerides | 1981 |
Changes in red cell deformability and other haemorrheological variables after myocardial infarction.
Topics: Adult; Aged; Blood Viscosity; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic | 1980 |
[Study of behaviour of fibrinogen and of some glycoproteins in arteriosclerotic clinical situations (author's transl)].
Topics: Acute Disease; Arteriosclerosis; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Fibrinogen; Glycoproteins; Humans; Hyperlipoproteinemias; Myocardial Infarction | 1980 |
[Blood viscosimetric factors in cardiovascular pathology].
Topics: Angina Pectoris; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Viscosity; Cardiovascular Diseases; Diabetic Angiopathies; Fibrinogen; Hematocrit; Humans; Leg; Myocardial Infarction; Vascular Diseases | 1980 |
Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
Topics: Adolescent; Adult; Aged; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoimmune Diseases; Blood Coagulation Tests; Disease Susceptibility; Female; Fibrinogen; Hemostasis; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Thromboembolism; Thrombophlebitis; von Willebrand Factor | 1995 |
The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
Topics: Birefringence; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Enzyme Activation; Fibrin; Fibrinogen; Fibrinolysis; Gels; Hemophilia A; Humans; Myocardial Infarction; Plasma; Prothrombin; Thrombin; Thromboplastin | 1995 |
Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
Topics: Adenosine Diphosphate; beta-Thromboglobulin; Blood Platelets; Cell Adhesion Molecules; Fibrinogen; Flow Cytometry; Humans; Myocardial Infarction; P-Selectin; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Platelet Activation; Platelet Membrane Glycoproteins; Recombinant Proteins; Recurrence; Serotonin; Streptokinase; Thrombin; Thrombolytic Therapy; Thromboxane A2 | 1995 |
Complement components and fibrinogen: correlations and association with previous myocardial infarction.
Topics: Adult; Antithrombin III; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Complement System Proteins; Confounding Factors, Epidemiologic; Fibrinogen; Humans; Lipids; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Protein C; Protein S; Radioimmunoassay; Risk Factors; Tissue Plasminogen Activator | 1995 |
[Relation between plasma fibrinogen and the function of collateral coronary vessels].
Topics: Adult; Aged; Blood Viscosity; Cholesterol, LDL; Collateral Circulation; Coronary Circulation; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Recurrence; Reference Values; Risk Factors; Stroke Volume; Ventricular Function, Left | 1995 |
Platelet size, fibrinogen and lipoprotein(a) in coronary heart disease.
Topics: Adult; Blood Platelets; Case-Control Studies; Cell Separation; Coronary Disease; Female; Fibrinogen; Flow Cytometry; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Platelet Function Tests; Risk Factors | 1995 |
Serum total sialic acid and lipid-associated sialic acid in normal individuals and patients with myocardial infarction, and their relationship to acute phase proteins.
Topics: Acute-Phase Proteins; alpha 1-Antichymotrypsin; alpha-Macroglobulins; C-Reactive Protein; Female; Fibrinogen; Humans; Lipids; Male; Myocardial Infarction; N-Acetylneuraminic Acid; Nephelometry and Turbidimetry; Orosomucoid; Radioimmunoassay; Risk Factors; Sialic Acids | 1993 |
[Fibrinogen and leukocyte number in coronary heart disease. Correlation with angiography and clinical degree].
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction | 1995 |
Influence of circulating D-dimer levels on assays of fibrinogen.
Topics: Adult; Angina, Unstable; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Myocardial Infarction; Pregnancy; Pregnancy Complications; Streptokinase; Thrombelastography; Thrombolytic Therapy | 1994 |
[Fibrinogen levels in ultra-high dosage streptokinase lysis].
Topics: Fibrinogen; Heparin; Humans; Myocardial Infarction; Partial Thromboplastin Time; Streptokinase | 1995 |
Outcome after thrombolytic therapy of nine cases of myopericarditis misdiagnosed as myocardial infarction.
Topics: Adolescent; Adult; Diagnostic Errors; Electrocardiography; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocarditis; Pericardial Effusion; Pericarditis; Risk Factors; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 1995 |
Changes in clot deformability--a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction.
Topics: Aged; Blood Coagulation; Fibrinogen; Humans; Hydrogen-Ion Concentration; Iodoacetamide; Kinetics; Male; Middle Aged; Myocardial Infarction; Sodium Chloride | 1994 |
Seasonal variations of plasma fibrinogen in elderly people.
Topics: Adult; Aged; Aging; Factor VII; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Seasons | 1994 |
Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Blood Coagulation; Female; Fibrinogen; Humans; Male; Middle Aged; Monocytes; Myocardial Infarction; Peptide Fragments; Prospective Studies; Prothrombin; Thromboplastin; Time Factors | 1994 |
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).
Topics: Cholesterol, LDL; Cohort Studies; Fibrinogen; Humans; Incidence; Lipoprotein(a); Male; Middle Aged; Models, Statistical; Multivariate Analysis; Myocardial Infarction; Prospective Studies; Risk Factors | 1994 |
Lipoprotein(a) levels in patients with myocardial infarction treated with anistreplase: no prediction of efficacy but inverse correlation with plasminogen activation in non-patency.
Topics: Adult; Aged; alpha-2-Antiplasmin; Anistreplase; Coronary Angiography; Coronary Circulation; Female; Fibrinogen; Fibrinolysis; Humans; Infusions, Intravenous; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen; Treatment Outcome | 1994 |
Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction.
Topics: Acute-Phase Reaction; Adult; Aged; C-Reactive Protein; Circadian Rhythm; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; von Willebrand Factor | 1994 |
Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring--the EARS study. European Atherosclerosis Research Study Group.
Topics: Adolescent; Adult; Alcohol Drinking; Antigens; Body Constitution; Body Mass Index; Case-Control Studies; Contraception; Disease Susceptibility; Europe; Factor VII; Fathers; Female; Fibrinogen; Humans; Lipids; Male; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Risk Factors; Smoking | 1994 |
Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase.
Topics: Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy; Time Factors | 1994 |
[Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
Topics: Aged; alpha-2-Antiplasmin; Coronary Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Risk Factors; Survivors | 1994 |
[Changes in hemocoagulation during thrombolytic therapy of acute myocardial infarct in relation to risks of thrombotic complications].
Topics: Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Risk Factors; Thrombolytic Therapy; Thrombosis | 1994 |
Tissue-type plasminogen activator and risk of myocardial infarction.
Topics: alpha-2-Antiplasmin; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Inactivators; Recurrence; Risk Factors; Tissue Plasminogen Activator | 1993 |
Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
Topics: Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Blood Coagulation; Fibrinogen; Fibrinolysin; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Hydrolases; Prothrombin Time; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1994 |
The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden.
Topics: Adult; Alleles; Fibrinogen; Genotype; Humans; Male; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Reference Values; Survivors; Sweden | 1993 |
[Evaluation of the fibrinolytic system in myocardial infarction].
Topics: Aged; alpha-2-Antiplasmin; Convalescence; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 1994 |
Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Coronary Angiography; Electrocardiography; Female; Fibrinogen; Heart; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy; Time Factors; Treatment Outcome | 1994 |
Variable and circadian response to a fixed high-dose (12 500 IU twice daily) subcutaneous heparin regimen after thrombolytic therapy for acute myocardial infarction.
Topics: Aspirin; Blood Coagulation Tests; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrinogen; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy | 1994 |
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
Topics: Adult; Aged; Aging; Angina Pectoris; Body Mass Index; Coronary Disease; Factor VIII; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Risk Factors; Triglycerides; von Willebrand Factor | 1993 |
[Importance of the fibrinogen concentration as an independent risk factor for ischemic heart disease].
Topics: Adult; Aged; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Reference Values; Retrospective Studies; Risk Factors; Thrombolytic Therapy | 1993 |
Fibrinogen and the albumin-globulin ratio in recurrent stroke.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Risk Factors; Serum Albumin; Serum Globulins; Vascular Diseases | 1993 |
Dental disease, fibrinogen and white cell count; links with myocardial infarction?
Topics: Adult; Female; Fibrinogen; Gingivitis; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Periodontitis; Risk Factors; Smoking; Social Class | 1993 |
Blood viscosity during thrombolytic therapy with anistreplase in acute myocardial infarction.
Topics: Aged; Anistreplase; Blood Coagulation Factors; Blood Viscosity; Cardiac Output; Coronary Vessels; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Plasma; Regression Analysis; Rheology; Thrombolytic Therapy; Vascular Patency | 1993 |
[Factor VII and protein-C markers are no prognostic indicators in acute coronary heart disease].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Angina, Unstable; Antigens; Child; Coronary Disease; Factor VII; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Protein C | 1993 |
[Fibrinogen substitution in systemic defibrination because of thrombolysis in acute myocardial infarction].
Topics: Fibrinogen; Humans; Myocardial Infarction; Risk Factors; Thrombolytic Therapy | 1993 |
Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.
Topics: Adult; Angina Pectoris; Cerebrovascular Disorders; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Family; Female; Fibrinogen; Heart Diseases; Humans; Hypertension; Intermittent Claudication; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors | 1993 |
Lipoprotein(a) concentrations are increased in patients with myocardial infarction and angiographically normal coronary arteries.
Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Lipids; Lipoprotein(a); Lipoproteins, HDL; Myocardial Infarction; Risk Factors; Triglycerides | 1993 |
Influence of acute myocardial infarction and rt-PA therapy on circulating fibrinogen.
Topics: Aged; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Immunoenzyme Techniques; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Recombinant Proteins; Thrombolytic Therapy | 1993 |
Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study.
Topics: Adult; Base Sequence; Case-Control Studies; Fibrinogen; Genetic Variation; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Myocardial Infarction; Risk Factors | 1993 |
Bad teeth and myocardial infarction. Roles for white cells and fibrinogen.
Topics: Fibrinogen; Humans; Leukocyte Count; Myocardial Infarction; Oral Hygiene; Periodontal Diseases; Risk Factors | 1993 |
Hemostatic risk factors of coronary artery disease in the Chinese.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Blood Glucose; Case-Control Studies; China; Cholesterol; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Factor VII; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Platelet Count; Risk Factors; Serine Proteinase Inhibitors; Taiwan; Triglycerides | 1995 |
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde.
Topics: Adult; Alleles; Base Sequence; Coronary Angiography; Coronary Disease; Fibrinogen; Genetic Linkage; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Multivariate Analysis; Myocardial Infarction; Polymorphism, Genetic; Smoking | 1996 |
Coronary artery disease in IDDM. Gender differences in risk factors but not risk.
Topics: Adolescent; Adult; Age of Onset; Angina Pectoris; Body Constitution; Comorbidity; Coronary Disease; Depression; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Hypertriglyceridemia; Lipids; Male; Motor Activity; Myocardial Infarction; Proportional Hazards Models; Risk; Risk Factors; Sex Factors; Smoking | 1996 |
Lipid peroxidation, antioxidant defences and red-cell membrane changes in relation to coronary risk index and symptomatic coronary heart disease.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Erythrocyte Membrane; Female; Fibrinogen; Free Radical Scavengers; Humans; India; Lipid Peroxidation; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Platelet Count; Reference Values; Sterol Esterase | 1995 |
Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
Topics: Adult; Aged; Cholesterol, LDL; Death, Sudden, Cardiac; Factor VII; Fibrinogen; Humans; Lipids; Lipoproteins, LDL; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Risk Factors | 1996 |
A variant of beta fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction.
Topics: Adult; Aged; Alleles; Case-Control Studies; Chromosomes, Human, Pair 4; Coronary Disease; Coronary Thrombosis; Female; Fibrinogen; Gene Frequency; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Risk Factors | 1996 |
A case-reference study on plasma fibrinogen concentrations and coronary atherosclerosis in Japanese.
Topics: Adult; Aged; Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Risk Factors | 1996 |
Thrombotic markers during myocardial infarction.
Topics: Adult; Biomarkers; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Thrombosis | 1995 |
Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Electrocardiography; Female; Fibrinogen; Fibrinolysin; Hemostasis; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Thrombin; Time Factors; Tissue Plasminogen Activator; Triglycerides; von Willebrand Factor | 1996 |
Von Willebrand factor in patients evolving Q-wave versus non-Q-wave acute myocardial infarction.
Topics: Aged; Analysis of Variance; Biomarkers; Electrocardiography; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; von Willebrand Factor | 1996 |
Non-traditional risk factors for atherosclerosis in high risk children.
Topics: Adolescent; Adult; Arteriosclerosis; Autonomic Nervous System Diseases; Case-Control Studies; Child; Electrocardiography, Ambulatory; Female; Fibrinogen; Humans; Hyperinsulinism; Hyperlipoproteinemias; Hypertrophy, Left Ventricular; Insulin Resistance; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Risk Factors; Thrombosis | 1996 |
Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men.
Topics: Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol, LDL; Cohort Studies; Comorbidity; Death, Sudden, Cardiac; Disease Susceptibility; Fibrinogen; Germany; Humans; Incidence; Lipids; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prevalence; Prospective Studies; Risk; Risk Factors; Smoking | 1997 |
Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
Topics: Acute-Phase Reaction; Alleles; Biomarkers; Coronary Disease; Fibrinogen; Homozygote; Humans; Male; Myocardial Infarction | 1997 |
Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.
Topics: Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Risk Factors | 1997 |
Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients.
Topics: Adult; Aged; Apolipoproteins B; Austria; Cholesterol, HDL; Comorbidity; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Kidney Failure, Chronic; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Phenotype; Prevalence; Renal Dialysis; Risk Factors; Smoking | 1997 |
Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case-control study in a sample of GISSI-2 patients.
Topics: Case-Control Studies; Deoxyribonucleases, Type II Site-Specific; Female; Fibrinogen; Gene Frequency; Genotype; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk | 1997 |
Association of a common polymorphism in the factor XIII gene with myocardial infarction.
Topics: Case-Control Studies; Factor XIII; Female; Fibrinogen; Humans; Leucine; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Plasminogen Activator Inhibitor 1; Point Mutation; Polymorphism, Genetic; Risk Factors; Valine | 1998 |
Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease.
Topics: Case-Control Studies; Cholesterol; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Factor VII; Factor XIIa; Female; Fibrinogen; Humans; Insulin; Male; Myocardial Infarction; Risk Factors; Survivors; Tissue Plasminogen Activator; Triglycerides | 1998 |
Antipeptide monoclonal antibodies to defined fibrinogen Aalpha chain regions: anti-Aalpha 487-498, a structural probe for fibrinogenolysis.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibody Specificity; Enzyme-Linked Immunosorbent Assay; Epitopes; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Immunoblotting; Mice; Mice, Inbred BALB C; Myocardial Infarction; Peptide Fragments; Species Specificity; Thrombolytic Therapy | 1998 |
[Acute coronary vessel occlusion after PTCA--possibility of risk stratification using quantitative coronary angiography, clinical determinants and laboratory chemistry parameters].
Topics: Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Risk Factors | 1997 |
Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Topics: alpha-2-Antiplasmin; Angina, Unstable; Antithrombin III; Endothelium, Vascular; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Peptide Hydrolases; Plasminogen; Prospective Studies; Time Factors; Tissue Plasminogen Activator | 1998 |
Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction.
Topics: Aged; Blood Coagulation; Blood Coagulation Factors; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Prospective Studies; Thrombolytic Therapy; Tissue Plasminogen Activator | 1998 |
Elevated plasma fibrinogen: cause or consequence of cardiovascular disease?
Topics: Aged; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Smoking | 1998 |
Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease.
Topics: Angina, Unstable; Antibodies, Anti-Idiotypic; Anticoagulants; Biomarkers; C-Reactive Protein; Chlamydia Infections; Chronic Disease; Dalteparin; Female; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Pneumonia, Bacterial; Prevalence; Prognosis; Risk Factors | 1998 |
[Role of biochemical and fibrinolytic parameters on cardiac events associated with Hanshin-Awaji earthquake-induced stress].
Topics: Blood Pressure; Blood Viscosity; Disasters; Endothelium, Vascular; Fibrinogen; Humans; Japan; Myocardial Infarction; Stress, Physiological; Stress, Psychological | 1998 |
Monocyte tissue factor-like activity in post myocardial infarction patients.
Topics: Blood Cell Count; Blood Coagulation; Case-Control Studies; Factor VII; Fibrinogen; Homeostasis; Humans; Male; Middle Aged; Monocytes; Myocardial Infarction; Neutrophils; Plasminogen; Plasminogen Activators; Thromboplastin; Tumor Necrosis Factor-alpha | 1998 |
Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Topics: Alcohol Drinking; Cardiovascular Diseases; Comorbidity; Factor VII; Fibrinogen; France; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Obesity; Plasminogen Activator Inhibitor 1; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires | 1998 |
[Etiopathogenesis of acute myocardial infarction: role of early leukocytosis].
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Female; Fibrinogen; Hemodynamics; Humans; Leukocytosis; Male; Middle Aged; Myocardial Infarction; Platelet Count; Stents; Thrombolytic Therapy; Time Factors | 1998 |
Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. The REGICOR Investigators.
Topics: Chi-Square Distribution; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Statistics as Topic | 1998 |
Relationship between plasma fibrinogen and coronary heart disease in women.
Topics: Adult; Aged; Angina Pectoris; Body Mass Index; C-Reactive Protein; Case-Control Studies; Coronary Disease; Female; Fibrinogen; Hospitalization; Humans; Lipids; Logistic Models; Menopause; Middle Aged; Myocardial Infarction; Reference Values; Risk Factors; Smoking | 1999 |
Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein: a potential contributor to cardiovascular risk.
Topics: Fibrinogen; Humans; Myocardial Infarction; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors | 1999 |
Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter.
Topics: Aged; Angina Pectoris; Angina, Unstable; Animals; Blood Proteins; Body Temperature; C-Reactive Protein; Cardiac Catheterization; Coronary Artery Disease; Coronary Vessels; Disease Progression; Energy Metabolism; Female; Fibrinogen; Humans; Lipids; Macrophage Activation; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Rupture, Spontaneous; Swine; Thermography | 1999 |
Arterial thrombosis in heart failure.
Topics: Adenosine Diphosphate; Coronary Thrombosis; Epinephrine; Fibrinogen; Heart Failure; Hemorheology; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Edema; Vasoconstrictor Agents; von Willebrand Factor | 1998 |
Thrombogenic factors and recurrent coronary events.
Topics: Adult; Aged; Factor VII; Factor VIIa; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Insulin; Lipids; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Prospective Studies; Recurrence; Risk Factors; Thrombosis; von Willebrand Factor | 1999 |
Saruplase versus other fibrinolytic agents.
Topics: Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator | 1998 |
Infection and myocardial infarction.
Topics: Adult; Aged; Antigens, Bacterial; Bacterial Infections; Bacterial Proteins; Chlamydia Infections; Cytomegalovirus Infections; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Herpesviridae Infections; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Serologic Tests; Virus Diseases | 1999 |
Association between job characteristics and plasma fibrinogen in a normal working population: a cross sectional analysis in referents of the SHEEP Study. Stockholm Heart Epidemiology Program.
Topics: Aged; Cross-Sectional Studies; Employment; Female; Fibrinogen; Humans; Life Style; Logistic Models; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors; Sex Factors; Social Class; Stress, Physiological; Surveys and Questionnaires; Sweden | 1999 |
Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control.
Topics: Adult; Aged; Alleles; Case-Control Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk Factors | 1999 |
Carotid intima-media thickness of young coronary patients.
Topics: Adult; Blood Glucose; Carotid Artery, Common; Carotid Artery, Internal; Cholesterol, HDL; Coronary Artery Disease; Fibrinogen; Humans; Iron; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; Transferrin; Tunica Intima; Ultrasonography | 1999 |
Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.
Topics: Abciximab; Adult; Aged; Antibodies, Monoclonal; Drug Therapy, Combination; Dual Specificity Phosphatase 2; Female; Fibrinogen; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Phosphatase 2; Protein Tyrosine Phosphatases; Recombinant Proteins; Recurrence; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator | 1999 |
D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Topics: Adult; Angina Pectoris; Aorta, Abdominal; Arteriosclerosis; Biomarkers; Blood Viscosity; C-Reactive Protein; Carotid Arteries; Cerebral Arteries; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Myocardial Infarction; Plasminogen; Plasminogen Activator Inhibitor 1; Prognosis; Severity of Illness Index; Stroke Volume; Ultrasonography, Doppler, Duplex; Ultrasonography, Doppler, Transcranial; Ventricular Function, Left | 1999 |
Lower cardiac mortality in smokers following thrombolysis.
Topics: Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Smoking; Thrombolytic Therapy; Treatment Outcome | 1999 |
Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction.
Topics: Aged; Biomarkers; Convalescence; Coronary Thrombosis; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Follow-Up Studies; Humans; Male; Middle Aged; Molecular Weight; Myocardial Infarction; Phosphorus; Phosphorylation; Protein Processing, Post-Translational; Recurrence | 1999 |
Development and evaluation of a new canine myocardial infarction model using a closed-chest injection of thrombogenic material.
Topics: Animals; Aspartate Aminotransferases; Blood Pressure; Blood Transfusion, Autologous; Coronary Disease; Coronary Thrombosis; Creatine Kinase; Disease Models, Animal; Dogs; Electrocardiography; Fibrinogen; Heart Rate; Hydroxybutyrate Dehydrogenase; Injections, Intra-Arterial; Isoenzymes; Myocardial Infarction; Organ Size; Pulmonary Wedge Pressure; Stroke Volume; Thrombin; Vascular Patency | 1999 |
C-reactive protein in offspring is associated with the occurrence of myocardial infarction in first-degree relatives.
Topics: Adult; Aged; Alleles; C-Reactive Protein; Cholesterol; Cohort Studies; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Triglycerides | 2000 |
[Thrombolytic therapy for acute myocardial infarction: circadian sensitivity].
Topics: Adult; Aged; Aged, 80 and over; Circadian Rhythm; Coronary Angiography; Echocardiography, Doppler; Electrocardiography; Fibrinogen; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Streptokinase; Thrombolytic Therapy; Treatment Outcome | 1999 |
Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
Topics: Acute Disease; Aged; Analysis of Variance; Angina, Unstable; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Syndrome; Time Factors | 1999 |
Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III.
Topics: Adult; Angina Pectoris; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Logistic Models; Male; Myocardial Infarction; Predictive Value of Tests; Risk Factors | 2000 |
Alteration of the fibrinogen molecule and its phosphorylation state in myocardial infarction patients undergoing thrombolytic treatment.
Topics: Adult; Aged; Case-Control Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Molecular Weight; Myocardial Infarction; Phosphorylation; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator | 2000 |
The alpha(E)C domain of human fibrinogen-420 is a stable and early plasmin cleavage product.
Topics: Animals; Blood Coagulation; Blotting, Western; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Humans; Mice; Myocardial Infarction; Peptide Fragments; Polymers; Thrombin; Transglutaminases | 2000 |
c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy co
Topics: Abciximab; Adenosine Diphosphate; Adsorption; Adult; Antibodies, Monoclonal; Anticoagulants; Blood Flow Velocity; Blood Platelets; Cell Culture Techniques; Endothelium, Vascular; Fibrinogen; Glass; Hemorheology; Humans; Immunoglobulin Fab Fragments; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Vitronectin; Time Factors; Umbilical Veins; von Willebrand Factor | 2000 |
Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits.
Topics: Amino Acid Chloromethyl Ketones; Animals; Binding Sites; Blood Coagulation; Blood Platelets; Coronary Circulation; Factor VIIa; Fibrinogen; Hemodynamics; Hemostatics; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; Rabbits; Recombinant Proteins; Thromboplastin | 2000 |
Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation.
Topics: Animals; Cattle; Chromatography, High Pressure Liquid; Enzyme Activation; Factor XIII; Fibrinogen; Humans; Intercellular Signaling Peptides and Proteins; Kinetics; Myocardial Infarction; Peptide Fragments; Peptides; Thrombin | 2000 |
Elevation of plasma fibrinogen in silent myocardial ischaemia.
Topics: Adult; Arteriosclerosis; Case-Control Studies; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis | 1999 |
Modifications of whole blood filterability during acute myocardial infarction.
Topics: Acute Disease; Aged; Blood Viscosity; Diabetes Complications; Erythrocyte Deformability; Female; Fibrinogen; Fibrinolytic Agents; Filtration; Humans; Hyperlipidemias; Hypertension; Male; Membranes, Artificial; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardium; Necrosis; Polycarboxylate Cement; Thrombolytic Therapy | 2000 |
Can streptokinase produce beneficial effects additional to coronary recanalization? Quantitative microvascular analysis of critically injured reperfused myocardium.
Topics: Animals; Blood Viscosity; Capillaries; Cobalt Radioisotopes; Coronary Circulation; Dogs; Drug Evaluation, Preclinical; Erythrocyte Count; Fibrinogen; Fibrinolytic Agents; Hematocrit; Hemoglobins; Image Processing, Computer-Assisted; Microcirculation; Microspheres; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Radionuclide Imaging; Streptokinase; Thrombolytic Therapy; Tin Radioisotopes | 2000 |
Plasma fibrinogen and coronary heart disease in urban Japanese.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Disease; Female; Fibrinogen; Humans; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Sex Factors; Urban Population | 2000 |
Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction.
Topics: Aged; Apolipoproteins B; Cholesterol; Female; Fibrinogen; Humans; Lipids; Logistic Models; Male; Middle Aged; Myocardial Infarction; Smoking; Time Factors | 2000 |
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol; Coronary Disease; Fibrinogen; Humans; Hypercholesterolemia; Inflammation; Leukocyte Count; Logistic Models; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Phospholipases A2; Pravastatin; Risk Factors; Triglycerides | 2000 |
Fibrinogen polymorphisms are not associated with the risk of myocardial infarction.
Topics: Analysis of Variance; Case-Control Studies; Chi-Square Distribution; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk | 2000 |
A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
Topics: Aged; Analysis of Variance; Case-Control Studies; Endothelium, Vascular; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; P-Selectin; Pilot Projects; Platelet Activation; Prospective Studies; Streptokinase; Thrombomodulin; Vitamin E; von Willebrand Factor | 2000 |
Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation.
Topics: Animals; Antibodies, Monoclonal; Antithrombins; Cell Movement; Chemokines; Fibrin; Fibrinogen; Hirudins; Microscopy, Electron; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocarditis; Myocardium; Neutrophils; Rabbits; Thrombin; Thromboplastin | 2000 |
Role of monocytes in the early phase of acute myocardial infarction.
Topics: Acute Disease; Aged; Creatine Kinase; Female; Fibrinogen; Humans; L-Lactate Dehydrogenase; Leukocyte Count; Male; Middle Aged; Monocytes; Myocardial Infarction | 2000 |
Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study.
Topics: Adult; alpha 1-Antitrypsin; Cardiovascular Diseases; Ceruloplasmin; Cohort Studies; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Orosomucoid; Survival Rate; Sweden; Time Factors | 2001 |
Parameters of red blood cell aggregation as correlates of the inflammatory state.
Topics: Acute-Phase Reaction; Adolescent; Adult; Aged; Aged, 80 and over; Angina, Unstable; Bacterial Infections; Biomarkers; C-Reactive Protein; Cell Aggregation; Erythrocytes; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Stress, Mechanical | 2001 |
C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; C-Reactive Protein; Coronary Disease; Factor Analysis, Statistical; Female; Fibrinogen; Humans; Interleukin-6; Male; Myocardial Infarction; Prognosis; Retrospective Studies; Risk Assessment; Syndrome; Tumor Necrosis Factor-alpha | 2001 |
Platelet aggregability under shear is enhanced in patients with unstable angina pectoris who developed acute myocardial infarction.
Topics: Aged; Angina, Unstable; Anticoagulants; Aspirin; Biomarkers; Comorbidity; Coronary Thrombosis; Creatine Kinase; Creatine Kinase, MB Form; Electrocardiography; Female; Fibrinogen; Hemorheology; Heparin; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Nitrates; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Risk Factors; Stress, Mechanical | 2001 |
Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
Topics: Angina Pectoris; Antithrombin III; C-Reactive Protein; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Risk Factors; Serine Proteinase Inhibitors; Smoking | 2001 |
Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Arteriosclerosis; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Retrospective Studies; Severity of Illness Index | 2001 |
Haemostasis in relation to dietary fat as estimated by erythrocyte fatty acid composition: the prime study.
Topics: Body Mass Index; Cholesterol; Cholesterol, HDL; Dietary Fats; Erythrocytes; Factor VII; Fatty Acids; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Smoking; Tissue Plasminogen Activator; von Willebrand Factor | 2001 |
Plasma fibrinogen level and long-term prognosis in Norwegian middle-aged patients with previous myocardial infarction. A 10 year follow-up study.
Topics: Female; Fibrinogen; Follow-Up Studies; Humans; Lipids; Logistic Models; Male; Middle Aged; Myocardial Infarction; Norway; Predictive Value of Tests; Prognosis; Prospective Studies; Statistics, Nonparametric; Stroke Volume; Surveys and Questionnaires | 2001 |
Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Recurrence; Tissue Plasminogen Activator; von Willebrand Factor | 2001 |
Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Angioplasty; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Predictive Value of Tests; Prognosis | 2001 |
A hypothesis to explain the reported association of the alpha-fibrinogen A312 allele with thromboembolic disease.
Topics: Alleles; Amino Acid Substitution; Case-Control Studies; Fibrin; Fibrinogen; Humans; Male; Myocardial Infarction; Polymorphism, Genetic; Thromboembolism | 2001 |
Characterization of polymorphic structure of cathepsin G gene: role in cardiovascular and cerebrovascular diseases.
Topics: Adult; Aged; Brain Infarction; Case-Control Studies; Cathepsin G; Cathepsins; Female; Fibrinogen; Gene Frequency; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Promoter Regions, Genetic; Serine Endopeptidases; Transcriptional Activation; Tumor Cells, Cultured | 2001 |
Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.
Topics: Adult; Age of Onset; Antibodies, Bacterial; Antibodies, Viral; Biomarkers; C-Reactive Protein; Chlamydia Infections; Chlamydophila pneumoniae; Cytomegalovirus; Cytomegalovirus Infections; Female; Fibrinogen; Humans; Immunoglobulin G; Inflammation; Leukocytes; Male; Middle Aged; Myocardial Infarction; Risk Factors; Serologic Tests | 2001 |
Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Coronary Artery Disease; DNA Primers; Fibrinogen; Genotype; Germany; Humans; Male; Massachusetts; Middle Aged; Mutation; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Promoter Regions, Genetic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Stroke; Venous Thrombosis; White People | 2001 |
Relationship between fibrinogen protein and fibrinogen function in postmyocardial infarction patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; N-Acetylneuraminic Acid; Recurrence; Retrospective Studies; Thrombophilia | 2001 |
Hyperfibrinogenemia increases the risk of cardiac events after coronary artery stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Cholesterol; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Recurrence; Risk Factors; Stents; Thrombosis | 2000 |
Fibrinogen: associations with cardiovascular events in an outpatient clinic.
Topics: Biomarkers; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Regression Analysis | 2002 |
C-reactive protein predicts death in patients with previous premature myocardial infarction--a 10 year follow-up study.
Topics: C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Lipids; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Smoking; Stroke Volume; Survival Rate | 2002 |
Fibrinogen, viscosity and white blood cell count predict myocardial, but not cerebral infarction: evidence from the Caerphilly and Speedwell cohort.
Topics: Blood Viscosity; Cerebral Infarction; Cohort Studies; Fibrinogen; Follow-Up Studies; Humans; Leukocyte Count; Logistic Models; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prospective Studies | 2002 |
Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome.
Topics: Acute-Phase Proteins; Aged; Angina Pectoris; Angina, Unstable; Biomarkers; Blood Proteins; C-Reactive Protein; Chronic Disease; Death, Sudden, Cardiac; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Neoplasm Proteins; Peptide Fragments; Peroxidases; Peroxiredoxin III; Peroxiredoxins; Physical Exertion; Prognosis; Protein Isoforms; Prothrombin; Risk Factors; Treatment Outcome; Troponin I | 2002 |
[Indicators of plaque stability].
Topics: Acute Disease; Adult; Angina, Unstable; C-Reactive Protein; Chest Pain; Clinical Trials as Topic; Coronary Angiography; Electrocardiography; Fibrinogen; Humans; Interleukin-6; Magnetic Resonance Angiography; Myocardial Infarction; Myocardial Ischemia; Prognosis; Risk Assessment; Risk Factors; Syndrome; Thrombolytic Therapy; Thrombosis; Time Factors; Tomography, X-Ray Computed; Troponin T; Tumor Necrosis Factor-alpha | 2002 |
Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina.
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Biomarkers; Cohort Studies; Coronary Artery Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Poland; Rest; Statistics as Topic; Syndrome; Troponin I | 2002 |
[Biohemorheologic factors and cardiovascular events curve in survivors of transmural acute myocardial infarct--24-month follow-up].
Topics: Blood Viscosity; Carrier Proteins; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Hemorheology; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prospective Studies; Survivors | 2002 |
Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men.
Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Blood Proteins; Ceruloplasmin; Cholesterol; Cohort Studies; Comorbidity; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Hypercholesterolemia; Incidence; Inflammation; Male; Middle Aged; Mortality; Myocardial Infarction; Orosomucoid; Risk Factors; Stroke; Sweden | 2002 |
Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction.
Topics: Aged; Biomarkers; Blood Coagulation; Case-Control Studies; Exercise; Female; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; von Willebrand Factor; Women's Health | 2002 |
Inflammation, fibrinogen and thrombin generation in patients with previous myocardial infarction.
Topics: Aged; Biomarkers; Case-Control Studies; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Thrombin | 2002 |
Observations on blood viscosity changes after acute myocardial infarction.
Topics: Alpha-Globulins; Blood Proteins; Blood Viscosity; Fibrinogen; Hematocrit; Mathematics; Myocardial Infarction; Plasma; Polycythemia; Serum Albumin; Time Factors | 1975 |
Heparin cofactor activity measured with an amidolytic method.
Topics: Acute Disease; Alpha-Globulins; Antithrombin III; Antithrombins; Biological Assay; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Heparin; Hexadimethrine Bromide; Humans; Liver Cirrhosis; Methods; Myocardial Infarction; Spectrophotometry; Thrombin | 1975 |
[Changes in the content of finbrinolysis activating and inhibiting factors and of fibrinogen in patients with thrombosis and prethrombotic conditions].
Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Plasminogen Activators; Thrombosis | 1975 |
Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis.
Topics: alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Arteriosclerosis; Blood Cell Count; Blood Coagulation; Blood Platelets; Diabetes Mellitus; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Platelet Factor 3; Platelet Factor 4; Sex Factors; Thrombophlebitis | 1975 |
Changes in protease inhibitors after acute myocardial infarction.
Topics: Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Complement C1 Inactivator Proteins; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Protease Inhibitors | 1976 |
Plasma-fibrinogen and thromboemboli after myocardial infarction.
Topics: Adult; Aged; Aspartate Aminotransferases; Circadian Rhythm; Creatine Kinase; Female; Fibrinogen; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Thromboembolism; Time Factors | 1976 |
Plasma-fibrinogen and thromboemboli after myocardial infarction.
Topics: Ancrod; Fibrinogen; Humans; Myocardial Infarction; Thromboembolism | 1977 |
[Myocardial infarct repair in the light of clinico-biochemical and morphological studies].
Topics: Adult; Aged; alpha-Macroglobulins; Asparagine; Creatine Kinase; Erythrocyte Count; Female; Fibrinogen; Haptoglobins; Humans; Hydroxyproline; Leukocyte Count; Male; Middle Aged; Mucoproteins; Myocardial Infarction; Myocardium; Transaminases; Wound Healing | 1977 |
The great circulatory paradox.
Topics: Autoradiography; Coronary Disease; Fibrinogen; Humans; Iodine Radioisotopes; Isotope Labeling; Myocardial Infarction | 1977 |
Fibrinolysis in patients with ischemic heart disease (in relation to the etiologic factor of myocardial infarction).
Topics: Acute Disease; Angina Pectoris; Coronary Disease; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Lipids; Middle Aged; Myocardial Infarction; Plasminogen; Serum Globulins; Streptokinase | 1975 |
Effect of myocardial infarction on components of fibrinolytic system.
Topics: Adult; Aged; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Plasminogen; Time Factors | 1977 |
[Possibilities of early diagnosis of thromboembolic complications in myocardial infarct by means of biochemical methods].
Topics: Adult; Blood Coagulation Tests; Chromatography, Paper; Factor XIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Plasminogen Activators; Plasminogen Inactivators; Serum Globulins; Thromboembolism; Thromboplastin; Time Factors; Urokinase-Type Plasminogen Activator | 1977 |
The esterification of cholesterol in plasma after acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; alpha 1-Antitrypsin; C-Reactive Protein; Cholesterol; Esters; Fibrinogen; Haptoglobins; Humans; Lipoproteins, HDL; Male; Middle Aged; Myocardial Infarction; Orosomucoid; Serum Albumin; Time Factors | 1975 |
Intensive plasmapheresis as a risk factor for arteriosclerotic cardiovascular disease?
Topics: Arteriosclerosis; Blood Viscosity; Erythrocyte Aggregation; Fibrinogen; Humans; Hyperlipidemias; Hypoproteinemia; Lipoproteins, LDL; Lipoproteins, VLDL; Myocardial Infarction; Nephrotic Syndrome; Plasmapheresis; Risk | 1977 |
Blood coagulation system pathophysiology in acute myocardial infarction: the influence of anticoagulant treatment on laboratory findings.
Topics: Anticoagulants; Blood Coagulation Disorders; Fibrinogen; Heart Failure; Heparin; Humans; Myocardial Infarction; Warfarin | 1979 |
[State of hemostasis and blood rheology in congestive circulatory insufficiency].
Topics: Blood Viscosity; Coronary Disease; Erythrocyte Aggregation; Fibrinogen; Heart Failure; Hematocrit; Hemostasis; Humans; Myocardial Infarction; Platelet Aggregation; Thromboembolism | 1979 |
Rheological factors in circulatory disorders.
Topics: Blood Viscosity; Cerebral Infarction; Cinnarizine; Erythrocyte Membrane; Fibrinogen; Humans; Intermittent Claudication; Myocardial Infarction; Physical Exertion; Vascular Diseases | 1979 |
The relation of coronary thrombosis to ischaemic myocardial necrosis.
Topics: Cardiomyopathies; Coronary Disease; Coronary Vessels; Death, Sudden; Fibrinogen; Humans; Myocardial Infarction; Necrosis; Radioisotopes | 1979 |
[The clinical significance of blood viscosity in degenerative angiopathies].
Topics: Blood Proteins; Blood Viscosity; Cholesterol; Coronary Disease; Female; Fibrinogen; Hematocrit; Humans; Lipids; Male; Myocardial Infarction; Vascular Diseases | 1979 |
[Content of fibrinogen degradation products, soluble fibrin and the fibrinolytic activity of blood in myocardial infarct].
Topics: Adult; Aged; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Solubility | 1979 |
[Blood sterol-fibrinogen complexes in chronic ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Protein Binding; Sterols | 1979 |
On significance of plasma fibrinogen level to assess severity of myocardial damage--an experimental study.
Topics: Animals; Cardiomyopathies; Female; Fibrinogen; Isoproterenol; Male; Myocardial Infarction; Myocardium; Necrosis; Prognosis; Propranolol; Rats | 1979 |
Fibrinopeptide a (FPA) in patients with acute myocardial infarction.
Topics: Acute Disease; Blood Coagulation; Electrocardiography; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Count; Time Factors | 1979 |
Myocardial damage vis-a-vis plasma fibrinolytic activity and fibrinogen level--an experimental study.
Topics: Animals; Blood Coagulation Tests; Dogs; Female; Fibrinogen; Fibrinolysis; Male; Myocardial Infarction | 1979 |
Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in myocardial infarction.
Topics: Adult; Aged; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Platelet Adhesiveness | 1979 |
[Significance of the nitroblue-tetrazolium test in myocardial infarction].
Topics: Adult; Aged; Aspartate Aminotransferases; Creatine Kinase; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Nitroblue Tetrazolium; Tetrazolium Salts | 1979 |
[Alterations of plasma plasminogen and fibrinogen, serum fibrin degradation products and degree of ADP induced platelet aggregation in acute myocardial infarction (author's transl)].
Topics: Adenosine Diphosphate; Adult; Aged; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Platelet Aggregation | 1979 |
A study of the catabolism of fibrinogen after myocardial infarction.
Topics: Acute Disease; Fibrinogen; Half-Life; Heparin; Humans; Myocardial Infarction; Phenindione; Time Factors | 1977 |
[Changes in systemic blood viscosity in subjects with regional chronic vasculopathies during spontaneous and induced ischemia].
Topics: Adult; Angina Pectoris; Arterial Occlusive Diseases; Blood Viscosity; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Osmotic Fragility | 1977 |
Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in acute myocardial infarction.
Topics: Adult; Aged; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Serum Globulins | 1978 |
[Nonenzymatic fibrinolysis in ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Epinephrine; Fibrinogen; Fibrinolysis; Heparin; Humans; Middle Aged; Myocardial Infarction | 1978 |
[Changes in blood and plasma viscosity in patients with myocardial infarct].
Topics: Blood Viscosity; Female; Fibrinogen; Hematocrit; Humans; Male; Myocardial Infarction; Plasma Cells | 1979 |
Decreased myocardial fibrinolytic activity following temporary ischaemia and reperfusion.
Topics: Animals; Coronary Circulation; Endocardium; Fibrin; Fibrinogen; Fibrinolysis; Haplorhini; Ischemia; Myocardial Infarction; Papio | 1975 |
[Influence of acute exertion and physical training on platelet function of the coronary patient].
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Platelet Adhesiveness; Platelet Aggregation | 1976 |
Affinity chromatography and quantitation of soluble fibrin from plasma.
Topics: Chromatography, Affinity; Disseminated Intravascular Coagulation; Electrophoresis, Disc; Fibrin; Fibrinogen; Fractional Precipitation; Humans; Myocardial Infarction; Solubility | 1977 |
[Urokinase treatment of threatened and acute myocardial infarct].
Topics: Adult; Aged; Endopeptidases; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Urokinase-Type Plasminogen Activator | 1977 |
[Diagnosis of thromboembolic diseases].
Topics: Aortic Aneurysm; Arterial Occlusive Diseases; Diagnosis, Differential; Embolism; Erysipelas; Fibrinogen; Humans; Myocardial Infarction; Phlebography; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Thrombosis; Ultrasonography | 1977 |
[Blood viscosity measurements in coronary infarct patients].
Topics: Blood Viscosity; Cholesterol; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Risk | 1977 |
[Blood and plasma viscosity during the various phases of the acute myocardial infarction (AMI). Preliminary study (author's transl)].
Topics: Acute Disease; Blood Viscosity; Cholesterol; Fibrinogen; Hematocrit; Humans; Myocardial Infarction; Prognosis; Rheology | 1977 |
Content of soluble fibrin in plasma of patients after myocardial infarction, with carcinomas and consumption coagulopathy.
Topics: Chromatography, Affinity; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Genital Neoplasms, Female; Humans; Myocardial Infarction; Solubility | 1977 |
Relationship between fibrinogen and blood viscosity.
Topics: Adult; Aged; Aging; Blood Viscosity; Brain; Fibrinogen; Humans; Infarction; Kidney; Middle Aged; Myocardial Infarction | 1976 |
Attempted diagnosis of ventricular mural thrombi in acute mycardial infarction using 125I-labelled fibrinogen.
Topics: Acute Disease; Aged; Coronary Disease; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Pericarditis | 1976 |
Proceedings: I-Labelled fibrinogen, autoradiography, and stereoarteriography in identification of coronary thrombotic occlusion in fatal myocardial infarction.
Topics: Angiography; Autoradiography; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction | 1976 |
Changes in coagulation factors following acute myocardial infarction in man.
Topics: Acute Disease; Adult; Blood Coagulation; Blood Coagulation Tests; Factor IX; Factor V; Factor VII; Factor X; Factor XI; Factor XII; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Time Factors | 1976 |
[Significance of plasma-protein paracoagulation test in the diagnosis of thromboembolic the disease].
Topics: Acute Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Myocardial Infarction; Protamines; Pulmonary Embolism; Thromboembolism | 1976 |
[Improvement of flow properties using Arwin in acute experimental infarct].
Topics: Angina Pectoris; Animals; Anticoagulants; Blood Pressure; Blood Viscosity; Dogs; Female; Fibrinogen; Heart Rate; Ligation; Male; Myocardial Contraction; Myocardial Infarction; Snakes; Venoms | 1976 |
[Intravascular disorders of microcirculation and microthrombus formation in patients with chronic ischemic disease of the heart].
Topics: Adult; Blood Coagulation; Coronary Disease; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Heparin; Humans; Hypertension; Kallikreins; Kininogens; Male; Microcirculation; Middle Aged; Myocardial Infarction; Thrombosis | 1976 |
[Disseminated intravascular coagulation in myocardial infarct].
Topics: Adult; Aged; Blood Coagulation; Blood Platelets; Cell Count; Cell Survival; Disseminated Intravascular Coagulation; Factor V; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction | 1976 |
[Rheologic properties of blood in patients with complicated and uncomplicated course of acute myocardial infarct].
Topics: Adult; Aged; Blood Viscosity; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Rheology | 1976 |
Identifying patients at risk for thromboembolism. Use of 125I-labeled fibrinogen in patients with acute myocardial infarction.
Topics: Acute Disease; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Myocardial Infarction; Risk; Thromboembolism; Thrombophlebitis | 1976 |
[An experimental model of electrically-induced coronary thrombosis in the closed chest].
Topics: Animals; Aspartate Aminotransferases; Blood Gas Analysis; Blood Pressure; Coronary Disease; Coronary Vessels; Creatine Kinase; Disease Models, Animal; Dogs; Electric Injuries; Fibrinogen; Fibrinolysis; Myocardial Infarction; Myocardium; Platelet Count; Time Factors | 1975 |
Cardiac heterotransplantation. Morphological and immunohistological studies.
Topics: Animals; Antigens; Complement System Proteins; Cyclophosphamide; Fibrinogen; Fluorescent Antibody Technique; Graft Rejection; Heart Transplantation; Immunoglobulin G; Inflammation; Mice; Microscopy, Fluorescence; Myocardial Infarction; Myocardium; Necrosis; Rats; Transplantation, Heterologous | 1975 |
Effect of fibrinogen on aggregation of red cells and on apparent viscosity of artificial thrombi in haemophilia, myocardial infarction, thyroid disease, cancer and control systems: effect of ABO blood groups.
Topics: ABO Blood-Group System; Blood Coagulation Tests; Blood Group Antigens; Blood Sedimentation; Blood Viscosity; Cell Aggregation; Erythrocytes; Fibrinogen; Hemophilia A; Humans; Microcirculation; Myocardial Infarction; Neoplasms; Regression Analysis; Rheology; Thyroid Diseases | 1975 |
Decision theory in the prevention of thrombo-embolism after myocardial infarction.
Topics: Aged; Decision Making; Fibrinogen; Heparin; Humans; Mathematics; Middle Aged; Myocardial Infarction; Probability; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Thrombosis | 1975 |
[Survival and state of patients during the 1st year after myocardial infarct (according to data of epidemiological study - myocardial infarct register)].
Topics: Adult; Aged; Angina Pectoris; Blood Coagulation Disorders; Blood Glucose; Cholesterol; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Prognosis; Recurrence; Thrombelastography; Thromboembolism; Time Factors | 1975 |
[Influence of a streptokinase-induced fibrinolysis on the extent of the acute experimental myocardial infarction (author's transl)].
Topics: Animals; Arteries; Blood Cell Count; Blood Platelets; Blood Pressure; Coronary Vessels; Dogs; Female; Fibrinogen; Fibrinolysis; Heart; Heart Rate; Hemostasis; Humans; Ligation; Male; Myocardial Infarction; Streptokinase | 1975 |
[Incidence of venous thrombosis in acute myocardial infarct diagnosed using 125 I-fibrinogen].
Topics: Acute Disease; Fibrinogen; Humans; Iodine Radioisotopes; Myocardial Infarction; Radionuclide Imaging; Thrombophlebitis | 1976 |
Formation of coronary arterial thrombi in relation to onset of necrosis in acute myocardial infarction in man. A clinical and autoradiographic study.
Topics: Aged; Coronary Disease; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Necrosis | 1976 |
Fibrinolytic effects of pro-urokinase combined with low-dose urokinase compared to high-dose urokinase in patients with acute myocardial infarction.
Topics: Aged; alpha-Macroglobulins; Dose-Response Relationship, Drug; Drug Combinations; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Recombinant Proteins; Thrombin Time; Urokinase-Type Plasminogen Activator | 1992 |
[Increased fibrinogen and factor VII activity levels in patients after myocardial infarction].
Topics: Adult; Blood Coagulation; Cholesterol; Coronary Thrombosis; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Reference Values; Triglycerides | 1992 |
[Formation of left ventricular thrombus in acute myocardial infarction: significance of the determination of fibrinogen, of products of fibrinogen degradation, and of plasminogen].
Topics: Aged; Female; Fibrinogen; Heart Diseases; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Prospective Studies; Thrombosis | 1992 |
Platelet size and outcome after myocardial infarction.
Topics: Blood Platelets; Fibrinogen; Humans; Myocardial Infarction; Platelet Count; Prognosis | 1992 |
Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction.
Topics: Aged; alpha-2-Antiplasmin; alpha-Macroglobulins; Female; Fibrin; Fibrinogen; Fibrinolysin; Hemostasis; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Substrate Specificity; Time Factors; Tissue Plasminogen Activator | 1992 |
Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis.
Topics: Acute-Phase Proteins; Adult; Coronary Artery Disease; Coronary Disease; Fibrin; Fibrinogen; Gels; Humans; In Vitro Techniques; Lipoproteins; Male; Molecular Structure; Myocardial Infarction; Polymers | 1992 |
[Variations of plasma Willebrand factor and fibrinogen in coronary pathology].
Topics: Angina Pectoris; Biomarkers; Coronary Disease; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; von Willebrand Factor | 1992 |
Hageman factor and risk of myocardial infarction in middle-aged men.
Topics: Aged; Antigens; Cholesterol; Factor VII; Factor XII; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Risk Factors | 1992 |
Plasma sialic acid in myocardial infarction.
Topics: C-Reactive Protein; Electrocardiography; Fibrinogen; Humans; Lipids; Myocardial Infarction; Orosomucoid; Sialic Acids | 1992 |
Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age.
Topics: Adult; Age Factors; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Electrocardiography, Ambulatory; Fibrinogen; Follow-Up Studies; Heart Rate; Humans; Male; Myocardial Infarction; Regression Analysis; Risk Factors | 1992 |
Fibrinogen: the plot thickens.
Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Fibrinogen; Humans; Myocardial Infarction; Platelet Aggregation; Risk Factors | 1992 |
Effectiveness and safety of a single intravenous bolus injection of tissue-type plasminogen activator in acute myocardial infarction. Bolus Dose-Escalation Study of Tissue-Type Plasminogen Activator (BEST) Investigators.
Topics: Adult; Aged; Electrocardiography; Female; Fibrinogen; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1992 |
Studies on the functionality of fibrinogen during rt-PA therapy: results of three different methods of fibrinogen determination.
Topics: Aged; Blood Coagulation Tests; Female; Fibrinogen; Humans; Immunoenzyme Techniques; Male; Middle Aged; Myocardial Infarction; Nephelometry and Turbidimetry; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator | 1992 |
Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
Topics: alpha-2-Antiplasmin; alpha-Macroglobulins; Complement C1 Inactivator Proteins; Drug Administration Schedule; Fibrinogen; Fibrinolysin; Humans; In Vitro Techniques; Myocardial Infarction; Plasminogen; Streptokinase; Tissue Plasminogen Activator | 1990 |
Serial thrombolysis-related changes after thrombolytic therapy with TPA in patients with acute myocardial infarction.
Topics: Adult; Aged; alpha-2-Antiplasmin; alpha-Macroglobulins; Antithrombin III; Blood Cell Count; Blood Coagulation Tests; Creatine Kinase; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen; Thrombin Time; Thrombolytic Therapy; Tissue Plasminogen Activator | 1990 |
Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction.
Topics: Animals; Antibodies; Antibodies, Monoclonal; Arteries; Chronic Disease; Coronary Aneurysm; Coronary Vessels; Epitopes; Fibrin; Fibrinogen; Fibronectins; Fluorescent Antibody Technique; Granulation Tissue; Ligation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains | 1990 |
Therapeutic defibrination with ancrod does not protect canine myocardium from reperfusion injury.
Topics: alpha-Macroglobulins; Ancrod; Animals; Blood Pressure; Coronary Circulation; Dogs; Fibrinogen; Fibrinolysin; Heart Rate; Leukocyte Count; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Peroxidase; Tissue Plasminogen Activator; Ventricular Fibrillation | 1991 |
[When will fibrinogen screening become available?].
Topics: Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Rabbits; Risk Factors | 1991 |
Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction.
Topics: Aged; Fibrinogen; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator | 1991 |
Are admission plasma fibrinogen levels useful in the characterization of risk groups after myocardial infarction treated with fibrinolysis?
Topics: Diagnostic Tests, Routine; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hematologic Tests; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Regression Analysis; Risk Factors | 1991 |
[The influence of lipoprotein (a) in thrombolysis with r-TPA for myocardial infarction].
Topics: Administration, Oral; Female; Fibrinogen; Humans; Injections, Intravenous; Lipoproteins; Male; Myocardial Infarction; Radioimmunoassay; Thrombolytic Therapy; Tissue Plasminogen Activator | 1991 |
Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction.
Topics: Aged; Coronary Angiography; Drug Therapy, Combination; Fibrinogen; Fibrinolytic Agents; Humans; Lipoprotein(a); Lipoproteins; Middle Aged; Myocardial Infarction; Plasminogen Activators; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1991 |
A method for enzyme- and immunohistochemical staining of large frozen specimens.
Topics: Animals; Fibrinogen; Fibronectins; Frozen Sections; Gelatin; Histocytochemistry; Immunohistochemistry; Mice; Microwaves; Myocardial Infarction; Myocardium; Swine | 1991 |
Histidine-rich glycoprotein in thrombolytic therapy: has it clinical relevance?
Topics: Anistreplase; Coronary Vessels; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Proteins; Streptokinase; Thrombolytic Therapy | 1991 |
How soon after quitting smoking does risk of heart attack decline?
Topics: Adult; Aged; Case-Control Studies; Confidence Intervals; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Time Factors | 1991 |
Promotion of thrombin activity by thrombolytic therapy without simultaneous anticoagulation.
Topics: Blood Coagulation; Drug Therapy, Combination; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator | 1990 |
[The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct].
Topics: Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy | 1991 |
[Systemic lytic state as marker of therapeutic success after rt-PA in bolus in myocardial infarction].
Topics: Adult; Aged; Female; Fibrinogen; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Streptokinase; Thrombolytic Therapy | 1990 |
[The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
Topics: Adult; Angina Pectoris; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibronectins; Humans; Male; Myocardial Infarction; Myoglobin; Physical Exertion; Thrombolytic Therapy; Time Factors | 1990 |
Fibrinogen, factor VII clotting activity and coronary artery disease severity.
Topics: Cholesterol; Coronary Angiography; Coronary Disease; Coronary Vessels; Factor VII; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Triglycerides | 1990 |
Bleeding time and other laboratory tests to monitor the safety and efficacy of thrombolytic therapy.
Topics: Bleeding Time; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematologic Tests; Hemorrhage; Humans; Myocardial Infarction; Platelet Function Tests; Streptokinase; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1990 |
Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction.
Topics: Adult; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator | 1990 |
Enhanced myocardial salvage by maintenance of microvascular patency following initial thrombolysis with recombinant tissue plasminogen activator.
Topics: Animals; Coronary Circulation; Disease Models, Animal; Dogs; Female; Fibrinogen; Infusions, Intravenous; Male; Microcirculation; Myocardial Infarction; Myocardial Reperfusion; Partial Thromboplastin Time; Recombinant Proteins; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Vascular Patency | 1990 |
Correlations between fibrinolytic function and acute myocardial infarction.
Topics: Adult; Case-Control Studies; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Male; Myocardial Infarction; Plasminogen Inactivators; Prospective Studies; Recurrence; Tissue Plasminogen Activator | 1990 |
Fibrinogen proteolysis and coagulation system activation during thrombolytic therapy.
Topics: Double-Blind Method; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Myocardial Infarction; Prospective Studies; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator | 1990 |
Bishop lecture. Contribution of the Framingham Study to preventive cardiology.
Topics: Blood Glucose; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Cholesterol; Electrocardiography; Fibrinogen; Humans; Life Style; Massachusetts; Myocardial Infarction; Prospective Studies; Risk Factors | 1990 |
A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex, APSAC) in acute myocardial infarction.
Topics: Adult; Aged; alpha-2-Antiplasmin; Anistreplase; Blood Coagulation; Blood Coagulation Tests; Drug Resistance; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Retrospective Studies; Thrombolytic Therapy | 1990 |
Plasma viscosity, fibrinogen and haematocrit in the course of unstable angina.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Blood Viscosity; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction | 1990 |
Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin.
Topics: Adult; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Fibrinogen; Fibrinopeptide A; Fluorouracil; Humans; Male; Myocardial Infarction; Prospective Studies; Protein C; Tongue Neoplasms | 1990 |
Hypercoagulable state after thrombolytic therapy in patients with acute myocardial infarction (AMI) treated with streptokinase.
Topics: Adult; Aged; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Streptokinase; Thrombin | 1990 |
Plasma HMW fibrinogen in patients with ischaemic heart disease.
Topics: Aged; Aged, 80 and over; Coronary Disease; Fibrinogen; Humans; Middle Aged; Molecular Weight; Myocardial Infarction; Prospective Studies | 1990 |
Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia.
Topics: Angina Pectoris; Beta-Globulins; beta-Thromboglobulin; Blood Coagulation; Fibrinogen; Fibrinopeptide A; Humans; Myocardial Infarction | 1985 |
[Beta-thromboglobulin and fibrinopeptide A in acute myocardial infarction].
Topics: Beta-Globulins; beta-Thromboglobulin; False Negative Reactions; False Positive Reactions; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Myocardial Infarction; Time Factors | 1985 |
[Clinical experiences with systemic high-dosage short-term fibrinolysis in acute myocardial infarct].
Topics: Adult; Aged; Cardiac Complexes, Premature; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Fibrinogen; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Streptokinase; Thrombin Time | 1986 |
[Thrombolytic therapy with urokinase--indications and results].
Topics: Coronary Artery Bypass; Factor XIII; Fibrinogen; Fibrinolysis; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Risk; Thrombosis; Urokinase-Type Plasminogen Activator | 1986 |
Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction.
Topics: Adult; Aged; alpha-2-Antiplasmin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Plasminogen Activators; Recombinant Proteins; Urokinase-Type Plasminogen Activator | 1986 |
Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI).
Topics: Acute-Phase Proteins; C-Reactive Protein; Complement C1 Inactivator Proteins; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Thrombophlebitis; Tissue Plasminogen Activator | 1987 |
Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activator.
Topics: Amino Acid Chloromethyl Ketones; Aprotinin; Blood Specimen Collection; Citrates; Citric Acid; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Myocardial Infarction; Tissue Plasminogen Activator | 1988 |
Alterations of antithrombin III after acute myocardial infarction.
Topics: Antithrombin III; C-Reactive Protein; Fibrinogen; Haptoglobins; Humans; Myocardial Infarction; Prealbumin; Retinol-Binding Proteins | 1988 |
Low dose urokinase preactivated natural prourokinase for thrombolysis in acute myocardial infarction.
Topics: Aged; Coronary Angiography; Drug Therapy, Combination; Enzyme Activation; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators; Prospective Studies; Recurrence; Urokinase-Type Plasminogen Activator; Vascular Patency | 1989 |
Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Topics: Coronary Angiography; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Radioimmunoassay; Recombinant Proteins; Recurrence; Time Factors; Tissue Plasminogen Activator | 1989 |
A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group.
Topics: Aged; Coronary Angiography; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Pilot Projects; Recurrence; Streptokinase; Stroke Volume; Tissue Plasminogen Activator; Vascular Patency | 1989 |
Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group.
Topics: Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Humans; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator | 1989 |
Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator.
Topics: Adult; Aged; Coronary Angiography; Electrocardiography; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Recurrence; Tissue Plasminogen Activator; Vascular Patency | 1989 |
Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.
Topics: Arteries; Fibrinogen; Fibrinolytic Agents; Humans; Myocardial Infarction; Plasminogen; Plasminogen Activators; Plasminogen Inactivators; Tissue Plasminogen Activator; Vascular Patency | 1989 |
[Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
Topics: Adult; Angina Pectoris; Angina, Unstable; Coronary Disease; Coronary Thrombosis; Creatine Kinase; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Inactivators; Tissue Plasminogen Activator; von Willebrand Factor | 1989 |
Fibrinolytic activity in coronary heart disease.
Topics: Adult; Angina Pectoris; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen | 1989 |
Lunar phases, myocardial infarction and hemorrheological character. A Western medical study combined with appraisal of the related traditional Chinese medical theory.
Topics: Adult; Aged; Aged, 80 and over; Blood Viscosity; Female; Fibrinogen; Hematocrit; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Myocardial Infarction; Periodicity; Platelet Adhesiveness; Time Factors | 1989 |
Human fibrinogen heterogeneity. A study of limited fibrinogen degradation.
Topics: Blood Coagulation; Electrophoresis, Polyacrylamide Gel; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Heparin; Humans; Immunoelectrophoresis; Molecular Weight; Myocardial Infarction; Streptokinase; Urokinase-Type Plasminogen Activator | 1989 |
[Fibrinogen, a cardiovascular risk factor].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Fibrinogen; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Risk Factors | 1989 |
[Fibronectin and fibrinogen/fibrin at the focus of an experimental myocardial infarct].
Topics: Animals; Fibrin; Fibrinogen; Fibronectins; Fluorescent Antibody Technique; Granulation Tissue; Heart Aneurysm; Myocardial Infarction; Rats | 1989 |
Bleeding after thrombolysis in acute myocardial infarction.
Topics: Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Streptokinase; Urokinase-Type Plasminogen Activator | 1989 |
Plasma fibrinogen in unstable coronary artery disease.
Topics: Angina Pectoris; Angina, Unstable; Body Weight; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Orosomucoid; Smoking | 1989 |
[Effect of fenofibrate on fibrinogen concentration and blood viscosity. Consequences for myocardial microcirculation in coronary heart disease?].
Topics: Blood Viscosity; Coronary Circulation; Coronary Disease; Drug Evaluation; Erythrocyte Aggregation; Exercise Test; Fenofibrate; Fibrinogen; Heart; Humans; Lipids; Microcirculation; Myocardial Infarction; Propionates; Radionuclide Imaging; Thallium Radioisotopes | 1989 |
Fibrinopeptide A levels in patients with acute ischaemic heart disease.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Myocardial Infarction | 1989 |
[Molecular markers of hemostatic mechanisms--fibrinopeptide A and fibrinopeptide B beta 15-42].
Topics: Aged; Blood Coagulation; Cerebral Infarction; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Middle Aged; Myocardial Infarction; Neoplasms; Peptide Fragments | 1989 |
Urinary fibrinopeptide A levels in ischemic heart disease.
Topics: Angina Pectoris; Angina, Unstable; Coronary Disease; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies | 1989 |
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.
Topics: Adult; Fibrinogen; Follow-Up Studies; Glycoproteins; Hemostasis; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Methods; Middle Aged; Myocardial Infarction; Plasminogen Activators; Plasminogen Inactivators; Prospective Studies; Recurrence; Risk; Triglycerides | 1987 |
Platelet function and plasma fibrinogen and their relations to gender, smoking habits, obesity and beta-blocker treatment in young survivors of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Blood Platelets; Female; Fibrinogen; Humans; Male; Myocardial Infarction; Obesity; Platelet Function Tests; Sex Factors; Smoking | 1988 |
[Characteristics of hemostasis, fibrinolysis and lipid indicators in children and their fathers with a history of myocardial infarction at a young age].
Topics: Adolescent; Adult; Antithrombin III Deficiency; Blood Coagulation; Child; Cholesterol; Cholesterol, HDL; Coronary Disease; Disease Susceptibility; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Triglycerides | 1986 |
Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.
Topics: Aged; Coronary Vessels; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Urokinase-Type Plasminogen Activator | 1986 |
Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulation.
Topics: Adult; Aged; Arterial Occlusive Diseases; Computers; Fibrinogen; Fibrinolysis; Humans; Infusions, Parenteral; Middle Aged; Myocardial Infarction; Plasminogen; Prospective Studies; Tissue Plasminogen Activator | 1986 |
[Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
Topics: Anistreplase; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Metabolic Clearance Rate; Molecular Weight; Myocardial Infarction; Plasminogen; Plasminogen Activators; Streptokinase; Urokinase-Type Plasminogen Activator | 1986 |
Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator.
Topics: Aged; Blood Coagulation; Coronary Circulation; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Recombinant Proteins; Time Factors; Tissue Plasminogen Activator | 1987 |
Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction.
Topics: Age Factors; Aged; Female; Fibrinogen; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Sex Factors; Tissue Plasminogen Activator | 1988 |
[Intravenous thrombolysis in myocardial infarction. Influence of the quality of the anticoagulation on the early recurrence rate of angina or infarction].
Topics: Adult; Aged; Anticoagulants; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Recurrence; Retrospective Studies; Streptokinase | 1988 |
Do different doses of intravenous streptokinase alter the frequency of coronary reperfusion in acute myocardial infarction?
Topics: Aged; Coronary Circulation; Creatine Kinase; Female; Fibrinogen; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Streptokinase | 1988 |
[Fibrinopeptide A and protein C in heart patients with acute coronary syndromes].
Topics: Acute Disease; Aged; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Protein C | 1988 |
[Changes in the plasma levels of fibrinopeptide A in acute myocardial infarction after administration of intravenous streptokinase].
Topics: Creatine Kinase; Fibrinogen; Fibrinopeptide A; Humans; Injections, Intravenous; Myocardial Infarction; Streptokinase | 1988 |
[Detection of left ventricular thrombi after acute myocardial infarction using Ga-67-DFO-DAS-fibrinogen].
Topics: Adult; Deferoxamine; Echocardiography; Female; Fibrinogen; Gallium Radioisotopes; Heart Diseases; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Radionuclide Imaging; Starch; Thrombosis | 1988 |
Fibrinogen concentration and coronary artery reperfusion after intravenous anisoylated plasminogen streptokinase activator complex or intracoronary streptokinase therapy.
Topics: Anistreplase; Coronary Circulation; Coronary Vessels; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Injections, Intravenous; Myocardial Infarction; Plasminogen; Streptokinase | 1987 |
[Hyperfibrinogenemia and pathological plasma viscosity. Pathogenetic factors in unstable angina pectoris?].
Topics: Angina Pectoris; Angina, Unstable; Blood Viscosity; Cardiac Catheterization; Coronary Angiography; Erythrocyte Aggregation; Fibrinogen; Hemodynamics; Humans; Myocardial Infarction | 1988 |
Streptokinase and reduced plasma viscosity: a second benefit.
Topics: Blood Cell Count; Blood Viscosity; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Humans; Microcirculation; Myocardial Infarction; Plasminogen; Prothrombin Time; Streptokinase | 1988 |
[Study of proteolytic systems of the blood in patients with myocardial infarction].
Topics: Adult; Aged; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Protease Inhibitors | 1988 |
Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection.
Topics: Anistreplase; Cardiac Catheterization; Coronary Angiography; Dose-Response Relationship, Drug; Female; Fibrinogen; Hemorrhage; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase; Time Factors | 1986 |
Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction.
Topics: Adult; Aged; Anistreplase; Fibrinogen; Follow-Up Studies; Half-Life; Heart; Hemostasis; Humans; Infusions, Parenteral; Kinetics; Middle Aged; Myocardial Infarction; Plasminogen; Recurrence; Streptokinase; Time Factors | 1986 |
Distribution of fibrinogen and albumin in normal, ischaemic, and necrotic myocardium during the evolution of myocardial infarction: an immunohistochemical study.
Topics: Albumins; Animals; Coronary Vessels; Dogs; Fibrinogen; Immunologic Techniques; Ischemia; Myocardial Infarction; Myocardium; Necrosis | 1986 |
Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction.
Topics: Aged; Anistreplase; Coronary Vessels; Electrophoresis, Agar Gel; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Prognosis; Streptokinase | 1986 |
Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Angiography; Coronary Circulation; Electrocardiography; Female; Fibrinogen; Heparin; Humans; Injections; Male; Middle Aged; Myocardial Infarction; Streptokinase; Subtraction Technique | 1987 |
Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.
Topics: Blood Coagulation; Electrophoresis, Agar Gel; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Myocardial Infarction; Polymers; Thrombosis; Time Factors | 1987 |
[Coronary thrombolysis after intracoronary and intravenous administration of streptokinase to myocardial infarct patients].
Topics: Adult; Aged; Coronary Vessels; Fibrinogen; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Myocardial Infarction; Streptokinase | 1987 |
[Fibrinolytic activity and coronary heart disease].
Topics: Adult; Angina Pectoris; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators | 1987 |
Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Topics: Collagen Diseases; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Myocardial Infarction; Neoplasms; Thromboembolism | 1987 |
[Fibrinolysis and hemorrhage after streptokinase in acute myocardial infarct].
Topics: Female; Fibrinogen; Hemorrhage; Humans; Male; Myocardial Infarction; Prothrombin Time; Streptokinase | 1987 |
Serum amyloid A concentrations during the course of acute ischaemic heart disease.
Topics: Aged; Amyloid; Coronary Disease; Creatine Kinase; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocarditis; Serum Amyloid A Protein; Time Factors | 1986 |
Usefulness of residual plasma fibrinogen after intravenous streptokinase for predicting delay or failure of reperfusion in acute myocardial infarction.
Topics: Coronary Circulation; Female; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Streptokinase | 1986 |
Plasma fibrinogen and serum enzymes: relative significance as prognostic indicator in acute myocardial infarction.
Topics: Adult; Aged; Aspartate Aminotransferases; Creatine Kinase; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis | 1986 |
[Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
Topics: Adult; Angina Pectoris; Blood Protein Electrophoresis; Chromatography, Gel; Coronary Artery Disease; Coronary Disease; Exercise Therapy; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion | 1986 |
Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
Topics: Angina Pectoris; Coronary Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Myocardial Infarction; Prognosis | 1985 |
Bypass surgery following thrombolytic therapy.
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Coronary Artery Bypass; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Middle Aged; Myocardial Infarction; Recurrence; Risk | 1985 |
[Treatment of profuse gastroduodenal hemorrhages in peptic ulcer and myocardial infarction].
Topics: Aged; Aminocaproic Acid; Blood Transfusion; Critical Care; Duodenal Ulcer; Evaluation Studies as Topic; Fibrinogen; Gastrectomy; Hemostatic Techniques; Humans; Male; Middle Aged; Myocardial Infarction; Peptic Ulcer Hemorrhage; Serum Albumin; Stomach Ulcer | 1985 |
Systemic effects of BRL 26921 during thrombolytic treatment of acute myocardial infarction.
Topics: Adult; Aged; alpha-2-Antiplasmin; Anistreplase; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase | 1985 |
Coronary thrombolysis with recombinant tissue-type plasminogen activator. A hematologic and pharmacologic study.
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Factors; Female; Fibrinogen; Fibrinolysis; Humans; In Vitro Techniques; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Tissue Plasminogen Activator | 1985 |
Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
Topics: Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Infusions, Intra-Arterial; Myocardial Infarction; Recurrence; Streptokinase | 1986 |
Fibrinopeptide A: a marker of acute coronary thrombosis.
Topics: Coronary Disease; Creatine Kinase; Female; Fibrinogen; Fibrinopeptide A; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Time Factors | 1985 |
[Haptoglobin phenotype distribution in patients at high risk of developing myocardial infarct].
Topics: Adult; Aged; Blood Coagulation Tests; Diabetes Mellitus; Disease Susceptibility; Female; Fibrinogen; Haptoglobins; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarction; Phenotype; Risk | 1985 |
Measurement of antistreptokinase antibodies.
Topics: Antibodies, Bacterial; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Streptokinase | 1985 |
Left ventricular thrombosis, wall motion abnormalities, and blood viscosity changes after first transmural anterior myocardial infarction.
Topics: Adult; Aged; Blood Viscosity; Coronary Disease; Echocardiography; Female; Fibrinogen; Heart; Humans; Male; Middle Aged; Movement; Myocardial Infarction | 1985 |
Fibrinopeptide A excretion in urine in patients with atherosclerotic artery disease.
Topics: Aortic Aneurysm; Arteriosclerosis; Fibrinogen; Fibrinopeptide A; Humans; Myocardial Infarction; Radioimmunoassay | 1985 |
Discrepant fibrinogen values during thrombolytic therapy. Comparison of aca and Data-Fi results using immunofixation. Electrophoresis as a reference.
Topics: Adult; Blood Protein Electrophoresis; Fibrinogen; Fibrinolysis; Humans; Male; Methods; Middle Aged; Myocardial Infarction; Streptokinase; Thrombophlebitis | 1985 |
The measurement of fibrinogen by the DuPont aca and Dade methods in patients receiving streptokinase infusions.
Topics: Coronary Vessels; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Injections, Intravenous; Methods; Myocardial Infarction; Streptokinase | 1985 |
Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology.
Topics: Adult; Aged; alpha-2-Antiplasmin; Blood Coagulation; DNA, Recombinant; Female; Fibrinogen; Fibrinolysis; Half-Life; Humans; Kinetics; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators; Radioimmunoassay | 1985 |
High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.
Topics: Adult; Aged; Aspirin; Coronary Angiography; Dipyridamole; Drug Evaluation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Perfusion; Plasminogen; Streptokinase | 1985 |
Evidence that changes in fibrinogen quality during acute phase reactions are of major importance for the amount of heparin precipitable fraction (HPF).
Topics: Acute Disease; Chemical Precipitation; Fibrinogen; Fibronectins; Heparin; Hip Prosthesis; Humans; Molecular Weight; Myocardial Infarction | 1985 |
[Immunologic diagnosis of intravascular blood clotting and intravascular thrombus formation among patients with ischemic heart disease].
Topics: Adult; Angina, Unstable; Autoantibodies; Coronary Disease; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemagglutination Tests; Humans; Male; Middle Aged; Myocardial Infarction; Thrombin | 1985 |
Frequency of venous thrombosis after myocardial infarction.
Topics: Aged; Anticoagulants; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Thrombophlebitis; Varicose Veins | 1971 |
Venous thrombosis after myocardial infarction.
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Myocardial Infarction; Radionuclide Imaging; Thrombophlebitis; Time Factors | 1972 |
Venous thrombosis after myocardial infarction.
Topics: Fibrinogen; Fibrinolytic Agents; Humans; Myocardial Infarction; Pulmonary Embolism; Thrombophlebitis | 1972 |
Serum fibrin-fibrinogen degradation products in acute myocardial infarction.
Topics: Aspartate Aminotransferases; Blood Sedimentation; Fibrin; Fibrinogen; Humans; L-Lactate Dehydrogenase; Myocardial Infarction; Time Factors | 1972 |
Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.
Topics: Adult; Age Factors; Blood Platelets; Cholesterol; Drug Synergism; Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Phenformin; Potassium; Recurrence; Time Factors | 1972 |
Incorporation of 125 I-labelled fibrinogen into coronary arterial thrombi in acute myocardial infarction in man.
Topics: Acute Disease; Aged; Arteries; Autopsy; Coronary Vessels; Dicumarol; Female; Fibrinogen; Heparin; Humans; Injections, Intravenous; Iodine Isotopes; Isotope Labeling; Male; Myocardial Infarction; Thrombosis; Time Factors | 1973 |
Long-term blood abnormalities in thrombosis.
Topics: Blood Coagulation Disorders; Blood Platelets; Fibrinogen; Humans; Myocardial Infarction; Pulmonary Embolism; Thrombophlebitis; Thrombosis | 1973 |
Serum fibrin-fibrinogen degradation products in acute myocardial infarction.
Topics: Acute Disease; Age Factors; Aged; Fibrin; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Serologic Tests; Thrombophlebitis | 1972 |
Letter: Fibrinolytic activity and postoperative deep-vein thrombosis.
Topics: Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Phenformin; Postoperative Complications; Preoperative Care; Thrombophlebitis | 1974 |
Acute phase reaction following intravenous administration of streptokinase.
Topics: Adult; Aged; alpha 1-Antitrypsin; Beta-Globulins; C-Reactive Protein; Ceruloplasmin; Fibrinogen; Fibrinolysis; Humans; Injections, Intravenous; Middle Aged; Myocardial Infarction; Orosomucoid; Plasminogen; Streptokinase; Thrombophlebitis; Time Factors | 1974 |
[Autoimmune reactions and blood coagulation status in patients with myocardial infarct].
Topics: Aged; Antibody Formation; Autoantibodies; Blood Coagulation; Complement Fixation Tests; Fibrinogen; Fibrinolysis; gamma-Globulins; Humans; Middle Aged; Myocardial Infarction; Myocardium; Time Factors | 1974 |
Therapeutic defibrination in the treatment of thrombotic disease.
Topics: Adult; Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysis; Humans; Immunoassay; Male; Middle Aged; Mitral Valve Stenosis; Myocardial Infarction; Plasminogen; Thrombophlebitis; Thrombosis; Urticaria; Venoms | 1968 |
A new approach to anticoagulant therapy.
Topics: Anticoagulants; Fibrinogen; Humans; Myocardial Infarction; Thrombosis; Venoms | 1968 |
Fibrinolytic activity and coronary-artery disease.
Topics: Adult; Age Factors; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Disease; Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Obesity; Phenformin | 1968 |
[Coagulation spectrum in coronary sclerosis and infarct].
Topics: Aged; Blood Coagulation; Blood Platelets; Coronary Disease; Dicumarol; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction | 1968 |
Apparent resistance to oral anticoagulant therapy and influence of hypnotics on some coagulation factors.
Topics: Anticoagulants; Barbiturates; Blood Coagulation; Blood Coagulation Tests; Dicumarol; Factor VII; Female; Fibrinogen; Humans; Hypnotics and Sedatives; Male; Middle Aged; Myocardial Infarction; Prothrombin | 1968 |
Leg-vein thrombosis following myocardial infarction.
Topics: Adult; Female; Fibrinogen; Humans; Iodine Isotopes; Leg; Male; Middle Aged; Myocardial Infarction; Pulmonary Embolism; Thrombophlebitis | 1970 |
[Determination of fibrinogen and fibrin degradation products (DFP) in the acute stage of myocardial infarction].
Topics: Age Factors; Aged; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Humans; Iodine Isotopes; Middle Aged; Myocardial Infarction; Prognosis; Thrombosis | 1973 |
[Proposal for the therapy of myocardial infarct in its initial stage].
Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Blood Vessels; Edema; Electrocardiography; Female; Fibrinogen; Heparin; Humans; Injections, Intravenous; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Prednisolone; Sulfates; Sulfur Radioisotopes; Thromboembolism; Thymidine; Time Factors; Tritium | 1974 |
[State of the blood coagulation system in patients with myocardial infarct and chest pain and the changes in it during the use of anticoagulants and fibrinolysin].
Topics: Aged; Angina Pectoris; Anticoagulants; Blood Coagulation; Factor V; Factor VII; Female; Fibrinogen; Fibrinolysin; Heparin; Humans; Male; Methods; Middle Aged; Myocardial Infarction; Prothrombin; Thrombelastography | 1967 |
Studies in cryofibrinogenemia.
Topics: Aminocaproates; Blood Protein Disorders; Blood Proteins; Blood Sedimentation; Carcinoma; Cold Temperature; Collagen Diseases; Cryoglobulins; Electrophoresis; Fibrinogen; Fibrinolysin; Heparin; Hodgkin Disease; Humans; Immune Sera; Immunoelectrophoresis; Leukemia, Lymphoid; Myocardial Infarction; Neoplasm Metastasis; Paper; Waldenstrom Macroglobulinemia | 1969 |
[A study of the mucopolysaccharide-thrombogenic mechanism predisposing to myocardial infarct].
Topics: Adult; Aged; Blood Coagulation Factors; Fibrinogen; Glycosaminoglycans; Heparin; Humans; Middle Aged; Myocardial Infarction | 1969 |
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
Topics: Adult; Agglutination Tests; Arthritis, Rheumatoid; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral; Erythrocytes; False Negative Reactions; False Positive Reactions; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemagglutination Inhibition Tests; Hodgkin Disease; Humans; Immunoassay; Immunodiffusion; Kidney Diseases; Liver Cirrhosis; Lymphoma, Non-Hodgkin; Male; Methods; Middle Aged; Myocardial Infarction; Neoplasms; Plasminogen; Staphylococcus | 1970 |
Changes in platelet adhesiveness, blood coagulation and fibrinolysis before and after the development of myocardial infarction. Investigation in 3 cases.
Topics: Aged; Blood Cell Count; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Factor V; Factor X; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Prothrombin Time; Trypsin Inhibitors | 1970 |
Detection of hypercoagulable states with protamine sulphate tests.
Topics: Aminocaproates; Animals; Blood Coagulation; Blood Coagulation Disorders; Chlorides; Densitometry; Disseminated Intravascular Coagulation; Dogs; Endotoxins; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Mercury; Methods; Myocardial Infarction; Protamines; Rabbits; Sulfates; Thromboembolism | 1972 |
[Fibrinolytic activity of the blood in the human coronary vessels].
Topics: Arteriosclerosis; Blood Specimen Collection; Cardiac Catheterization; Coronary Disease; Coronary Vessels; Electric Countershock; Enzyme Activation; Enzyme Repression; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Hypertension; Myocardial Infarction; Plasminogen; Radiography | 1974 |
[Nonenzymatic fibrinolysis in patients with ischemic heart disease].
Topics: Adult; Aged; Blood Coagulation Tests; Blood Platelets; Coronary Disease; Epinephrine; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Middle Aged; Myocardial Infarction; Plasminogen; Prothrombin; Thrombin | 1974 |
[Anticoagulant therapy with "regulated hypocoagulation of the blood" in the initial period of myocardial infarct].
Topics: Blood Coagulation Tests; Drug Evaluation; Ethyl Biscoumacetate; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Male; Myocardial Infarction; Plasminogen; Thrombin; Time Factors | 1974 |
[Correlation between indices of hemocoagulation and lipid metabolism in patients with myocardial infarct].
Topics: Adult; Aged; Blood Coagulation; Blood Platelets; Cholesterol; Fibrinogen; Fibrinolysis; Heparin; Humans; Lipid Metabolism; Lipids; Lipoproteins, LDL; Middle Aged; Myocardial Infarction; Triglycerides | 1974 |
About increase of aggregation of red cells with an increase of temperature in normal and abnormal blood (i.e. cancer). Effect of ABO blood groups and proteins.
Topics: ABO Blood-Group System; Anticoagulants; Blood Donors; Blood Group Antigens; Blood Proteins; Blood Sedimentation; Blood Viscosity; Cell Aggregation; Edetic Acid; Erythrocytes; Fibrinogen; Hematocrit; Hot Temperature; Humans; Myocardial Infarction; Neoplasms; Serum Albumin; Vascular Diseases | 1973 |
Intravascular coagulation in acute renal failure after myocardial infarction.
Topics: Acute Kidney Injury; Aged; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Heparin; Humans; Kidney; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic | 1974 |
[Study of hemostasis in patients with myocardial infarct and its prognostic significance].
Topics: Age Factors; Blood Coagulation; Blood Coagulation Tests; Fibrin; Fibrinogen; Fibrinolysis; Globulins; Humans; Leukocytes; Myocardial Infarction; Prognosis | 1974 |
[Pathogenetic aspects of cellular hemostasis in ischemic heart disease].
Topics: Adenosine Diphosphate; Angina Pectoris; Arteriosclerosis; Basophils; Blood Coagulation; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation | 1974 |
[The phenomenon of oblique frequency distribution as exemplified by blood clotting factors. A neglected problem].
Topics: Acute Disease; Blood Coagulation Factors; Chronic Disease; Fibrinogen; Humans; Kidney Diseases; Myocardial Infarction; Probability; Prothrombin; Pulmonary Embolism; Thrombin | 1974 |
Fibrin degradation products and the 125I-labeled fibrinogen test in patients with myocardial infarction.
Topics: Adult; Aged; Animals; Antibodies; Aspartate Aminotransferases; Bronchitis; Bronchopneumonia; Erythrocytes; Female; Fibrin; Fibrinogen; Humans; Injections, Intravenous; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Sheep; Thrombophlebitis | 1974 |
[Animal experiments on the effect of mechanical assistance of circulation with the intra-aortal balloon pump on the coagulation system].
Topics: Adult; Aged; Animals; Aorta, Thoracic; Assisted Circulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Dogs; Factor IX; Factor V; Factor VIII; Factor X; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Prothrombin Time; Time Factors | 1972 |
Immunologic study of fibrinogen and its split products in venous thrombosis.
Topics: Adult; Anticoagulants; Blood Cell Count; Blood Platelets; Ethyl Biscoumacetate; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Fluorescent Antibody Technique; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Neutrophils; Phagocytosis; Phenformin; Phlebography; Platelet Adhesiveness; Pulmonary Embolism; Pyrazoles; Thrombophlebitis; Time Factors | 1972 |
Influence of ABO blood groups and fibrinogen on thrombus formation and aggregation of red cells in cardiovascular and malignant diseases: new aspects of biorheological characterization of disease.
Topics: ABO Blood-Group System; Blood Coagulation; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cell Aggregation; Diabetes Mellitus; Erythrocytes; Fibrinogen; Graft Rejection; Hematocrit; Hemophilia A; Humans; Hyperthyroidism; Kidney Failure, Chronic; Kidney Transplantation; Melanoma; Myocardial Infarction; Prognosis; Rheology; Serum Albumin; Thrombosis; Transplantation, Homologous | 1973 |
The use of anticoagulants in the prevention of venous thrombosis after myocardial infarction.
Topics: Adult; Aged; Anticoagulants; Catheterization; False Positive Reactions; Female; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Thrombophlebitis; Warfarin | 1972 |
Density gradient separation of human platelets from plasma and the role of plasma in adenosine diphosphate induced platelet electrophoretic mobility changes.
Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Centrifugation, Density Gradient; Electrophoresis; Fibrinogen; Humans; Myocardial Infarction; Phosphatidylcholines; Plasma; Platelet Adhesiveness | 1972 |
Early determination of serum fibrin-fibrinogen degradation products in an intensive care unit.
Topics: Arrhythmias, Cardiac; Burns; Diabetic Coma; Fibrin; Fibrinogen; Heart Failure; Humans; Intensive Care Units; Lung Diseases, Obstructive; Myocardial Infarction; Poisoning; Shock, Cardiogenic; Tetanus | 1972 |
The 125I fibrinogen test and its uses.
Topics: Adult; Age Factors; Aged; Dextrans; Female; Fibrinogen; Humans; Injections, Intravenous; Iodine Radioisotopes; Methods; Middle Aged; Myocardial Infarction; Occlusive Dressings; Phlebography; Physical Exertion; Pregnancy; Puerperal Disorders; Surgical Procedures, Operative; Thrombophlebitis | 1972 |
[Fibrinogen-fibrin degradation products (FDP) in patients with various diseases].
Topics: Adolescent; Adult; Angina Pectoris; Chronic Disease; Diabetes Mellitus; Female; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Neoplasms | 1972 |
[Plasmatic haptoglobin in chronic coronary disease and in myocardial infarct. Physiopathological significance. Diagnostic importance].
Topics: Arteriosclerosis; Chronic Disease; Coronary Disease; Fibrinogen; Haptoglobins; Humans; Myocardial Infarction | 1973 |
[Mechanisms of stimulating effect of alcohol in the development of myocardial infarct].
Topics: Adult; Alcoholic Intoxication; Blood Coagulation; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction | 1973 |
The diagnosis of acute fibrinous pericarditis using 125 I labelled fibrinogen.
Topics: Acute Disease; Aged; Female; Fibrinogen; Heart Auscultation; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Pericarditis; Radionuclide Imaging | 1973 |
Venous thromboses in myocardial infarction. Comparison in heparin dosage.
Topics: Acute Disease; Female; Fibrinogen; Heart Failure; Heparin; Humans; Injections, Intravenous; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Thrombophlebitis | 1973 |
The clinical significance of the plasminogen level.
Topics: Adolescent; Adult; Afibrinogenemia; Blood Coagulation Tests; Contraceptives, Oral; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Infections; Liver Cirrhosis; Male; Menstruation; Middle Aged; Myocardial Infarction; Neoplasms; Plasminogen; Sex Factors; Surgical Procedures, Operative; Thrombosis; Wounds and Injuries | 1973 |
Prognostic value of serum fibrinogen-related antigen levels after myocardial infarction.
Topics: Antigens; Fibrinogen; Humans; Myocardial Infarction; Prognosis; Thrombophlebitis; Time Factors | 1973 |
[Differential sex-dependent biomorphosis of fibrinogen metabolism].
Topics: Adult; Age Factors; Aged; Female; Fibrinogen; Hepatitis A; Humans; Male; Middle Aged; Myocardial Infarction; Pneumonia; Sex Factors | 1973 |
Viscosity of blood in patients with myocardial infarction, haemophilia and thyroid diseases. Effect of fibrinogen, albumin and globulin.
Topics: Blood Coagulation; Blood Viscosity; Fibrinogen; Hemophilia A; Humans; Hyperthyroidism; Hypothyroidism; Myocardial Infarction; Serum Albumin; Serum Globulins; Stress, Mechanical; Thrombosis; Thyroid Diseases | 1973 |
[Blood lipid content and the coagulation system in coronary insufficiency in young persons].
Topics: Adult; Blood Coagulation; Fibrinogen; Fibrinolysis; Humans; Lipids; Male; Middle Aged; Myocardial Infarction | 1973 |
Leg vein thrombosis diagnosed by 125I-fibrinogen test after acute myocardial infarction.
Topics: Acute Disease; Adult; Age Factors; Aged; Anticoagulants; Female; Fibrinogen; Heart Failure; Humans; Iodine Radioisotopes; Leg; Male; Methods; Middle Aged; Myocardial Infarction; Sex Factors; Tachycardia; Thrombophlebitis; Time Factors; Ventricular Fibrillation | 1973 |
Quantitation of plasma fibrinogen in the presence of fibrinogen degradation products.
Topics: Animals; Barbiturates; Buffers; Cattle; Chromatography, Gel; Clot Retraction; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Hydrogen-Ion Concentration; Immune Sera; Immunoelectrophoresis; Methods; Myocardial Infarction; Phosphates; Prothrombin Time; Rabbits | 1973 |
The influence of fibrinogen degradation products on the reptilase-time of plasma.
Topics: Animals; Blood Coagulation; Chromatography, DEAE-Cellulose; Fibrin; Fibrinogen; Fibrinolytic Agents; Glycine; Heparin; Humans; Hydrogen-Ion Concentration; Myocardial Infarction; Peptide Hydrolases; Prothrombin Time; Rabbits; Snakes; Thrombin; Venoms | 1973 |
Quantitative biochemical changes in rats following isoproterenol-induced myocardial infarction.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Proteins; Blood Sedimentation; Densitometry; Fibrinogen; Iron; Isoproterenol; L-Lactate Dehydrogenase; Lactates; Lipids; Male; Myocardial Infarction; Necrosis; Neuraminic Acids; Pentaerythritol Tetranitrate; Rats; Time Factors | 1973 |
[Fibrinolysis in acute myocardial infarct with increased risk].
Topics: Acute Disease; Adult; Aged; Austria; Blood Viscosity; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Streptokinase | 1973 |
A novel approach to evaluate the validity of thrombolytic treatment in acute myocardial infarction.
Topics: Acid-Base Equilibrium; Acute Disease; Blood Pressure; Blood Viscosity; Cardiac Output; Catecholamines; Central Venous Pressure; Coronary Care Units; Echocardiography; Electrocardiography; Fatty Acids, Nonesterified; Fibrinogen; Heart Ventricles; Humans; Hydrocortisone; Hydrogen-Ion Concentration; Kymography; Lactates; Myocardial Infarction; Myocardium; Pulmonary Artery; Radionuclide Imaging; Streptokinase; Time Factors; Vascular Resistance | 1973 |
The frequency of deep venous thrombosis in patients with acute myocardial infarction judged by the 125-I-tagged human fibrinogen technique.
Topics: Acute Disease; Aged; Denmark; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Thrombophlebitis | 1973 |
Potential significance of plasma viscosity and hematocrit variations in myocardial ischemia.
Topics: Blood Flow Velocity; Blood Pressure; Blood Viscosity; Coronary Circulation; Coronary Disease; Fibrinogen; Heart Ventricles; Hematocrit; Humans; Mathematics; Models, Theoretical; Myocardial Infarction | 1974 |
Value of determination of serum fibrin-fibrinogen degradation products in acute myocardial infarction.
Topics: Aged; Aspartate Aminotransferases; Creatine Kinase; Female; Fibrin; Fibrinogen; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Prognosis | 1974 |
Editorial: The cause-effect relationship between recent coronary artery occlusion and acute myocardial infarction.
Topics: Autopsy; Coronary Disease; Fibrinogen; Iodine Radioisotopes; Myocardial Infarction | 1974 |
Letter: Thrombosis and myocardial infarction.
Topics: Acidosis; Death, Sudden; Fibrinogen; Humans; Hypoxia; Myocardial Infarction; Thrombosis; Time Factors | 1974 |
[Coronary thrombosis in acute myocardial infarct, is it a primary or secondary phenomenon?].
Topics: Acute Disease; Aged; Autopsy; Coronary Disease; Electrocardiography; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Myocardial Infarction; Necrosis; Thrombosis; Time Factors | 1974 |
Influence of smoking on deep vein thrombosis after myocardial infarction.
Topics: Age Factors; Aged; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Smoking; Thrombophlebitis; Varicose Veins | 1974 |
Increased incidence of deep vein thrombosis after myocardial infarction in non-smokers.
Topics: Age Factors; Aged; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Middle Aged; Myocardial Infarction; Smoking; Thrombophlebitis; Varicose Veins | 1974 |
The possible use of 125I-labeled fibrinogen for the detection of mural thrombosis following myocardial infarction.
Topics: Aged; Autopsy; Cardiac Tamponade; Electrocardiography; Fibrinogen; Hemiplegia; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Pericarditis; Thrombophlebitis; Thrombosis; Time Factors; Ventricular Fibrillation | 1974 |
Thrombolytic therapy with streptokinase.
Topics: Embolism; Fibrinogen; History, 20th Century; Myocardial Infarction; Plasminogen; Prothrombin Time; Pulmonary Embolism; Streptokinase; Thromboembolism; Thrombophlebitis; Thrombosis | 1970 |
[Fibrinolytic therapy in severe angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Blood Platelets; Blood Viscosity; Electrocardiography; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Streptokinase; Time Factors | 1971 |
The diagnosis of deep vein thrombosis using the 125 I fibrinogen test.
Topics: Abdomen; Adult; Aged; Cesarean Section; Female; Femoral Neck Fractures; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Myocardial Infarction; Phlebography; Pregnancy; Prostatectomy; Puerperal Disorders; Thrombophlebitis; Vagina; Veins | 1972 |
[Sexual differences in fibrinogen during aging].
Topics: Adolescent; Adult; Aged; Aging; Child; Female; Fibrinogen; Hepatitis A; Humans; Male; Middle Aged; Myocardial Infarction; Pneumonia; Regeneration; Sex Factors | 1972 |
[Use of anticoagulants in myocardial infarct].
Topics: Adult; Aged; Anticoagulants; Blood Pressure; Evaluation Studies as Topic; Female; Fibrinogen; Heart Aneurysm; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Rupture; Thrombelastography | 1972 |
The I 125 -labeled fibrinogen test and phlebography in the diagnosis of deep vein thrombosis.
Topics: Adult; Delivery, Obstetric; Female; Fibrinogen; Fractures, Bone; Genital Diseases, Female; Humans; Iodine Radioisotopes; Leg; Male; Methods; Middle Aged; Myocardial Infarction; Phlebography; Postoperative Complications; Prostatectomy; Thrombophlebitis; Time Factors | 1972 |
Levels of soluble fibrin monomer complexes in the course of myocardial infarction.
Topics: Adult; Arteriosclerosis; Coronary Disease; Diagnosis, Differential; Fibrin; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Prognosis; Protamines; Serum Globulins | 1972 |
Sequential changes of plasma proteins after myocardial infarction.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Blood Sedimentation; C-Reactive Protein; Ceruloplasmin; Female; Fibrinogen; Haptoglobins; Humans; Immunoglobulins; L-Lactate Dehydrogenase; Male; Middle Aged; Mucoproteins; Myocardial Infarction; Trypsin Inhibitors | 1972 |
Plasma 125 I-labelled fibrinogen clearance in diagnosis of deep venous thrombosis after myocardial infarction.
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Leg; Metabolic Clearance Rate; Myocardial Infarction; Myocardium; Thrombophlebitis | 1972 |
Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to "risk factors" for myocardial infarction.
Topics: Blood Coagulation; Blood Glucose; Blood Pressure; Body Constitution; Body Weight; Cholesterol; Factor VII; Factor VIII; Factor X; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Obesity; Plasminogen; Prothrombin; Sampling Studies; Skinfold Thickness; Smoking; Spirometry; Thromboplastin; Triglycerides; Vital Capacity | 1972 |
[Diagnostic value of some blood indices in myocardial infarct].
Topics: C-Reactive Protein; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction | 1971 |
Blood hypercoagulability, thrombosis, and acute myocardial infarction.
Topics: Acute Disease; Blood Coagulation Disorders; Chromatography; Fibrin; Fibrinogen; Humans; Myocardial Infarction; Thrombosis | 1971 |
Blood rheological abnormalities complicating blood hypercoagulable-thrombotic states.
Topics: Blood Coagulation; Blood Viscosity; Chromatography; Fibrinogen; Humans; Myocardial Infarction; Rheology; Thrombosis | 1971 |
[The value of some humoral indices in the differential diagnosis of micro- and macrofocal myocardial infarcts].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Blood Sedimentation; C-Reactive Protein; Cholesterol; Clinical Enzyme Tests; Diagnosis, Differential; Fibrinogen; Focal Infection; Fructose-Bisphosphate Aldolase; Humans; Leukocyte Count; Myocardial Infarction | 1971 |
Study of plasma fibrinogen and fibrinolytic activity in acute myocardial infarction.
Topics: Aspartate Aminotransferases; Blood Sedimentation; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction | 1971 |
[Biological half-life of fibrinogen labelled with radioactive iodine I-131 in coronary disease].
Topics: Adult; Aged; Blood Coagulation; Cardiovascular Diseases; Coronary Disease; Ethyl Biscoumacetate; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction | 1970 |
Diffusion of plasma proteins into cells: a manifestation of cell injury in human myocardial ischemia.
Topics: Adult; Aged; Blood Proteins; Child, Preschool; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Infant; Male; Middle Aged; Mortality; Myocardial Infarction; Serum Albumin; Serum Globulins | 1967 |
Reaction pattern to three stresses--electroplexy, surgery, and myocardial infarction--of fibrinolysis and plasma fibrinogen.
Topics: Adult; Electroshock; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Serum Globulins; Stress, Physiological; Surgical Procedures, Operative | 1969 |
Plasma protein electrophoretic pattern and blood viscosity in arteriosclerotic heart disease.
Topics: Aged; Anticoagulants; Blood Protein Electrophoresis; Blood Viscosity; Cholesterol; Coronary Disease; Fibrinogen; Humans; Lipoproteins; Myocardial Infarction | 1970 |
[Functional state of the thrombocytes and blood coagulation in patients with myocardial infarct complicated by shock].
Topics: Adult; Aged; Blood Cell Count; Blood Coagulation; Blood Platelets; Capillaries; Cell Adhesion; Cell Aggregation; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Thrombelastography; Thrombosis; Time Factors | 1970 |
[Age characteristics of the changes in the blood coagulation and anticoagulation system in patients with acute coronary insufficiency].
Topics: Adult; Aged; Aging; Angina Pectoris; Antithrombins; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Thrombelastography; Thrombin | 1970 |
A study of plasma fibrinogen content and its fibrinolytic activity following acute myocardial infarction.
Topics: Acute Disease; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction | 1970 |
The rheology of red blood cell aggregates.
Topics: Anemia, Sickle Cell; Blood Proteins; Blood Viscosity; Elasticity; Erythrocyte Aggregation; Fibrinogen; Humans; Microcirculation; Myocardial Infarction; Osmotic Pressure | 1970 |
[Observations on the fibrinogen consumption rate in thrombotic and hemorrhagic disorders].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fibrinogen; Hemophilia A; Hemorrhage; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Myocardial Infarction; Raynaud Disease; Thrombophlebitis; Thrombosis | 1970 |
[State of the blood coagulation and anti-coagulation system in patients with chronic coronary insufficiency in the post-infarct period].
Topics: Blood Coagulation; Chronic Disease; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Myocardial Infarction; Prothrombin; Thrombin; Thrombosis | 1971 |
Fibrinogen degradation products.
Topics: Cerebrovascular Disorders; Disseminated Intravascular Coagulation; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Liver Cirrhosis; Myocardial Infarction; Neoplasms; Pulmonary Embolism; Vascular Diseases | 1971 |
[Behavior of the blood compensating system in patients with cardiac infarction in the light of recent studies. I. Behavior of fibrinogen and fibrinolytic activity].
Topics: Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction | 1967 |
[Some indices of coagulograms and thrombelastograms in person having sustained myocardial infarction under 40 years of age].
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Humans; Myocardial Infarction; Thrombelastography | 1967 |
[Whole-blood viscosity and myocardial infarction].
Topics: Aged; Blood Viscosity; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Rheology | 1967 |
[Statistical and clinical study of the significance of fibrinogenemia in the course of myocardial infarct].
Topics: Adult; Aged; Anticoagulants; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; Prognosis; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1967 |
[Problem of the differential diagnosis and therapy of climacteric cardiopathy].
Topics: Adult; Aged; Aging; Angina Pectoris; Aspartate Aminotransferases; Blood Sedimentation; Body Temperature; C-Reactive Protein; Climacteric; Coronary Disease; Diagnosis, Differential; Electrocardiography; Estradiol; Female; Fibrinogen; Heart Diseases; Humans; Leukocyte Count; Male; Menopause; Methyltestosterone; Middle Aged; Myocardial Infarction; Pain; Serum Globulins; Testosterone | 1967 |
Hemorrheologic observations in acute myocardial infarction.
Topics: Blood Proteins; Blood Viscosity; Dextrans; Erythrocyte Aggregation; Fibrinogen; Glucose; Hematocrit; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Rheology | 1968 |
Failure of safflower oil hyperlipemia to inhibit limitation of the size of experimental streptokinase-treated myocardial infarction.
Topics: Animals; Blood Coagulation Tests; Coronary Disease; Dogs; Fatty Acids, Essential; Fibrinogen; Fibrinolysis; Hyperlipidemias; Myocardial Infarction; Myocardium; Prothrombin Time; Streptokinase; Thrombelastography | 1968 |
[On closed heart injuries].
Topics: Adolescent; Adult; Aged; Child; Fibrinogen; Heart Injuries; Heart Septum; Heart Valves; Humans; Male; Middle Aged; Myocardial Infarction; Rupture | 1968 |
[Hydrocortisone, nonesterified fatty acids and the blood coagulation system in acute myocardial infarct].
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Cholesterol; Fatty Acids, Nonesterified; Fibrinogen; Fibrinolysis; Heparin; Humans; Hydrocortisone; Middle Aged; Myocardial Infarction; Prothrombin Time | 1968 |
[On some clinical and humoral changes during the 3d week of disease with myocardial infarct].
Topics: 17-Ketosteroids; Adult; Aged; Angina Pectoris; Blood Sedimentation; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies | 1968 |
[The prognostic value of certain humoral changes in myocardial infarct].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Blood Sedimentation; C-Reactive Protein; Cholesterol; Fibrinogen; Fructose-Bisphosphate Aldolase; Humans; Leukocyte Count; Myocardial Infarction; Prothrombin | 1968 |
[Studies on blood clotting disorders in patients with myocardial infarction and angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Blood Coagulation Disorders; Fibrinogen; Heparin; Humans; Middle Aged; Myocardial Infarction | 1968 |
[Clinical significance of plasma fibrinogen].
Topics: Adolescent; Adult; Afibrinogenemia; Aged; Animals; Dextrans; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Rabbits | 1968 |
A study of myocardial infarction. Procedures of important laboratory investigations.
Topics: Blood Viscosity; Erythrocytes; Fibrinogen; Humans; Methods; Myocardial Infarction | 1968 |
[Thrombogenesis in atherosclerosis of the coronary arteries].
Topics: Arteriosclerosis; Blood Coagulation Disorders; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction | 1968 |
Diagnosis of suspected or occult pulmonary embolus.
Topics: Adult; Female; Fibrin; Fibrinogen; Humans; Immunoassay; Myocardial Infarction; Pulmonary Embolism | 1969 |
[Cryofibrinogenemia in endangiitis obliterans with myocardial infarct and multiple thromboses].
Topics: Blood Protein Disorders; Fibrinogen; Humans; Myocardial Infarction; Thromboangiitis Obliterans; Thromboembolism | 1966 |
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease.
Topics: Adolescent; Adult; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen | 1966 |
[The diagnostic significance of plasma fibrinogen in myocardial infarct and the angina pectoris syndrome].
Topics: Adult; Aged; Angina Pectoris; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction | 1966 |
[Qualitative changes in fibrinogen in rheumatism and coronary insufficiency].
Topics: Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Rheumatic Fever | 1966 |